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Abstract 
This thesis reports the syntheses and DNA binding properties of a number of novel DNA 
binding complexes. 
A library of ruthenium(II) and rhenium(I) complexes incorporating extended terpyridine 
type ligands has been synthesised (1). 
The library consists of a series of structurally related complexes in which we have varied 
the number of hydrogen bonding sites, charge, chirality and steric demand on the 
complexes. Experimental data offers clear evidence that these complexes interact with 
DNA, possibly in an intercalative mode, and that varying the characteristics above has 
significant effects on the nature of the interaction with DNA. 
Furthermore a series of achiral mono (2) and bimetallic complexes of ruthenium(II) (3) 
and rhenium(I) (4) incorporating the well-characterised intercalating domain dppz have 
been assembled. The novel achiral ruthenium system shows good affinity for CT-DNA 
and there is a 13-fold increase in binding affinity for the di-cationic complex over the 
mono-cationic complex. The binding of the di-rhenium and bis-ruthenium complexes 
show increased affinity for CT-DNA however bis-intercalation is not seen and the major 
contribution to the interaction comes from electrostatic and groove binding interactions. 
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Introduction 
1.1 DNA-the molecule of life 
Deoxyribose nucleic acid (DNA) is described as a chemical repository for 
the genetic information of an organism. This apparently "simple" bio- 
polymer, consisting of four distinct building blocks, is capable of storing, 
retrieving and processing immense amounts of genetic information 
quickly and efficiently upon cellular demand. The information stored 
within the DNA in the form of the genetic code, governs every 
characteristic of every living species on earth. 
DNA is designed in such a way that it can be easily copied, allowing vital 
information to be passed on from generation to generation. Although the 
information is never lost it is sometimes altered, either as a result of 
breeding where the individual genetic characteristic from the father and 
the mother is mixed, or as a result of a physical alteration such as miss- 
copying or damage sustained from an external source. These alterations 
are called mutations and often trigger a cascade of events that eventually 
lead to the host developing a disadvantageous condition such as some 
form of disease or a characteristic that will enable it to become fitter and 
stronger than before. 
Over the last half-century, scientists have begun to unlock many of the 
mechanisms of the processes surrounding the function of DNA, such as 
replication, damage repair, transcription and its function in the cell cycle. 
It is now the ultimate goal of genetic scientists to gain control of the 
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functions of DNA by designing novel molecular scale tools and probes 
that can be easily introduced to the cell and perform specific pre- 
determined tasks. One such goal is to be able to selectively switch a 
gene on or off in a process called 'gene modulation' and this thesis 
describes a small step towards this goal through the use of metal-based 
DNA binding agents. 
If a mutation occurs in a gene, which has a marked negative affect on its 
host, the ability to switch this gene off and stop it being replicated 
throughout the host, or even repair the gene on the chromosome would 
be a priceless commodity in the fight against disease. 
The primary feature of any natural or synthetic molecule that interacts 
with DNA is its ability to form a tight pre-defined complex with the DNA 
molecule. That means that the targeting molecule must be able to read 
the genetic code for itself, so that it can be sure to bind to the correct site 
or gene on a DNA molecule that contains many hundreds of thousands of 
potential binding sites. In order to achieve this, one must have an 
understanding of the structural and physical characteristics of DNA that 
can be exploited in the design of site-specific DNA binding molecules. 
1.2 The structure of DNA2 
DNA is a biopolymer made from four code-dependant alternating sub 
units of nucleotides, consisting of a nucleoside bonded through a 5' 
phosphate ester linkage to phosphoric acid. A nucleoside is a 2' deoxy 
ribose sugar with a heterocyclic amine base bonded to the C1 carbon of 
the ribose sugar (Figure 1.1). 
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Figure 1.1: - A nucleoside (A) and a nucleotide (B) 
B 
The polymer is formed by the 5' phosphoric acid forming another 
phosphate ester linkage to 3' hydroxyl of an adjacent nucleotide. 
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Figure 1.2: - Schematic of DNA showing the 5'-43' polarity of the 
structure 
1.2.1 The DNA bases and Watson-Crick base pairing' 
The code that DNA stores so effectively is made up of four "letters" which 
represent the four DNA bases. The purine bases are adenine (A) and 
guanine (G) and pyrimidine bases are thymine (T) and cytosine (C) 
(Figure 1.3). 
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Adenine (A) Guanine (G) 
Figure 1.3: - The DNA bases 
Thymine (T) 
NHýL0 
Cytosine (C) 
In the early 1950s when Watson and Crick were working investigating the 
structure of DNA, they made the observation that wherever an A 
appeared in the sequence it was always paired with T. Likewise 
wherever G appeared it was always paired with C. This led them to 
propose that DNA consisted of two complementary strands which were 
held together through hydrogen bonds between complementary base 
pairs TA and GC (Figure 1.4). 
H 
N-H-------- 0 
N -H-N 
N 
O 
A T 
N 0--------- H-N 
N -H -------- 
/\ 
N={ /N 
N- H--------0 
H 
GC 
Figure 1.4: - The complementary hydrogen bonding in DNA base pairs 
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1.2.2 The DNA helix' 
With the help of an X-ray diffraction pattern and the knowledge of DNA 
base-pairing Watson and Crick were able to propose a complete 
structural model of DNA. 
The important features of their model are: 
1. Two helical polynucleotide chains are coiled around a common 
core. 
2. The purine and pyrimidine bases are stacked along the central axis 
of the helix whereas the phosphate and deoxyribose units are on 
the outside of the helix. The planes of the bases are perpendicular 
to the central axis 
3. The diameter of the helix is 20 A. Adjacent bases are separated 
by 3.4 A along the helical axis and are offset by a rotation of 36°. 
Hence the helical structure repeats after ten residues on each 
chain. 
4. The two chains run in opposite directions and are held together by 
hydrogen bonds between the base pairs. Each base pair consists 
of one pyrimidine and one purine. 
5. The sequence of bases along a polynucleotide chain is not 
restricted in any way. The precise sequence of bases carries the 
genetic code. 
Due to steric restrictions, each base pair consists of a purine and a 
pyrimidine base. The regular nature of the helical phosphate backbone 
means that the glycosidic bonds that attach the deoxyribose sugars to the 
bases are always 10.85 A apart. A purine-pyrimidine base pair fits 
perfectly into this space. There is insufficient space for two purines but 
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too much for two pyrimidines meaning they would be placed too far apart 
for any hydrogen bonding interaction to occur. 
1.2.3 The major and minor grooves2 
A consequence of the helical structure of DNA is that there are two helical 
grooves that run the entire length of the DNA molecule. These are called 
the major and the minor groove (Figure 1.5). The major groove is wider 
(12 A) than the minor groove (6 A). The bases themselves can be 
accessed from both the major and the minor groove, allowing molecules 
such as proteins and other small molecules to read the code and bind to 
the DNA molecule sequence specifically. 
Figure 1.5: - Picture of DNA showing the major and minor grooves 
1.3 The function of DNA' °2 
The information stored in the genetic code needs to be replicated upon 
demand, conserved through generations and decoded in order to carry 
out everyday cellular functions. The overall process of copying, and 
decoding has been termed the "central dogma" of molecular genetics. 
6 
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1.3.1 The central dogma of molecular genetics 
According to the central dogma of molecular genetics, the function of 
DNA is to store genetic information and pass it onto RNA, and the 
function of RNA is to read, decode and use the information to make 
proteins. 
C Replication 
DNA 
Transcription 
RNA 
Translation Protein 
Replication is the process by which a identical copy of DNA is made. 
Replication occurs every time a cell divides so that the information can be 
preserved and passed onto the new cell. 
Transcription is the process by which genetic messages contained in 
DNA are read or transcribed. The product of transcription, messenger 
RNA (mRNA) leaves the cell nucleus and carries the protein blueprint to 
the sites of protein synthesis within the cell called the ribosome. 
Translation is the process by which genetic messages carried in the 
mRNA is decoded and used to build proteins. 
1.3.2 DNA replication 
DNA replication begins with a partial unwinding of the DNA double helix, 
at an area known as the replication fork. One of the DNA strands is first 
of all nicked and broken by DNA topoisomerase, which results in the loss 
of tension that keeps the DNA in its coiled and super-coiled state within 
the chromosome. Then the unwinding of the original DNA double helix is 
accomplished by DNA helicase. The unwound section of the DNA 
appears as a bubble when viewed under an electron microscope and is 
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thus known as the replication bubble. The starting point for the DNA 
synthesis is a small RNA primer, which is placed in position by RNA 
primase. DNA polymerase is an aggregate of several different protein 
subunits, called a holoenzyme. The holoenzyme then recruits free 
deoxynuclotide triphosphates (dNTP's) to hydrogen bond to their 
complementary bases on the template strand. DNA polymerase is 
described as being template dependent. It will read the sequence of 
bases on the template strand, then synthesise the complementary 
information strand, but it can only read the template strand in the 3-+ 5' 
directions. The dNTP's are then joined together by the reaction of the free 
3' hydroxyl of the primer with the triphosphate on the 5' end of the 
adjacent dNTP. The result is that the new complementary DNA strand 
can only grow in the 5'-+3' direction. Because the parent DNA strands 
are complementary and run anti-parallel only one new strand can begin 
with its 3' end adjacent to the replication fork and grow continuously as 
the replication fork moves along the DNA. This is called the leading 
strand. The other strand (the lagging strand) must grow in the opposite 
direction. This is achieved by the formation of a number of short sections 
of DNA called Okazaki fragments. These fragments are ligated together 
by DNA ligase to form a continuous strand of DNA. In the final step of the 
process DNA polymerase III removes the RNA primer and replaces it with 
DNA bases to form the full DNA strand, which will be exactly 
complementary to the original template strand (Figure 1.6). 
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3' 
leading strand primer 
replication fork //new strand 
3' 
original strand 
ýaki fragment 
lagging strand 
5' 
Figure 1.6: - Schematic of replication 
Dc: x = original strand 
newly synthesized strand 
Figure 1.7: - Conservative, and semi-conservative modes of replication 
Since each new strand is complementary to its template strand, two 
identical new copies of the DNA double helix are produced during 
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replication. In each new helix, one strand is the old template and one is 
newly synthesised. The replication process is therefore described as 
semi-conservative (Figure 1.7). Crick described this process as being like 
a hand in a glove. The hand and glove separate, a new hand forms 
inside the old glove and a new glove forms around the old hand2. 
1.3.3 Structure and function of RNA2 
Ribose nucleic acid (RNA) is structurally very similar to DNA, with a few 
significant differences. The sugar in RNA is ribose rather than 2'- 
deoxyribose and the base thymine is replaced by urasil in RNA. RNA 
molecules are also shorter and exist only as single strands, although 
double stranded portions can be formed when the RNA folds and 
hydrogen bonds to itself. The sole function of DNA is to store genetic 
information, but there are a number of types of RNA all with differing 
functions in the cell. 
1. Ribosomal RNA (rRNA) exists outside of the cell nucleus in the 
cytoplasm of the cell in structures called ribosomes. Ribosomes are 
small granular structures where protein synthesis takes place. Each 
ribosome is a complex consisting of about 60% rRNA and 40% 
protein. 
2. Messenger RNA (mRNA) records the information stored in the DNA 
within the cell nucleus and carries it to the ribosome where it is 
decoded and used to direct the biosynthesis of proteins. 
3. Transfer RNA (tRNA) is used to deliver the correct amino acids one 
by one to protein chains growing at ribosomes. 
4. Small nuclear RNA (snRNA) is used to process the mRNA as it is 
transferred from the cell nucleus to the ribosome. 
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1.3.4 RNA synthesis: Transcription2 
Messenger RNA is synthesised in the cell by transcription of DNA, a 
process similar to DNA replication. Again a small segment of the DNA 
unwinds which exposes the bases of the two DNA strands. A DNA 
dependent RNA polymerase then lines up the ribonucleotides with their 
complementary bases on the DNA strand and then ligates them together 
to form mRNA. 
Unlike DNA replication where both strands of the DNA are copied, only 
one of the strands is transcribed into mRNA. The DNA strand that is 
transcribed is called the template strand or the antisence strand, and its 
complement is called the information strand (also called the coding or 
sense strand). Since the template strand and the information strand are 
complementary, and as the template strand and the mRNA molecule are 
also complementary, it follows that the mRNA produced during 
transcription is a copy of the DNA information strand. 
The synthesis of RNA by RNA-polymerase takes place in three distinct 
stages; 1) initiation, 2) elongation, and 3) termination. Transcription starts 
at specific sites called promoters. These promoters are regions of DNA 
rich in AT bases. RNA-polymerase is a holoenzyme consisting of four 
subunits. The sigma subunit recognises the promoter sequence and 
initiates mRNA synthesis. RNA synthesis proceeds in the 5'-), 3' direction 
analogous to DNA synthesis for the same reasons. The termination of 
transcription is as strictly governed as its initiation. The DNA template 
strand contains stop signals that stop the synthesis of the mRNA at the 
end of the gene, so that only information specific to any one given gene is 
transcribed to the mRNA. The termination signals for mRNA synthesis 
are normally denoted as a GC rich region of DNA, followed by an AT rich 
sequence. There is also a two-fold symmetry of the CG rich region, which 
allows the formation of a hairpin. 
11 
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1.3.2 Groove binding interactions 
When a molecule associates either in the major or minor groove of DNA it 
is said to be a groove-binding agent3. Because the DNA bases can be 
accessed through both of the grooves, there is enormous scope for 
sequence specific interactions. Figure 1.9 shows the recognition sites of 
A-T and G-C base pairs that are accessible in the major and minor 
grooves6. 
Major groove side 
T 
R 
'H \ 
_-H-N N Oýý 
N , H---N 
dR 
H---O dR 
r 
G-C 
1H 
'NH----O 
:: JN 
/N 
N---- N-N 
dR NJ dR 0 
Minor groove side A-T 
Figure 1.9: - Recognition sites accessible from the grooves of DNA 
The major groove contains the largest number of recognition sites. For A- 
T base pairs these include the adenine N-7 and thymine C-4 carbonyl as 
hydrogen bond acceptors, the adenine C-6 amine as a hydrogen bond 
donor and the thymine methyl group as stabilisation for van der Waals' 
interactions. For the G-C base pair, guanine N-7 and the guanine C-6 
carbonyl can function as hydrogen bond acceptors and the cytosine C-4 
amine can act as a hydrogen bond donor. The minor groove has far 
fewer recognition sites than the major groove. Despite this most minor 
groove-binding agents bind in the minor groove7. The G-C base pair 
contains guanine N-3 and the cytosine C-2 carbonyl as hydrogen bond 
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acceptors and the guanine C-2 amine as a hydrogen bond donor. The A- 
T base pair only has the adenine N-3 and the thymine C-2 carbonyl are 
available to act as hydrogen bond acceptor sites. The sequence 
selectivity of the binding has been shown to depend on a combination of 
hydrogen bonding, van der Waals' interactions and hydrophobic contacts 
3 with the bases and the walls of the groove, s 
Most minor groove binding ligands show an enhanced preference for A-T 
rich regions of DNA. This has been contributed to the steric protrusion of 
the C-2 amine of guanine above the floor of the minor groove, along with 
the narrower groove in A-T rich regions, which helps to maximise 
hydrophobic, and van der Waals' contacts between the molecule and the 
groove walls8. 
1.3.3 Netropsin and Distamycin as minor groove binders3 
The two naturally occurring minor groove binding anti-tumour antibiotics, 
Netropsin and Distamycin have been extensively studied. They provide a 
good example of the non-covalent interactions, which are important in 
directing sequence specific binding. 
14 
Chapter 1 Introduction 
NH 
H3N4 
N'\ H 
HN 
p uThc, N H 
NHs 
NN 
Me 0N NH 
0 Me 
Netropsin 
0 
Me 
NH NH3 
N NH 
O 
Me 
Distamycin 
Netropsin and Distamycin are both crescent shaped ligands containing 
two and three N-methylpyrrole carboxamides respectively. Foot printing 
and NMR experiments along with analysis of crystal structures has shown 
that Netropsin targets 5'-AATT-3' whilst Distamycin binds as a head to tail 
dimer and targets 5'-AAATT-3' (Figure 1.10). 
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A) 
6 
Figure 1.10: - Key hydrogen bonding interactions for A) Netropsin and B) 
Distamycin binding to AT rich DNA 
The crystal structure of Netropsin binding to the Dickerson dodecamer, 5'- 
d(CGCGAATTCGCG)2 shows van der Waals' interactions with the 
deoxyribose backbone lining the groove. The selectivity comes from 
three hydrogen bonds between the hydrogens on Netropsin and adenine 
N-3 or thymine C-2 carbonyl on adjacent base pairs of opposite strands. 
The two positive charges interact with the N-3 of the adenines flanking 
the binding site as well as forming a salt bridge secondary interaction with 
the phosphate backbone. Distamycin shows similar interaction to 
Netropsin. 
The high binding affinities (K=109 M) and selectivity of Netropsin and 
Distamycin have been attributed to the local short-range ligand DNA 
interactions rather than from any entropy driven process resulting from 
the displacement of ordered water from the minor groove and desolvation 
of the ligand itself. 
16 
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1.3.6 Intercalation 
Intercalation describes the process in which planar aromatic compounds 
insert between two adjacent base pairs in the DNA double helix. This 
stabilizes, lengthens, stiffens and unwinds duplex DNA. Interactions 
involved in intercalation are it-n stacking interactions, dipole-dipole 
electronic interactions and hydrophobic interactions. The energetic cost 
of distorting the helix and disrupting the existing base pair stacks has a 
profound effect on the binding affinity and selectivity of the intercalating 
ligand. An informative account by Barton and Long addresses many of 
the confusing experimental criteria required to establish intercalation9. 
Simple intercalators such as ethidium bromide show little or no selectivity 
in their binding although they have a slight preference for G-C rich 
sequences of DNA3. 
Most intercalators bind best to mixed sequences of alternating purine 
pyrimidine bases. The neighbour exclusion principle states that 
intercalators can, at most, only bind at alternate base pair sites on DNA. 
However in practice the binding site size is larger than two base pairs due 
to the local disruption in the DNA duplex upon intercalation 3. 
7 Br 
NH2 
HiN 
N\ 
Ethidium bomide 
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Intercalators have proved to be particularly useful in the inhibition of 
polymerase activity because the duplex is stabilized and therefore harder 
to unwind. In addition the enzyme is unable to bind to the disrupted 
regions of DNA, which in turn results in the inhibition of replication, 
transcription, endonuclease activity or any other enzyme involved in DNA 
modification. There are a number of commercial anti-tumour drugs such 
as amasacrine that act by inhibiting topoisomerase II, which, as described 
earlier, is involved in winding and unwinding (super coiling) of DNA during 
transcription and replication. 
MeO 
/ 
NHSO2Me 
\I 
HN 
ýýý 
ýý ýi 
Amsacrine (m-AMSA) 
Amsacrine has been shown to bind selectively to alternating purine- 
pyrimidine sequences3. 
1.5 Metal complexes as DNA binding ligands 
Up until the late 1970s most of the synthetic and natural DNA binding 
molecules had been organic in nature. As researchers delineate on a 
molecular level how genetic information is expressed, a more complete 
understanding of how to target DNA sites with specificity is being 
developed. This in turn is leading to possible new chemotherapeutic 
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agents and probes such as transition metal complexes. The complexes 
of d6 transition metals have been found to be very suitable as DNA 
binding agents due to their inertness and stability under physiological 
conditions. Coupling this with their well-defined and tunable molecular 
architecture and their high solubility in aqueous media, there is huge 
potential for developing these molecules as site-specific DNA binding 
agents. 
The primary mode of binding for these transition metal complexes is 
intercalation and they have become known as metallointercalators. All 
the complexes studied contain an extended aromatic ligand, which 
protrudes away from the metal centre and is ideally set up for 
intercalation. It has also been shown that the nature of the ancillary 
ligands has a marked effect on the binding affinity and selectivity of these 
DNA binding molecules. By systematically changing the nature of these 
ancillary ligands it is possible to tune the DNA binding properties and the 
photo-reactive properties of the molecules. Moreover by taking 
advantage of the rich photophysical handles that these complexes poses 
it is easy to monitor and quantify their binding to DNA. Once the exact 
mode, strength and site-specificity of the binding has been determined it 
is possible (due to the rich photochemical and redox properties of these 
molecules) to perform chemistry on the DNA bases themselves. 
1.5.1 Early complexes incorporating phenanthroline and 
bipyridine ligands 
Lippard and co workers were the first to establish that a square planar 
metal complex containing an aromatic heterocyclic ligand could bind to 
DNA through intercalation10. Barton and co workers soon extended the 
complexes to three dimensions, when they started using octahedral metal 
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centres. The early studies focused on the tris(phenanthroline) complexes 
of zinc, cobalt and ruthenium (Figure 1.11)11.12. 
2+ ý2+ 
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A-[Ru(phen)3]2+ A-[Ru(phen)2]2` 
Figure 1.11: - The A&d-enantiomers of trisphen Ruthenium(II) 
Through NMR13 and photophysical studies 12,14. They suggested that the 
cationic tris-(phenanthroline) complexes bound to DNA through all three 
of the noncovalent modes discussed earlier. One important observation 
to come from these early studies was that there was a small but 
significant preference for the right-handed 0-isomer when bound to right- 
handed B-form DNA. However the binding modes and exact orientation 
of these tris-(phenanthroline) ruthenium(II) complexes have been open to 
much debate. 
In the early papers to emerge from Barton's laboratory the mode of 
interaction of [(phen)3Ru]2+ with B-form DNA was deemed to be 
electrostatic and hydrophobic contacts with the DNA in the major groove, 
with partial intercalation of one of the phenanthroline ligands into the DNA 
base stack. Equilibrium dialysis experiments showed that the intrinsic 
binding constant was small ca. 10-3 mol"1 dm3 and highly dependent upon 
salt concentration, which indicates a large electrostatic component to the 
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binding free energy12. Luminescence quenching experiments revealed a 
bi-exponential decay indicating two emitting species were present, one of 
which is quenched more readily than the other15. Barton proposed that 
the species which was more readily quenched was bound in a groove 
binding interaction, and was therefore more accessible to the quenching 
agent, where as the other species was intercalated deep within the major 
groove of DNA and was much less accessible to the quenching agent. 
The chiral discrimination of the binding event was rationalised by 
assuming propeller twist of A-[(phen)3Ru]2+ was symmetry matched to the 
right handed helix found in B-form DNA allowing it to bind preferentially 
over A-[(phen)3Ru]2+. Barton also reported sequence selectivity based 
upon steady-state polarisation of excited states, which show that the 
preference for the i-[(phen)3Ru]2+ increases upon increasing GC content 
of the DNA although no change in binding affinity is observed. This has 
been rationalised by the fact that the major groove becomes narrower 
with increasing GC content and therefore closer in width to the diameter 
of [(phen)3Ru]2+ thus amplifying the important steric contacts between the 
complex and the sides of the groove needed for chiral discrimination. 
Chiral discrimination of this type is clearly dependent upon matching the 
symmetry of the metal complex with that of the DNA double helix. 
However the debate is still raging as to whether the tris-phenanthroline 
ruthenium(II) complexes are able to intercalate into the base stack of 
DNA at all. 
In 1992 Norden and co-workers published the results of an NMR study16 
they had undertaken, seemingly contradicting all of the structural 
elucidations proposed by Barton. They show NOE data which shows that 
both 0- and A-[(phen)3Ru]2+ bind to the AT region of the self 
complementary oligonucleotide [d(CGCGATCGCG)21 in the minor groove. 
The cross peaks observed between protons on the metal complex and 
the oligonucleotide show they are at distances of less that 5A apart. The 
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H2 of adenine located at the bottom of the minor groove is shown to 
interact with protons on one of the phenanthroline rings and sugar 
protons H1' and H4' both facing the minor groove interact with the 
phenanthroline protons. Both enantiomers exhibit similar cross peaks, 
however more were observed with the A-enantiomer but higher 
concentrations of drug were needed to see them. The oligonucleotide 
cross peaks are not affected in any way upon binding of the drug 
indicating no change in conformation on interaction with the drug, 
indicating no intercalation is taking place. The binding kinetics are rapid 
and the complex is in fast exchange resulting in sharp signals, which 
again is an indication of no intercalation taking place. In summary both A 
and 0-[(phen)3Ru]2+ binds to the AT region of [d(CGCGATCGCG)2] 
through electrostatic and groove binding interaction within the minor 
groove. The issue of intercalation was disproved once-and-for-all when 
Chaires et al. published viscosity data showing only a very small increase 
in viscosity upon binding of tris-phenanthroline ruthenium(II) to DNA 
indicating a non-intercalative mode of interaction17. 
Finally, a detailed spectroscopic and modelling account by Rodger et a/. 
showed that the equilibrium binding constant was dependent upon the 
degree of saturation of the DNA by the drug complex18. They also report 
two modes of interaction. A-[(phen)3Ru]2+ was shown by CD and LD 
studies to orientate in the major groove through partial insertion of one of 
the phen moieties into the major groove (Figure 1.12). The phen moiety 
orientates itself within the major groove in plane with the base pairs 
although phen does not protrude far enough away from the metal centre 
to facilitate full intercalation. The i-[(phen)3Ru]2+ species binds 
exclusively in the minor groove by slotting a phen moiety vertically into the 
groove nearly perpendicular to the plane of the base pairs (Figure 1.12). 
This mode results in considerable widening of the minor groove to 
maximise interactions between the backbone and the other two phen 
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ligands on the complex. Again strong preferences were seen for AT 
regions of DNA over GC regions. 
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Figure 1.12: - Energy minimised binding modes of A-[(phen)3Ruf + left 
and d-[(phen)3Ruf + right. 
Although tris-phenanthroline ruthenium(II) complexes were shown to bind 
to DNA and show a degree of symmetry recognition, the binding affinities 
for DNA were unimpressive, and were highly dependent upon sequence, 
salt and temperature. In order for these metallointercalators to become 
useful in chemotherapeutics all of these problems needed to be 
addressed. 
1.5.2 dpphen complexes of ruthenium(II) 
Increasing the surface area of the intercalating ligand in these complexes 
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should serve to maximise the stacking interaction, and thereby increasing 
the binding affinity. In 1984 Barton and co-workers reported the 
ruthenium(II) complexes of dpphen (dpphen = 4,7-diphenyl-1,10- 
phenanthroline)19. This ligand was essentially an extended version of 
phen, which could offer more surface area on the Iigands to interact with 
DNA (Figure 1.13). 
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Figure 1.13: - dpphen complexes of ruthenium(II) 
Barton suggested that the extended surface area of the ligands served to 
enhance the chiral recognition already observed in [(phen)3Ru]2+. 
Luminescence quenching experiments seemed to show that A- 
[(dpphen)3]2+ bound to B-form DNA exclusively through an electrostatic 
interaction whereas A-[(dpphen)3Ru]2+ interacts with B-form DNA by 
intercalation of one of the dpphen ligands and subsequent threading of a 
pendant phenyl from the major groove to the minor groove. 
Again the growing number of researchers investigating metal complex 
DNA interactions disputed these initial claims and in 1997 a 
communication was published by Norden showing the absence of any 
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chiral discrimination whatsoever between A- and 0-[(dpphen)3Ru]2+ and 
B-form DNA20. UV studies (Figure 1.14) on each of the enantiomers 
showed that the observed hypochromisity is identical in each case 
indicating similar interactions of both enantiomers. 
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Figure 1.14: - UV spectrum of d-[(dpphen)3Ruf + A-[(dpphen)3Ruf 
(.... ) and 50% ethanol () in the presence of CT-DNA. 
Furthermore, the induced CD spectrum of the A-enantiomer is equal in 
magnitude but opposite in sign to that of the A-enantiomer (Figure 1.15) 
again indicating both enantiomers interact with B-form DNA in a similar 
manner. 
25 
chapter 1 Introduction 
150 
100 
50 
E 
U 
0 
U 
Cl) 
-50 
-100 
_1cn 
5x . , . 
ý ý ý ý ol 
vv 
200 300 400 500 600 
). / nm 
Figure 1.15: - CD spectra of [(dpphen)3Rur in acetate buffer (-), 50% 
ethanol (-) and CT-DNA (..... ) 
LD studies indicated a number of random orientations of both 
enantiomers of [(dpphen)3Ru]3+ with respect to the DNA axis, indicating a 
non-rigid non-intercalative mode of interaction. One possible reason for 
this discrepancy in binding behaviour may be the poor solubility and 
general hydrophobic nature of [(dpphen)3Ru]2+. In the initial studies 
Barton and co-workers used the dichloride and perchlorate salts of the 
complex which needed 10% DMSO in the buffer to ensure solubility. The 
presence of DMSO could possibly alter the conformational properties of 
B-form DNA and falsely induce chiral discrimination. Norden and co- 
workers worked on the di-acetate salt of the complex, which showed 
greater solubility allowed them to carry out the binding studies in a pure 
aqueous medium. 
By now it was clear that in order to design sequence-specific DNA binding 
drugs a system needed to be developed that formed a well-defined 
predictable anchor either in the major or minor groove around which 
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further functionality can be built. 
1.5.3 Ruthenium(II) dppz complexes 
Barton and Sauvage were the first to take this lead by preparing the 
bisphen ruthenium(II) complex of dipyrido[3,2-a: 2', 3'-c]phenazine 
(dppz)21 
N 
ý_N 
2+ 
"Ný 
dppz [(phen)2Rudppz]2' 
Figure 1.16: - dppz and its associated ruthenium(II) complex 
1.5.4 The molecular light switch effect 
[(phen)2Rudppz]2+ has been shown to have an atypical electronic 
structure compared to other tris-diimine complexes of ruthenium(Il)22"24. 
Electrochemical and photophysical measurements in both the ground and 
excited states show that the charge transfer is directed from the metal 
centre to the phenazine ring of the dppz ligand. The major non-radiative 
deactivation pathway of this excited state is likely to be the protonation of 
one or both of the nitrogen atoms in the phenazine ring. This makes the 
excited state of this complex extremely dependent upon its 
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microenvironment. The complex shows a strong metal to ligand charge 
transfer luminescence in hydrophobic solvents such as acetonitrile, or 
dichloromethane. In aqueous or protic solvents, however, this excited 
state is completely quenched and no emissions are observed because 
protons are available to protonate the ring nitrogens and facilitate non- 
radiative decay. Upon titration of DNA into aqueous solution of the 
complex this luminescence returns, indicating that the ring nitrogens of 
the dppz ligands are being shielded from the solvent. 25 
This suggests that the dppz ligand is intercalated deep within the n 
system and behaving as though it is in a hydrophobic solvent. This 
phenomenon has been termed the "molecular light switch effect" and has 
proved a very useful handle through which the binding can be monitored. 
Although the mode of interaction of [(phen)2Rudppz]2+ with B-form DNA 
has been established as intercalation of the phenazine ligand into the 
base pair stack, luminescence lifetime studies showed bi-exponential 
decay indicating the presence of two emitting species, one with a 
considerably longer lifetime than the other. 
The two species have been identified as perpendicular and side-on 
modes of intercalation (Figure 1.17). 
In the side on mode, one of the ring nitrogens on the phenazine ligand is 
still accessible by water as it points out into the major groove, resulting in 
quenching of the excited state, albeit much slower than if it were free in 
solution. In the perpendicular mode both of the phenazine ring nitrogens 
are fully intercalated into the base pair stack, rendering them inaccessible 
by water, which results in a greatly enhanced and longer lived excited 
state. 
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Figure 1.17: - Side on (left) and perpendicular (right) modes of 
intercalation of dppz into B-form DNA 
The preparation of a series of substituted derivatives of [(phen)2Rudppz]2+ 
(Figure 1.18) served to strengthen this hypothesis. None of the 
derivatives can be called molecular light switches as they all showed 
some luminescence in aqueous solution26. However upon titration of CT- 
DNA they all showed differing degrees of enhancement of the 
luminescence and of the excited state lifetimes. Complexes of DPPM, 
DPPM2 and DPPA all show significant enhancement of luminescence 
upon titration with CT-DNA indicating the kind of protection from solvent 
upon intercalation seen in the parent complex [(phen)2Rudppz]2+. The 
excited state decay observed for [(phen)2RuDPPM2]2+ is another good 
indicator towards of two modes of intercalation as it shows a tri- 
exponential decay. As DPPM2 is asymmetric, the methyl group on the 
terminal phenyl ring can either point into the groove or into the base pair 
stack upon intercalation. 
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Figure 1.18: - Substituted dppz derivatives 
The positioning of the methyl group on the terminal phenyl ring of DPPM2 
partially shields the phenazine nitrogen from water, different degrees of 
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quenching can be expected at the free nitrogen and the shielded nitrogen 
sites resulting in the tri-exponential decay. 
In1993 Norden et al. published new data on the resolved enantiomers of 
[(phen)2Rudppz]2+. They showed by flow LD, CD and luminescence 
titrations that both the A- and A- forms of the complex bind to B-form DNA 
with similar binding affinities ca. 108 mol-1 dm3 27. However they observed 
the relative quantum yield of the A-enantiomer was some 60-80 times 
higher than for the A- enantiomer. They proposed that this was due to 
the existence of two binding modes originating from a ligand distribution 
effect. They report a higher fraction of the shorter lifetime species at low 
[Ru]/[DNA] ratios and suggest this is because isolated ligands in the 
lattice are more accessible to solvent than closely packed ligands at the 
saturation point. In 1997 Norden and co-workers extended this theory by 
presenting evidence suggesting that the intercalation takes place from 
within the minor groove. If this were the case then there would be no 
room within the minor groove to accommodate the second binding 
orientation proposed by Barton et aL28. They report that binding of both 
0- and A-[(phen)2Rudppz]2+ to T-4 DNA is not hindered in any way. T-4 
DNA is 100% glycosylated at the cytosine 5-CH2-OH position in the major 
groove which would provide a significant steric obstacle for the complex 
to overcome. Additionally, there were no significant difference between 
the lifetimes observed with poly(dA). poly(dT) and poly(dC). poly(dC) ruling 
out preferential binding to the AT regions of T-4 DNA free from 
glycosylation. 
In 1998 Barton et al. published a study based upon competitive binding 
experiments with well-known well characterised major and minor groove 
binding agents29.0-a-[Rh[(R, R)-Me2trien]phi]3+ has been shown to bind 
in the major groove of [d(5'-GAGTGCACTC-3')] at the highlighted 
residues. When rac-[(phen)2Rudppz]2+ was mixed with the duplex at 
relatively low mixing ratios and then 0-a-[Rh[(R, R)-Me2trien]phi]3+ was 
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titrated into the complex, the luminescence intensity observed from the 
ruthenium complex at 617nm decreased until a molar ratio of 1: 1 Rh / 
duplex was reached. The intense absorption at 375nm assigned to the 
phenazine ir--*it transition of the ruthenium complex, increases to a 
maximum at 1: 1 Rh / duplex. This showed that the rhodium complex 
directly displaces the intercalated ruthenium complex. Competitive 
binding of rac-[(phen)2Rudppz]2+ with Distamycin shows no decrease in 
the ruthenium emission but in fact the intensity of the emission is 
increased. This is due to stiffening of the duplex by Distamycin resulting 
in greater protection of the ruthenium complex from solvent. Binding of 
rac-[(phen)2Rudppz]2+ with a 1: 1 mixture of [poly(dA). poly(dT)] and 
[poly(dG). poly(dC)] DNA shows that the luminescence decay is a linear 
combination of the decay profiles in the presence of [poly(dA). poly(dT)] 
and [poly(dG). poly(dC)] independently. This shows that although binding 
affinities are high for each DNA polymer, in direct competition -85% of 
the complexes are bound preferentially to [poly(dA). poly(dT)]. As CT- 
DNA (42% GC) and T-4 DNA (34% GC) are rich in A-T regions, and the 
decay profiles of rac-[(phen)2Rudppz]2+ binding to both samples are so 
similar even with T-4DNA being 100% glycosylated in the major groove. 
This seems to indicate that rac-[(phen)2Rudppz]2' binds preferentially to 
AT sites on both the natural DNA sequences and the binding would be 
unperturbed glycosylation within the major groove of GC sites. 
In the same year Collins and Aldrich-Wright published data showing that 
bis-phen ruthenium(II) complexes of dpq and dpqc (dpq = dipyrido-[3,2- 
d: 2', 3'-f]-quinoxaline and dpqc = dipyrido-[3,2-a: 2', 3'-c]-(6,7,8,9- 
tetrahydro)-phenazine) (Figure 1.19), two ligands related to dppz, bind 
DNA oligonucleotides through intercalation from the minor groove30. This 
demonstrates how small structural perturbations can dramatically alter the 
binding characteristics of a system. 
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1.5.5 PHEHAT complexes as metallointercalators 
2+ 
2+ 
Kirsch de-Mesmaeker et al. extended the area of the intercalating ligand 
even further when his group prepared the bisphen ruthenium(II) complex 
of 1,10-phenanthroline[5,6-b]-1,4,5,8,9,12-hexaazatriphenylene 
(PHEHAT) (Figure 1.20)31. 
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Figure 1.20: - The structure of PHEHAT and its ruthenium(II) complex 
PHEHAT complexes display the light switch effect of the dppz complexes 
and binding affinities to are comparable to those of the dppz complex. 
The metal to ligand charge transfer (MLCT) excited state in PHEHAT 
complexes is very oxidising32'34, and is thus able to photo-cleave the 
phosphate backbone of DNA forming photo-adducts. The primary 
process that initiates DNA cleavage corresponds to a photo-induced 
electron transfer, generally from a guanine base to the excited state 
complex. Barton and co-workers has shown that this electron transfer 
process is long range and can take place over a distance of some 40 
base pairs. An informative review of DNA charge transport chemistry has 
been presented by Barton et a1.35 
1.5.6 Designing a ligand as a base pair mimic 
In contrast to the dppz ligands, the 9,10-phenanthrenequinone ligand 
(phi) was designed to provide an expanse of aromatic structure across 
the base pair rather than along the diad axis36. The phi ligand projects far 
from the metal centre due to the use of imines as the coordinating 
chelaters, as can be seen in the parent complex [(phen)2Rhphi]3+ (Figure 
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Figure 1.20: - 9,10-phenanthrenequinone di-imine and its complex 
The phi ligand was first designed in an attempt to match the positioning of 
aromatic rings with those of the base pairs. The phi complex also differs 
from the dppz complexes in terms of the photochemistry and, therefore in 
terms of their utilisation. Phi complexes of both ruthenium(II) and 
rhodium(III) show no detectable photoinduced emission and therefore the 
will be no photochemical signature to exploit upon DNA binding. However, 
phi complexes of rhodium have been continually exploited as they have 
the ability to cleave DNA at the site of intercalation when they are 
irradiated with high-energy light (310 - 320 nm). The DNA cleavage 
pattern is non-specific and cleavage takes place wherever the complex 
intercalated. The ability of rhodium phi complexes to site-specifically 
cleave DNA has been invaluable in characterising how meta Ilocomplexes 
bind to DNA with specificity, as well as high affinity. 
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1.5.6 Designing a ligand to detect base pair mismatches 
The rhodium complex of the ligand chrysi (chrysi = 5,6-chrysinequinone 
diimine) (Figure 1.21) shows preferential binding to base pair mismatches 
over normal base pairs within B-form DNA37'38. As the chrysi ligand is an 
extension of the phi ligand, the reason for the preferential binding is due 
to sterics. The chrysi ligand is too big to intercalate between a normal 
base pair, but a base pair mismatch results in significant perturbation of 
the DNA structure around the mismatch allowing the chrysi ligand to be 
easily accommodated. This is reflected in the fact that, on binding to 
double helical DNA, the binding constant for the chrysi complex is over 
two orders of magnitude lower than of the phi complex. 
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Figure 1.21: - chrysi and its corresponding rhodium(111) complex 
Once bound to the site of the mismatch, the complex can photochemicaly 
cleave the DNA at the adjacent 3' base on each strand. Many diseases 
such as hereditary nonpolyposis colorectal cancer are due to the failure of 
mismatch repair (MMR) systems within the diseased cells which then 
leads to an accumulation of base pair mismatches. The ability of these 
complexes to selectively target these mismatch sites within diseased cells 
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shows their enormous potential as future diagnosis or site-specific 
chemotherapeutic agents. 
1.5.7 Cyclometalated rhodium(III) intercalators 
Replacement of the bipy ligand with ppy (ppy = 2-phenylpyridine) in the 
two rhodium complexes [(bipy)2Rhphi]3+ and [(bipy)2Rhchrysi]3+ results in 
the formation of [(ppy)2Rhphi]+ and [(ppy)2Rhchrysi]+ (Figure 1.22). 
O 
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Figure 1.22: - Cyclometalated rhodium complexes of phi and chrysi 
These cyclometalated complexes have extremely similar geometries and 
shapes as their bipy counterparts but they are mono-cations. This 
reduction in charge should allow easier passage of these complexes 
across cellular membranes etc. However, binding and photo-cleavage 
studies show a decrease in binding affinity of two orders of magnitude 
due to reduced electrostatic contributions and a 14-fold decrease in the 
efficiency of [(ppy)2Rhphi]+ to photo-cleave DNA over its tri-cationic 
[(bipy)2Rhphi]3+ sister complex39. The metal-carbon bonds present in the 
cyclometalated species results in an induction of electron density from the 
ligand to the metal centre. As photo-cleavage occurs by the abstraction 
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of a hydrogen atom from the sugar backbone by the intercalating ligand, 
the shift in electron density results in a higher energy MLCT transitions 
and reduced ability to abstract the proton, hence a decrease in efficiency. 
Nonetheless these complexes are worth pursuing as the orientation, due 
to the trans-effect of the nitrogen donor in each of the ppy ligands is axial. 
This will significantly reduce the number of structural isomers formed if an 
asymmetric substituted form of the ppy ligand is used, resulting in 
increased product yields and easier purification procedures. 
1.5.8 Rhenium intercalators 
The diversity of bidentate di-imine ligands means that they can be co- 
ordinated easily to other metal centres. Rhenium(l) complexes 
incorporating di-imine ligands have been shown to have all the necessary 
spectroscopic characteristics needed to be useful nucleic acid probes. 
Also complexes with the general formula [(CO)3PyReL2]` have had 
extensive structural characterisation and are known to have an octahedral 
geometry with the three carbonyls occupying a facial arrangement. 
In 1995 two papers were published simultaneously by Wing-Wah Yam et 
a/., and Schanze et al. reporting the synthesis and DNA binding studies 
on three structurally similar rhenium(l) complexes of dppz and dppn (dppn 
= benzo[I]dipyrido-[3,2-a: 2', 3'-c]phenazine) (Figure 1.23)40,41. 
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Figure 1.23: - Rhenium(I) intercalators based upon dppz 
All three complexes showed hypochromicity in all of their absorption 
bands when titrated with CT-DNA. The luminescence titration studies 
turned out to be far more interesting. The dppz derivative showed a 13- 
fold increase in emission intensity upon titration with CT-DNA as opposed 
to only a 1.3-fold increase from the dppn derivative. This anomaly was 
credited to the greater extension of the aromatic ligand in dppn resulted in 
aggregation in aqueous solution and inhibited binding to DNA. Analysis 
of the emission data for the dppz complex titrated with CT-DNA with the 
McGhee-von Hippel model revealed a binding constant of 4.2x104 mol-1 
dm3 and a binding site size of 2. Analysis of the UV-Visible titration data 
for the dppn complex revealed a binding constant of 6.4x104 mol-1 dm3 
with CT-DNA42. 
The binding of both complexes was also studied with poly(dA). poly(dT) 
and poly(dG). poly(dC) shoed a greatly enhanced preference of both the 
dppz, and dppn complexes for AT sites. The binding data shows an 
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affinity for DNA approximately 10 fold lower than that of the ruthenium(II) 
analogues which can presumably accredited to there being less charge 
on the rhenium(I) complexes. 
1.5.9 Iridium based systems 
Recently Barton et al, have reported the synthesis and DNA binding 
studies of the tris-heteroleptic complex [lr(bipy)(Phen)(phi)J3+ (Figure 
1.24)'3 
7 
3+ 
%N, N 
ýN 
'Ir, Ný 
N- 
N 
[lr(bipy)(phen)phi]3* 
Figure 1.24: - The tris-heteroleptic (Ir(bipy)(Phen)(phi)f + complex 
UV-visible titrations with CT-DNA show strong hypochromicity in the n->i* 
transition of the phi ligand, indicating that it is deeply intercalated in the 
DNA helix analogous to its rhodium(Ill) counterpart. Unlike the 
rhodium(Ill) complex, the iridium(Ill) complex shows a chemically 
reversible reduction centred on the phi ligand. This reduction has been 
used to probe its interaction with DNA and coulometric titrations reveal a 
binding affinity k=1.1x106 mol'' dm3 which is an order of magnitude 
lower than its rhodium counterpart. 
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Electrochemistry is becoming an increasingly useful tool for probing both 
the interactions of metal loi nte rca lators with DNA and the charge transport 
properties of the DNA n-stack. 
1.5.10 DNA recognition based on shape selection 44 '45 
Due to their shape and polarity, different intercalating ligands stack with 
different orientations within the DNA double helix and, as such, provide 
somewhat different strategies for the specific recognition of sites on DNA. 
This phenomenon is emphasised by the fact that two complexes of dppz 
[(CO)3PyRedppz]+ and [(phen)2Rudppz}2+ show small but significant 
preferences for A-T rich sequences of DNA over their G-C rich 
counterpart. 
As the extended heterocyclic ligands of dppz and phi complexes 
intercalate between the base pairs of the DNA, the other ancillary ligands 
on the complexes are brought into close proximity with the DNA base 
pairs and, as a result, specific noncovalent interactions between the 
ancillary ligand functionalities and functionality in the DNA groove can be 
made. 
A good example of how secondary interactions are important in 
recognising distinct binding sites is the sequence specificity between the 
two rhodium phi complexes [(phen)2Rhphi]3+ and [(phi)2Rhbipy]3+ 
[(phen)2Rhphi]3+ shows a moderate preference for sites with high 
propeller twisting towards the major groove. This means [(phen)2Rhphi]3+ 
preferentially cleaves at 5'-YYR-3' (where Y is pyrimidine and R is purine) 
sites. Comparison of the crystal structures of DNA oligonucleotides with 
the photo-cleavage patterns for [(phen)2Rhphi]3+ enabled the 
determination of the critical structural features for recognition. It was 
proposed that the propeller twisting allows shape selection by opening up 
the B form DNA purines in 5'-WR-3' dramatically, thus permitting facile 
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intercalation of the phi ligand. In contrast, 5'-RRY-3' not only closes the 
major groove, but also places the pyrimidines in highly unfavourable 
positions with respect to the phenanthroline rings. [(phi)2Rhbipy]3+ shows 
almost no sequence or structure specificity. Inspection of the geometry of 
this metal complex shows that the non-intercalating phi ligands are 
positioned away from possible steric clashes with the helix. Therefore, a 
simple comparison of the shapes between these two metal complexes 
highlights the idea that steric clashes or their avoidance can dominate site 
selectivity Figure 1.25). 
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Figure 1.25: - Rhodium(Ill) phi complexes showing steric interactions 
important in sequence recognition. 
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1.5.11 Direct readout of recognition sites within the 
grooves of DNA 
Another strategy for site-specific recognition of DNA is the utilisation of 
direct hydrogen bonding or van der Waals' interactions between 
functionality on the ancillary ligands of the intercalator and sites within the 
DNA grooves. By incorporating complementary functionality into the 
ancillary ligands, the desired specificity can be achieved. A family of 
rhodium amine complexes, based around the phi ligand, have been 
synthesised and the selectivity for a four base pair site has been 
tested 46,47 It is found that [(NH3)4Rhphi]3+, [en2Rhphi]3+ and 
[[12]andN4Rhphi]3+ cleave specifically at 5'- G C-3' sites. The well-defined 
structural geometry of these complexes indicated the possibility of 
hydrogen bond formation between axial amines of the metal complexes 
and the 0-6 of guanine. A control complex incorporating a thiocrown 
[[12]aneS4Rhphi]31', which lacks hydrogen bonding capability was tested 
in parallel experiments and was seen to bind with no specificity. 
The introduction of an 0-6 methyl guanine in place of guanine on the 
targeted oligonucleotides disrupts binding to this site, indicating a 
hydrogen bonding interaction is present. In contrast, replacement of 
guanine with 7-deazaguanine did not disrupt recognition, suggesting that 
hydrogen bonding to the N7 of the guanine is not an important factor in 
the binding and recognition of these metal complexes. 
Barton and co-workers designed and synthesised a complex specifically 
to bind into a 5'-TGCA-3' site48. The targeting of the site was based upon 
hydrogen bonding contacts between axial amines and the 0-6 of guanine, 
as well as van der Waals' contacts between the pendant methyl groups 
on the metal complexes and the methyl groups on the flanking 
thymines46. Photo-cleavage data indicated that the complex binds to the 
target 5'-TGCA-3' site and the binding constant is 9x 107 mol'1 dm3 49. A 
high resolution NMR structure49.50 and, recently, a crystal structure51 of 
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the metal complex intercalated into the major groove confirm that this 
complex targets the sequence in the major groove and, remarkably, each 
of the predicted contacts are present (Figure 1.26). 
5' 5' 
3+ 
T CH3 A 
CH 
D 
NGO H2N C 
N' N 
N HN'Rh` 
C NHz OG 
H3C 
/ 
A H3C T 
3' 3' 
Figure 1.26: - d-[(R, R)Me2trienRhphiJ3+ (left) and its non-covalent 
interactions with 5 -TGCA-3 
The crystal structure of the rhodium intercalator bound specifically to the 
central 5'-TGCA-3' site at eight base pair oligonucleotide is solved at 2A 
resolution and it is the first crystallographically characterised 
meta I loi ntercalato r bound to a DNA duplex (Figure 1.27). The structure 
shows that the base pairs are well stacked, and the phi ligand is deeply 
intercalated between them. The conformation of the deoxyribose sugars 
at the intercalation site is B-form which shows that metallo intercalation 
causes minimal structural perturbation to the DNA, and that the 
intercalated ligand resembles an inserted base pair. 
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Figure 1.27: - X-ray crystal structure of d-[(R, R)Me2trienRhphiJ3+ 
intercalated into a DNA duplex 
1.5.12 Cationic lanthanide complexes as DNA binding 
agents 
David Parker et al. have assembled a series of cationic lanthanide 
complexes with a pendant N-methylphenanthridinium chromophore52.53 
(Figure 1.28). These are some of the first lanthanide complexes, which 
have a well-defined structure and are kinetically stable towards 
racemisation in solution. 
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Figure 1.28: - Cationic lanthanide complexes developed by Parker et al. 
In these complexes the pendant N-methylphenanthridinium moiety serves 
to intercalate into the DNA helix and the chiral metal complex sits in the 
groove of the DNA. The chirality of the complexes is defined by the 
configuration of the remote carbon stereogenic centre. The complexes 
showed good affinity for DNA with the A-enantiomer binding stronger than 
the A-enantiomer. There is also a preference for GC sequences of DNA 
(for the A-enantiomer k=8.7x10-6 moll dm3 duplex' for [(GC)612 and 
1.6x10"5 mol 1 dm3 duplex 1 [(AT)6]2)53. The complexes also showed 
extremely good affinity for circular Plasmid DNA52. The coordinatively 
unsaturated complexes [Ln. 2] which contain two coordinated water 
molecules have been shown to bind reversibly to hydrogen phosphate 
anions offering scope for hydrolytic activity with the phosphate backbone 
54 of DNA 
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1.6 Bimetallic DNA binding complexes 
1.6.1 Modulation of DNA binding properties by ancillary 
ligands 
One of the first bimetallic DNA binding complexes was assembled around 
the bis chelating ligand dpb (dpb= 2,3-bis(2-pyridyl)benzo[g]quinoxaline). 
The ligand has two bidentate chelating sites and is therefore capable of 
binding to two metal centres simultaneously55.56 When the two metal 
centres are (phen)2Ru2+ the complex shows very little affinity for DNA, as 
the steric bulk of the four phenanthroiine ligands prevents efficient 
intercalation of the extended aromatic ligand into the DNA double helix. 
When the two metal centres are (NH3)4Ru2+ the steric bulk of the ancillary 
ligands is dramatically reduced and the complex is free to interact with 
DNA (Figure 1.29). 
7 q+ 
-R4` H, 
[(Ru(phen)2)2dpb]4 
Figure 1.29: - Phen and NH3 complexes of dpb 
((Ru(NHa)jzdpbj" 
Analysis of the binding with a model related to the McGhee-von Hippel 
model developed by Bard et al. returned a binding constant of 8.3x105 
mol-1 dm3 and a site size of 6 base pairs reflecting the bulkiness of the 
complex. 
4+ 
NH3 NHa 
NH3 
aN Y/ YI/ NH3 
HaN 1 
NH N NH3 
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1.6.2 Linking two DNA binders together 
In order to further increase the affinity of metallointercalators for DNA the 
first series of bimetallic bis-intercalators have begun to emerge. Kelly et 
a/. developed the first of these systems. They simply took the relatively 
poor DNA binding complex [(bipy)3Ru]2+ and linked two of them together 
with an aliphatic chain (Figure 1.30) 57.58 
ý 
4+ 
iI "N1fl 
NN,, 
I 
IN 
R\ Ný N-Ru-N 
N 
--N 
"\, -/j 
U 
n=3,5 or 7 
Figure 1.30: - Bimetallic DNA binding complex developed by Kelly et al. 
The binding affinity is improved by two orders of magnitude in the 
bimetallic species over the monometallic species, with the optimum linker 
length reported to be seven carbons in length. Also, the salt dependency 
of the bimetallic species was drastically reduced compared to the 
monomer with significant amounts of bimetallic species bound even at 
salt concentrations in excess of 500 mM. 
1.6.3 Covalently joining two dppz moieties together 
In 1996 Norden and his group published DNA binding data on a novel 
bimetallic system bridged by head to head dppz ligands (Figure 1.31) 59 
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Figure 1.31: - Bis-dppz bimetallic ruthenium(II) complex 
This system incorporates two chiral ruthenium centres and the DNA 
binding characteristics differ between all three isomers 00, AA and AA. 
For the AA-complex, stopped flow linear dichroism and circular dichroism 
spectra suggest a binding confirmation in which the concave face of the 
bis-dppz ligand envelops the sugar phosphate backbone, thus placing 
one RuL2 moiety in each groove. However, the A0- complex binds in a 
distinctly different way, possibly with both metal centres in the same 
groove. The complexes are non-luminescent in aqueous solution, as 
well as in the presence of DNA, so competitive binding studies with the 
well characterised A-[(phen)2Rudppz]2+ were used to determine binding 
affinities. The order of binding strength was found to be AA > AA ca. ý 
5x1011 mol 1 dm3. 
1.6.4 A DNA staple 
Norden et al. took this system one stage further by synthesising the 
bimetallic species of the [(phen)2Rudppz]2+ complex (Figure 1.32)60 
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Figure 1.32: - DNA staple developed by Norden and his group 
They have named this a DNA staple, as both of the bisphen ruthenium(II) 
units pass directly through the core of the DNA into the groove on the 
opposite side of the DNA (Figure 1.33). 
0i 0 
Figure 1.33: - Schematic DNA-interaction modes of the DNA staple. (A) 
Electrostatic external binding. (B) Groove binding. The 
subunits positioned in either minor or major groove of DNA. 
(C) Mono-intercalation. One subunit intercalated the other 
one, either in a groove or freely dangling (D) Bis- 
intercalation. Both subunits intercalated, either in the minor 
or the major groove, the bridging chain residing in the 
opposite groove. 
This gives very high binding affinities and extremely slow dissociation 
rates. According to Norden, normal emission and absorption were not 
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appropriate for obtaining binding constants for this system61. The 
equilibrium binding constants have been determined by an emission 
dilution experiment. DNA is added to a solution of the drug until 
saturation binding is reached. This is assumed to be 4: 1 ratio of DNA 
phosphate to drug as determined from a continuous variation analysis. 
The emission intensity is monitored as the solution is diluted with buffer. 
The data is corrected for dilution effects and the data is fitted to a revised 
form of the McGhee-von Hippel model based upon a site size of four 
base pairs. The equilibrium binding constants to CT DNA has been 
determined to be 3x10"8 mol-' dm3 for the 0-i enantiomer at 110mmol 
NaCl. This value has been adjusted to 1.7x10'1° mof'dm3 for binding at 
50mmol NaCl61. The association kinetics were determined by 
conventional stop flow kinetic analysis. 
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1.6.5 A bipyrimidine bridged system 
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Figure 1.34: - bis-ruthenium(II) bpm bridged complex and schematic 
representation of the three diasterioisomers 
The Australian group of Keene et al. have synthesised and published 
data on the bipyrimidine bridged bis-ruthenium(II) species 
[{Ru(Me2bipy)2}2(µ-bpm)]4+ (where Me2bipy = 4,4'-dimethyl-2,2'-bipyridine; 
bpm = 2,2'-bipyrimidine) (Figure 1.34)62. 
The binding of the A0, AA and AA isomers to the synthetic oligonucleotide 
d(3'-CAATCCGGATTG-5')2 was characterised by 1H NMR spectroscopy. 
Titration of the complexes with the dodecamer induced significant shifts in 
the proton resonances of the sugar residues and the aromatic proton 
resonances of the metal complexes. The resonances corresponding to 
the H3' and H3 on the metal complexes shifts systematically throughout 
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the titrations and were used to estimate the binding constants. Binding 
constants ca. 3x103 and 2x103 mol 1 dm3 were calculated for the AA- and 
AA- isomers, respectively. 
NOESY experiments were performed to try to determine the mode of 
interaction of the complexes. The complexes were found to reside in the 
minor groove with one of the bidentate Me2phen ligands from each metal 
centre slotting into the groove (Figure 1.35). 
A 
G\ 
G Nºt, 
\NH' 
'T 
Ruýý Ru C =ý/ 
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Figure 1.35: - A schematic showing the AA-stereo isomer of 
[(Ru(Me2bpy)2)2(ju-bpm)J4+ binding to the central 
CCGG region of the dodecanucleotide 
d(CAATCCGGATTG)2. The metal complex is bound 
across the minor groove in a manner that positions only 
one bidentate ligand from each ruthenium into the 
groove and close to the cytosine residues and away 
from the guanine amino groups. If the central C and G 
residues on each strand were interchanged (i. e. C to G 
and G to C) the guanine amino groups would sterically 
hinder the metal complex binding. 
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1.6.6 A supramolecular cylinder as a major groove binder 
Hannon et al. have demonstrated the use of a supramolecular cylinder as 
a major groove DNA binding agent63. The cylinders that are formed from 
the spontaneous self-assembly of three imine-based ligands around two 
divalent iron centres to form a triple helical structure (Figure 1.36). 
H2Ný"ý 'NHZ 
O=\ 
EtOH 
RT 
2h 
FeC12 
.S 
IN 
N 
`/ 
Figure 1.36: - The molecular structure of the ligand and the tetracationic 
triple helical supramolecular cylinder [Fe2(C25H2oN4)3]Cl4 
Once assembled, these cylinders have a size and shape that is 
comparable to those of zinc finger proteins and bind in the major groove 
of the DNA spanning five base pairs. Once bound, they proceed to wrap 
up the duplex in a intramolecular fashion which can be observed by CD, 
NMR and AFM imaging techniques. 
This is a good example of the way in which supramolecular assemblies 
allow chemists to bridge the size gap between traditional small molecule 
and larger biomolecule DNA-recognition motifs. 
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1.7 Conclusions 
We have seen in this introduction that DNA is essential to life and that 
any modifications to the information stored within it can be catastrophic 
for the organism it resides in. Many of the secrets of its structure and 
function have now been unearthed leading to the development of new 
DNA binding agents. Among these are new probes of DNA structure and 
function, new tools to recognise and modify DNA and new 
chemotherapeutic agents designed to fight disease. 
Transition metal complexes are a growing class of DNA binding 
compounds, and we have seen how these have developed from simple 
molecules with moderate affinities to large supramolecular assemblies 
that can target DNA with high affinity and selectivity. 
Most of the complexes discussed here are chiral in nature and due to 
shortcomings in present synthetic methodology can only be synthesised 
as racemic mixtures which require difficult and time consuming chiral 
separations. This problem is amplified when the system is extended to 
contain more than one chiral metal centre. 
Having seen the potential of the bimetallic systems for increasing the 
binding affinity and selectivity of metal complexes for DNA we have 
undertaken a study to try to develop a series of achiral monometallic 
complexes with high affinity and selectivity for DNA and then extend this 
to achiral bimetallic complexes. This approach greatly simplifies the 
synthetic procedures required to build large well-defined complexes 
designed to interact with DNA 
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Chaoter2 Extended teryridine complexes... 
Extended terpyridine complexes 
of ruthenium(II) and rhenium(l) 
2.1 Introduction 
For many years now ruthenium(II) and rhenium(l) complexes containing 
polypyridyl chelating ligands have been extensively studied. The rich 
photophysical and redox properties associated with these complexes 
makes them potentially useful in light harvesting-66, electron transfer67-69, 
non-linear optics70-72, catalytic water splitting73, self-assembly74 and 
recently probes for biological systems75. 
This chapter is concerned with the synthesis and characterisation of a 
series of ruthenium(II) and rhenium(I) complexes incorporating 4'- 
extended terpyridine ligands with a view to producing a series of novel 
complexes with favourable DNA binding properties. 
3 2'ý 61 3" 
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Figure 2.1: - Terpyridine and 4-extended terpyridines showing the atom 
numbering Scheme. 
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A series of transition metal complexes incorporating 4'-extended 
terpyridine ligands have been synthesised, which are expected to bind to 
DNA through intercalation of the extended terpyridine moiety into the 
base stack of DNA. The system allows variation of numerous 
characteristics of the molecules such as charge, chirality and hydrogen- 
bonding ability without changing the overall shape of the complex (Figure 
2.2). 
x 
N X=CHorN 
X X-, 
Nx 
ML =terpy Ru2+ 
X X- (phen)ZRu2+ 
N (CO)sPyRe+ 
\ /X 
Figure 2.2: - Schematic of the extended terpyridine systems designed 
for DNA binding 
The complexes can be achiral (ML = terpyRu2+) or chiral (ML = 
(phen)2Ru2+. The overall charge on the complexes varies from +1 in the 
rhenium complexes to +2 in the ruthenium complexes. 
The DNA binding characteristics of each of these complexes has been 
carried out, to determine what effects these changes have and this 
aspect will be discussed in detail in Chapters five and six. 
The five ligands chosen as the intercalating domains for this study are 
2,4,6-tris(2-pyrimidyl) 1,3,5-triazine (2.2) (Tpymt), 2,4,6-tris(2-pyridyl)1,3,5- 
triazine (Tpt), 2,2': 4,4": 6,2"-quaterpyridine (2.5) (Qtpy), 4'-phenyl- 
2,2': 6', 2"-terpyridine (2.6) (P-terpy) and tetra-2-pyridyl-1,4-pyrazine (2.7) 
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(Tpp), shown in Figure 2.3. These ligands are all flat polyaromatic 
structures, which should be ideally set up for intercalation into the DNA 
base stack. 
Tpymt Tpt Qtpy 
(2.2) (2.6) 
P-terpy 
(2.5) 
NN 
N 
NN 
Tpp 
(2.7) 
Figure 2.3: - The extended terpyridine ligands used in this study 
The four ligands Tpymt, Tpt, Qtpy and P-terpy all have the same general 
shape, however, they differ in the number and position of nitrogens in the 
aromatic system. Tpp is a slightly different shape to the other four ligands 
and it contains an extra aromatic ring, which increases the surface area 
available for intercalation. 
2.1.1 Terpyridine coordination modes 
Terpyridine and 4'-extended terpyridines are multidentate ligands 
meaning they can coordinate to a metal through one, two or three of their 
59 
Chapter2 Extended ternvridine complexes... 
basic ring nitrogens. This is termed rii, r12 or t coordination (Figure 2.4), 
however, more common names are mono-dentate, bidentate and 
tridentate. 
XM 
\NIý 
/N 
I/ 
n1coordination mode n3 coordination mode n2 coordination mode 
Figure 2.4: - i7', X72 and r3 coordination of terpyridine derivatives to 
transition metals 
2.1.2 Ruthenium polypyridyl chemistry 
Ruthenium complexes of general formulae [RuL6]2+, [Ru(L2)3]2+ and 
[Ru(L3)2]2+, (L = py; L2 = phen; L3 = terpy, etc. ) can be prepared by a 
variety of methods. The chemistry of ruthenium has been extensively 
reviewed by Seddon et a/. 76 and Shröeder et aL77. 
A convenient starting material for the preparation of tris di-imine 
ruthenium(II) complexes is (phen)2RuCI2.2H20. This is prepared from 
RuCI3.3H20 and phenanthroline in dry DMF as described by Sullivan et 
a!. 78. LiCI is added to ensure there are Cl- ions present to prevent tri- 
substitution. 
(phen)2RuCI2.2H20 can be reacted with a third bidentate ligand to form 
tris-chelate compounds. A review by Balzani et al. not only describes 
modern synthetic procedures towards ruthenium tris chelate complexes, 
but extends this to polynuclear systems79. These reactions are normally 
carried out in water or water/alcohol solvent systems, with moderate to 
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high yields (30-90%) for the mononuclear systems. Purification of the 
complexes can be achieved with chromatography on alumina, silica or ion 
exchange columns. Generally the main impurity results from ligand 
scrambling to form tris-phenanthroline ruthenium(II). Keeping reaction 
times and temperatures to a minimum can reduce this. 
The reaction of the related compound (bipy)2RuCI2.2H20 with terpyridine 
to form [(bipy)2RuN, N-terpy]2+ has been reported previously by Constable 
et aL (Scheme 2.1)80. This synthesis was achieved by refluxing 
(bipy)2RuCI2.2H20 with terpyridine in methanol. 'H NMR and crystal 
structures show that the desired six-coordinate octahedral complex is 
formed, with the terpyridine acting as a bidentate ligand. 
Terpyridine, MEOH, reflux 10hr 
2+ 
N 
R uN 
N_ 
N oe 
Qt 
Scheme 2.1: - Synthesis of f(bipy)2RuN, N-terpyf 
The coordination chemistry of i3-bound terpyridine and higher 
oligopyridines with ruthenium(II) has been subject to a number of 
reviews, 81M particularly with respect to their use in light harvesting and 
energy transfer complexes. 
The convenient starting material terpyRuC13.3H20 (2.8) can be prepared 
from the reaction of terpy with RuCI3.3H20 in ethanol at reflux for 3 
hours85. 
Further reaction of terpyRuC13.3H20 with a second terpyridine or 
oligopyridine (L) results in the formation of a complex of general formula 
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[terpyRuL3]3+. A range of solvents have been used for this reaction 
including methanol, ethanol, or water ethanol mixtures. The solvent 
system that the ligand is most soluble in is usually chosen as the solvent, 
as extended terpyridine and oligopyridines tend to be quite insoluble. The 
application of a reducing agent such as N-methylmorpholine or 
triethylamine helps the reduction of ruthenium(Ill) to ruthenium(II). The 
reactions are typically high yielding 70-90% with chromatographic 
purification achieved with acetonitrile toluene mixtures on 81-84 or 
ion-exchange resin. 
2.1.3 Rhenium(I) polypyridyl chemistry 
Two recent reviews on the photophysical properties of rhenium(l) 
complexes of phenanthroline86 and one on the self-assembly of 
rhenium(I) boxes etc. 87 cover all of the relevant rhenium(l) coordination 
chemistry required for this study. 
If (CO)5ReCI is heated to reflux in toluene in the presence of a bidentate 
di-imine ligand such as 1,10-phenanthroline, compounds of general 
formula (CO)3CIRe(phen) are produced. The complexes have an 
octahedral geometry with the three carbonyls occupying one face of the 
octahedron (Scheme 2.2) this is due to the trans effect. The carbonyl 
ligands, which are strong it acceptors exert a greater trans directing effect 
than the chloride ligand, so the di-imine ligand substitutes two carbonyl 
ligands in the equatorial plane trans to two other carbonyls88. 
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1,10-phenanthroline OC 
Toluene, reflux 3hours ''"., 
(CO)SReCI OC 
Scheme 2.2: - Synthesis of rhenium(I) di-imine complexes 
The axial chloride can now be substituted with an organic nitrite ligand 
such as acetonitrile. This has been achieved in a number of ways, but 
the simplest seems to be the reaction of the rhenium(l) chloride with silver 
triflate in acetonitrile. This reaction is virtually quantitative and the only 
side product, insoluble silver chloride, can be easily filtered off. 
There are a number of examples of (CO)3ReX coordinated to terpyridine 
type ligands (X= Cl, Br, I). In all cases the terpyridine acts as a bidentate 
ligand. 
P-terpy and Qtpy have been coordinated to the (CO)3ReBr centre by 
Orrell et al. and dynamic NMR studies have been reported89"92. Variable 
temperature studies show that the rhenium centre flips between the two 
available bidentate coordination sites of the terpyridine moiety. 
In all cases the synthesis of (CO)3XReL3 (L3 = terpyridine moiety) is 
archived by refluxing a 1: 1 mixture of (CO)5ReX and L3 in a high boiling 
point solvent such as toluene, benzene or heptane. Yellow orange 
microcrystalline solids are obtained upon prolonged cooling. 
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2.2 Synthetic studies 
2.2.1 Ligand synthesis 
Tpymt (2.2) was synthesised from the high temperature trimerisation or 2- 
cyanopyrimidine. The crude Tpymt was purified by acidic extraction from 
the melt followed by charcoal decolourisation treatment. The resulting 
hydrochloride salt was deprotonated with ammonia solution giving 
analytically pure Tpymt in 40% yield (Scheme 2.3)93. 
Synthesis of 2-cyanopyrimidine (2.1) was achieved as published by 
Gohring et a!. with a DABCO catalysed substitution of 2-chioropyrimidine 
with sodium cyanide in DMSO94 (Scheme 2.3). 
X01 DABCO(, ) , 45°C 
N CN 140°C, 4 days 
+ NaCN 
DMSO, 4hrs " 
(2.1) 
(2.2) 
Scheme 2.3: - Synthesis of Tpymt (2.2) from 2-chloropyrimidine (2.1) 
P-Terpy95 (2.5) and Qtpy96 (2.6) were synthesised by modifications to 
literature procedures. The procedures consisted of two consecutive 
condensations. Firstly 2-acetylpyridine and either benzaldehyde or 4- 
pyridinecarboxaldehyde were reacted with NaOH in ethanol/water. This 
produced the 1,5-bis(2-pyridyl)-3-phenyl-pentan-1,5-dione or the 1,5- 
bis(2-pyridyl)-3-(4-pyridyl)-pentan-1,5-dione, respectively. This was 
further condensed with ammonium acetate in ethanol to produce the 
appropriately 4-substituted terpyridine (Scheme 2.4). 
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NaOH, H2O/EtOH 
oN Stir Mrs 
OEt 
N 
0 
N 
NaOH, H20/EtCH 
i Stir ihrs 
OH 
NH. OAO, roflux ihrs 
NH. OAc, rof1ux ahn 
Scheme 2.4: - Synthesis of P-terpy (2.5) and Qtpy (2.6) 
(2.6) 
1-1 
Tpp (2.7) was synthesised as reported by Goodwin et al. from the high 
temperature condensation of pyridoin and ammonium acetate97. 
2.2.2 Extended terpyridine complexes with the Terpy Ru(II) 
domain 
The complexes [TerpyRuTpt]2+98 (2.9), [TerpyRuP-terpy]2+85 (2.10) and 
[TerpyRuTpp]2+99 (2.11) (Figure 2.5) had been previously reported and 
similar procedures were employed in their synthesis. 
In all cases except Qtpy a slight excess of the appropriate ligand was 
refluxed in methanol with terpyRuC13.2H20 (2.8) for 10 minutes. A small 
amount of the reducing agent N-methylmorpholine was then added and 
the solution was refluxed for a further 1-3 hours then cooled to 0°C. 
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Figure 2.5: - Extended terpyridine complexes of TerpyRu(II) 
The purple or red solution was filtered through celite and the methanol 
was reduced to 1ml. NH4PF6 was added, followed by water, which 
induced the precipitation of the complexes as their PF6 salts. 
Purification was achieved on silica chromatography columns with 5% 
KN03(aq) in acetonitrile as the eluent. All 1H NMR, MS and 
microanalysis data was in agreement with previously published reports98, 
85,99 
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Scheme 2.5: - Synthesis of 4! -extended terpy complexes using methanol 
as the solvent 
The synthesis of [TerpyRuQtpy] 2+ (2.12) was successful with the 
methanol method described above for the other complexes but in an 
extremely low yield. It was found that if the synthesis was performed at 
an elevated temperature of 180°C using freshly distilled ethylene glycol 
as the solvent the yield of (2.12) was increased from 15% to 50%. Work 
up and purification was as for the other complexes. The low yield is 
presumably due to other species formed from the coordination of the 4'- 
pyridyl moiety. 
Since Tpymt was first synthesised in large quantities in 197693, there 
have been very few reports of transition metal complexes of Tpymt as it 
hydrolyses to a bis(2-pyrimidyl)carboximidato complex upon coordination 
to an electron withdrawing metal centre, such as copper(II)93 (Figure 2.6). 
Cu(N03)2.3H2O + 
NI /N 
Hz4 N 
-- 
1" O 
N\N H2O-Cu 
O \N\ H20 
ýN NI ý 
Figure 2.6: - Copper assisted hydrolysis of Tpymt 
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In order to reduce the risk of hydrolysis in the formation of [Terpy Ru 
Tpymt]2+ the synthesis was designed around a short reaction time and dry 
degassed solvents. Several solvent systems were tried such as 
methanol, ethanol, and nitromethane, however, in each case no reaction 
occurred even when silver was used to remove the chlorides from the 
terpyRuC13. The probable reason for the failure of these reactions is the 
insolubility of the Tpymt ligand in these solvents. 
In order to ensure enough ligand dissolved in the reaction mixture there 
needed to be a large excess of ligand, at least 10-fold and high 
temperatures were needed to aid the solubility of Tpymt. Dry ethylene 
glycol was deemed to meet these criteria and, treatment of terpyRuCl3 
(2.8) and 10 equivalents of Tpymt in N2-saturated ethylene glycol at 
180°C for 30 minutes resulted in the formation of a deep purple solution. 
After the solution had slowly cooled to room temperature, the product was 
treated with saturated aqueous NH4PF6, which resulted in the 
precipitation of a purple solid (2.13). The solid was collected, washed 
with ice-cold water, ice-cold diethylether and air dried (Scheme 2.6). 
NN rý HOýýOH 
180°C, 15min 
ii) Cool, NH4PFe 
(2.8) (2.13) 
Scheme 2.6: - Synthesis of (TerpyRuTpymtf + (2.13) 
(PF 32 
Purification of (2.13) was achieved with ion exchange chromatography 
using Sephadex CM-C25 ion exchange resin. The deep purple band 
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removed from the column was shown to exclusively contain 
[TerpyRuTpymt]2+ (2.13). The product was obtained in 70% yield and 1H 
NMR, FAB-MS, elemental microanalysis and a single crystal X-ray 
structure are all in agreement with the desired structure. This is the first 
reported octahedral transition metal complex of Tpymt that is stable to 
hydroysis. Once synthesised (2.13) has been shown to be air and 
moisture stable with no detectable hydrolysis even after 24 hours in 
aqueous solution at 30°C. 
2.2.3 Extended terpyridine complexes with the 
(phen)2Ru(II) domain 
When (phen)2RuCI2.2H20 (2.14) was refluxed in methanol with two 
equivalents of the appropriate extended terpyridine ligand, a colour 
change from black to red-orange occurred between 1 and 4 days 
(Scheme 2.7). After cooling and filtration, the methanol was removed and 
the crude product was purified by silica chromatography. After removal of 
considerable amounts of [(phen)3Ru]2+ the product of general formula 
[(phen)2RuL]2+ (L = extended terpy) was obtained in 30-70% yield (Figure 
2.7). 
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Figure 2.7: - Extended terpyridine complexes of (phen)2Ru2+ 
All attempts to synthesise the Tpymt complex in this series failed due to 
the hydrolysis of the ligand to the above mentioned bis(2- 
pyrimidyl)carboximidato species, along with a pyridine-2-carboxylic acid 
amide species (Figure 2.8). These products proved difficult to separate 
but they were easily identified by FAB-MS. 
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Figure 2.8: - Hydrolysis products from the attempted synthesis of 
((phen)2RuTpymtf + 
2.2.4 Extended terpyridine complexes with the (CO)3LRe+ 
domain. 
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Scheme 2.7: - Synthesis of rhenium(I) extended terpyridine complexes 
Building on methodology developed by various groups in the 1980's and 
1990's for bipy type complexes of rhenium(I) we have synthesised a 
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number of extended terpyridine complexes with rhenium(l) as the central 
metal ion. The general Scheme for the synthesis is outlined below 
(Scheme 2.7). 
Reaction of (CO)5ReCI the desired extended terpyridine ligand in refluxing 
toluene for four hours then cooling resulted in the precipitation of the 
brightly coloured (CO)3CIReTerpy complex (2.19-2.22). After washing with 
chloroform to remove the excess ligand the complexes were isolated in 
90 - 95% yield. The complexes are very insoluble and only weak broad 
1H NMR spectra could be obtained in d6-DMSO. However the expected 
number of signals and their relative integrations were consistent with the 
expected structures (Figure 2.9). Furthermore, MS and accurate mass 
data were consistent with the formation of the desired complexes. 
CI 
OC" 
.. 
IN 
OC 
, lRe` 
N-- 
N- 
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OC Re` N- -ý N 
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(2.21) 
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NN 
OC 'ie -N- 
-N' 
CO 
(2.19) 
(2.20) 
OC NN '". 
CC-Re------ 
Co 
\ýýj- 
(2.22) 
Figure 2.9: - Extended terpyridine complexes of (CO)3CIRe(I) (2.19-2.22) 
It was clear that in order to render the complexes soluble the chloride had 
to be substituted with a neutral ligand such as acetonitrile. This would 
induce a +1 charge on the complexes making them soluble in aqueous 
media. 
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The chloride complexes (2.19-2.22) were reacted with AgCF3SO3 in 
refluxing distilled acetonitrile for 10 hours resulting in the substitution of 
the chloride with acetonitrile. The silver chloride produced from the 
reaction was removed by filtration through celite and the acetonitrile 
complex (2.23-2.26) was recovered from solution by precipitation as 
triflate salts (Figure 2.10) with excess diethylether. All 1H NMR spectra, 
FAB-MS and elemental microanalysis were consistent with the formation 
of the desired complexes. 
0 
I + 1 
oc 
(2.25) 
111 7+ NN 
OC Re N 
CN 
N 
N 
--_3 
- 
CO 
(2.24) 
III -, 
7 
OC 
ý.. 
iNN 
OC Re N& N 
Co 
(2.23) (2.26) 
Figure 2.10: - Rhenium(1) acetonitrile complexes (2.23-2.26) of the 
extended terpyridine ligands 
2.3 lH NMR spectroscopic studies 
The 400 MHz 1H NMR spectrum of (2.13) in d3-nitromethane showed only 
the signals associated with the complex and no impurities. The downfield 
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aromatic region is shown below (Figure 2.11). 
r- 
jII 
2.00 202 2.00 3.11 5.18 419 202 
9.0 8.5 8.0 7.5 70 
de 
a k 
Figure 2.11: - Downfield region of the 400 Mhz 1H NMR (d3- 
nitromethane) spectrum of (TerpyRuTpymtf + (2.13) with 
the proton labelling Scheme 
The spectrum is well defined and integrates to 20 protons in total, which 
is the number of protons expected in the complex (2.5). Although the 
complex shows two-fold symmetry, the exact assignments of the protons 
is still not obvious. The proton assignments were made with the help of 
the COSY spectrum shown in Figure 2.12. Protons residing on each 
I 
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ligand set can easily be identified, Terpy (red) and Tpymt (blue). 
7.5 
B. 7 
0 
xe 
Figure 2.12: - 
1H COSY spectrum of [TerpyRuTpymtJ2+ (2.13) showing 
cross coupling between terpy (red) and Tpymt (blue) 
protons 
The four doublets residing at 9.15ppm, 8.91 ppm, 8.60ppm and 8.16ppm 
all have large coupling constants of around 9Hz indicating they are 
adjacent to ring nitrogens. The doublet at 8.91 ppm is cross-coupled to 
the triplet at 8.64ppm, which integrates to one proton, and they are j and k 
respectively on the free pyrimidine ring of tpymt. As protons g and i are 
rendered inequivalent due to coordination to ruthenium they can be 
assigned to the double doublets at 9.15ppm and 8.16ppm. Both of these 
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protons cross couple to the triplet at 7.54ppm, which can therefore be 
assigned to proton h. The triplet at 7.88ppm which integrates to only one 
proton must be the central proton a on the terpy ligand, with the doublet 
at 9.30ppm (j = 5Hz) being protons b. The remaining doublet at 8.60ppm 
with 9Hz splitting can be assigned to proton f. Analysis of the cross 
coupling allows the protons at 7.41 ppm (doublet), 7.15ppm (triplet) and 
8.00ppm (triplet) to be assigned to protons c, d and e, respectively. 
1H NMR spectra of compounds (2.15), (2.16), and (2.18) are extremely 
complex due to the asymmetric coordination mode of the extended 
terpyridine ligands. This destroys any symmetry in the complex rendering 
all the aromatic protons inequivalent. Even with the help of 2D COSY 
spectra, full assignment of all of the protons could not be achieved. 
However, each of the spectra integrates to the expected number of 
protons for each compound. 
The rhenium(l) chloride complexes (2.19-2.22) were extremely insoluble 
and only very poor 1H NMR spectra could be obtained in d6-DMSO. 
Although the spectra were very broad and weak, the correct number or 
aromatic signals can be seen for each of the complexes. 
The rhenium(I) acetonitrile complexes (2.23-2.26) were much more 
soluble and therefore well resolved. All of the spectra integrated to the 
correct number of protons for each of the complexes but as in the bis- 
phen complexes, the spectra were more complicated than the free 
ligands themselves. This indicates the extended terpyridine ligands are 
coordinated in a , i2-mode. This p2-coordination mode removes the plane 
of symmetry found in the free ligand and renders all of the protons 
inequivalent and therefore difficult to assign. In each complex the 
coordinated acetonitrile ligand appeared as a singlet, integrating to three 
protons around 2.2ppm. This showed a downfield shift of around 0.5- 
1 ppm for the acetonitrile upon coordination to the metal, which is 
comparable to values reported elsewhere'oo 
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2.4 Mass spectrometry studies 
The mass spectra of all the complexes were determined by the mass 
spectrometry service within the Department of Chemistry. The spectra 
were collected by either FAB or positive ion electrospray techniques. The 
data are summarised in Table 2.1 and each M/z value is consistent with 
the desired structure of each complex. Typically, the spectra show the 
sequential loss of any counter ions followed by loss of any other 
monodentate ligands such as pyridine or carbonyl. In general ligands 
coordinated in a bidentate or tri-dentate fashion are not removed from the 
metal centre upon ionisation. 
Table 2.1: - Mass spectrometric data for the extended terpyridine complexes 
Complex M/Z % Assignment 
[TerpyRuTpymt][PF6]2 795 25 [TerpyRuTpymt][PF6]+ 
650 100 [TerpyRuTpymt]' 
[TerpyRuTpt][PF6]2 791 100 [TerpyRuTpt][PF6]' 
646 10 [TerpyRuTpt]+ 
[TerpyRuQtpy][PF6]2) 791 70 [TerpyRuQtpy][PF6]; 
646 50 [TerpyRuQtpy]` 
[TerpyRuP-terpy][PF6]2 788 100 [TerpyRuTpymt][PF6]+ 
[TerpyRuTpp][PF6]2 867 80 [TerpyRuTpymt][PF6]' 
145 30 [TerpyRuTpymt]+ 
[(phen)2RuTpt][PF6]2 919 40 [(phen)2RuTpt][PF6]+ 
774 40 [phen)2RuTpt]+ 
[(phen)2RuQtpy][PF6]2 916 25 [(phen)2RuQtpy][PF6]' 
772 40 [(phen)2RuQtpy]' 
[(phen)2RuP-Terpy][PF6]2 915 70 [(phen)2RuP-Terpy][PF6]+ 
771 15 [(phen)2RuP-Terpy]' 
[(phen)2RuTpp][PF6]2 850 60 [(phen)2RuTpp]+ 
670 80 [(phen)RuTpp]{ 
688 60 [(phen)RuTpp]F' 
707 80 [(phen)RuTpp]F2' 
(CO)3CIReTpt 618 35 [(CO)3CIReTpt]' 
590 75 [(CO)2CIReTpt]+ 
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582 75 [(CO)3ReTpt]+ 
562 30 [(CO)CIReTpt]' 
534 25 [CIReTpt]' 
555 80 [(CO)2ReTpt]+ 
(CO)3CIReQtpy 618 50 [(CO)3CIReQtpy]' 
590 55 [(CO)2CIReQtpy]+ 
582 90 [(CO)3ReQtpy]' 
554 70 [(CO)2ReQtpy]+ 
(CO)3CIReP-terpy 615 30 [(CO)3CIReP-terpy]+ 
587 80 [(CO)2CIReP-terpy]' 
879 100 [(CO)3ReP-terpy]` 
552 30 [(CO)2ReP-terpy]+ 
(CO)3CIReTpp 694 5 [(CO)3CIReTpp]+ 
666 10 [(CO)2CIReTpp]+ 
638 10 [(CO) CIReTpp]+ 
610 15 [CIReTpp]+ 
[(CO)3MeCNReTpt][CF3SO3] 624 10 [(CO)3MeCNReTpt]+ 
583 60 [(CO)3ReTptJ+ 
555 30 [(CO)2ReTpt]i 
532 10 [(CO)ReTpt]' 
[(CO)3MeCNReQtpy][CF3S03] 582 40 [(CO)3ReQtpy]+ 
554 50 [(CO)2ReQtpy]` 
525 30 [(CO) ReQtpy]` 
[(CO)3MeCNReP-terpy][CF3SO3] 702 30 [(CO)2ReP-terpy][CF3SO3]` 
674 100 [(CO)ReP-terpy][CF3SO3]` 
552 80 [(CO)2ReP-terpy]+ 
2.5 X-ray diffraction studies 
X-ray quality crystals of [TerpyRuTpymt][PF6]2, (2.13) [(phen)2RuP- 
terpy][PF6]2 (2.17) and [(phen)2RuTpp][PF6]2 (2.18) were grown from the 
vapour diffusion of diethylether into an acetonitrile or nitromethane 
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solution of the complex and the structures were solved by Harry Adams 
and Sharon Spey in the X-ray structure determination service of this 
Chemistry Department. 
The projection of the asymmetric unit cell of [TerpyRuTpymt][PFe]2 is 
shown in Figure 2.13. 
ON, 
0( 
0000, 
Figure 2.13: - Projection of the asymmetric unit cell showing the two 
orientations of the cation and disorder of the anions in the 
crystal structure of (TerpyRuTpymt][PF6J2 
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r1l) A 
(8A) 
Figure 2.14: - ORTEP plot and stick representation of the crystal 
structure one of [TerpyRuTpymtf cations present in the 
unit cell. Hydrogens and lone pairs are removed for clarity 
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The unit cell contains two different orientations of [TerpyRuTpymt][PF6]2. 
There is also some observed disorder on the positioning of the PF6 
counter ions. 
Figure 2.14 shows the ORTEP plot and a stick model of the cations 
present in the unit cell of [TerpyRuTpymt][PF6]2. The structure shows a 
distorted octahedral geometry with the two terpyridine type ligands 
coordinated in an orthogonal arrangement similar to all other bis- 
terpyridine coordination complexes. The Tpymt ligand projects in a 
tongue like fashion away from the metal centre and appear to be ideally 
set up for intercalation into the base stack of double helical DNA. 
Surprisingly, the pendant pyrimidine ring is in plane with the rest of the 
ligand despite repulsion between the line pairs on nitrogens N8->N9 and 
N10->N11. 
The ORTEP plot and stick model of [(phen)2RuP-terpy][PF6]2 is shown in 
Figure 2.15. The most striking feature of this complex is the P-terpy 
ligand is coordinated to the ruthenium centre in a bidentate 112 mode. The 
ruthenium centre has distorted octahedral coordination geometry with 
bond lengths and angles comparable to other tris-phenanthroline type 
complexes of ruthenium(II). The P-terpy ligand projects away from the 
ruthenium complex just as the Tpymt ligand did in the previous structure. 
There is, however, considerable distortion from planarity in the P-terpy 
ligand, which may affect its ability to intercalate into DNA, but this may be 
due to crystal packing forces. The non-bonded pyridine of the P-terpy 
ligand is folded out of plane against one of phenanthroline ligands, 
leading to a narrower complex than the [TerpyRuTpymt]2+. 
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Figure 2.15: - ORTEP plot and stick model of the [(phen)2RuP-terpyf 
cation. Hydrogens and lone pairs are removed for clarity 
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The ORTEP plot of [(phen)2RuTpp][PF6]2 is shown in Figure 2.16. There 
is a problem with the modelling of one of the PF6 counter ions in this 
structure. One of the PF6 counter ions lies close to a special position, 
however, when forced into this position the R factor increases 
significantly. The ruthenium(II) cation is, however, well modelled. Again 
the structure shows the terpyridine type ligand bonded to ruthenium in a 
bidentate mode. The extra area available for interaction with DNA due to 
the extra pyridine ring should be noted. 
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Figure 2.15: - ORTEP plot of the ((phen)2RuPTppf + cation. Hydrogens 
and lone pairs are removed for clarity 
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2.6 Electrochemistry studies 
The cyclic voltammogram of [TerpyRuTpymt]2+ is shown in Figure 2.17. 
The CV was recorded in acetonitrile solution with 0.1M Bu4NPF6 as the 
supporting electrolyte. The CV's were recorded at 150mvs-1 and showed 
good reversibility with AEp< 1 00mV and I Epc / Epa I=1, unless otherwise 
stated. All the data were corrected for internal resistance using the AG&G 
electrochemistry power suite software package based upon normalization 
of the ferrocene oxidation couple. Table 2.2 shows the CV data for all of 
the other extended terpyridine complexes. 
-2.00 200 
Figure 2.17: - CV (current vs. Volts) for (TerpyRuTpymtf ' in acetonitrile 
Vs. Ag+/AgCI 
All of the ruthenium complexes show characteristic reversible 
ruthenium' 'r" redox couples. The position of these couples is dependant 
upon the nature of the extended terpyridine ligand in the complex. In 
both the TerpyRu2+ and (phen)2Ru2+ series, the more nitrogen atoms 
present in the ligand the more anodic the oxidation becomes. The series 
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is as follows; Tpymt>Tpp=Tpt>Qtpy>P-terpy with the ligands containing 9, 
6,6,4 and 3 nitrogens respectively. The inclusion of nitrogens in the 
terpy ligands serves to reduce the 7r-electron density on the ligand 
resulting in reduced it-back bonding to the ruthenium centre. This means 
that the Ru(III) oxidation state will not be stabilised as well and therefore a 
higher potential has to be applied to oxidise the ruthenium(II) complex. 
Contrary to this trend, the ligand based reductions become easier as the 
number of nitrogens increase; P-terpy=Qtpy>Tpt=Tpp>Tpymt. As the 
ligands become more electronegative it becomes easier to reduce them 
and the L°1-1 couple appears at a lower negative potential. 
Table 2.2: - Electrochemistry data for the 4'-extended terpy complexes 
in acetonitrile solution vs a Ag/AgCI electrode 
Com ound 
_ 
Oxidations Reductions 
[TerpyRuTpymt]2+ +1.62 89 -0.44 -1.18 -1.39 -1.57b 
[TerpyRuTpt]2+ +1.48 74 -0.71 -1.35 -1.59 -1.88b 
(TerpyRuQtpy]2+ +1.37 77 -1.10 -1.41 -1.78b 
[TerpyRuP-terpy]2` +0.91 81 -1.07 -1.94 
[TerpyRuTpp]2+ +1.50 69 -0.95 -1.40 -1.60b 
[(phen)2RuTpt]2' +1.49 92 -0.96 -1.41 -1.72b 
[(phen)2RuQtpy]2+ +1.34 85 -1.13 -1.39 -1.67b 
[(phen)2RuP-terpy]2 +1.28 86 -1.25 -1.37 -1.45b 
[(phen)2RuTPp]2 +1.43 92 -0.87 -1.37 -1.59b -1.71 
b 
[(CO)3MeCNReTpt]' +1.66b - -0.57 -1.02b -1.28b 
[(CO)3MeCNReQtpy]+ +1.41b - -1.11 -1.28b -1.60b 
[(CO)3MeCNReP-terpy]+ +1.36b - -1.15 -1.36b -1.55b 
a Op < 100 mV for all reversible reductions 
b event was chemically irreversible, therefore only Ep values are quoted 
The corresponding rhenium"" oxidation is characteristically irreversible 
but the same trend in oxidation potential is observed. 
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2.7 Spectroscopic studies 
The UV-Visible absorption spectra and luminescence emission spectra 
were recorded for all the extended terpyridine complexes. Unless 
otherwise stated, the spectra were recorded in acetonitrile solution at 
room temperature. As the spectra were used to monitor the binding of 
the complexes to DNA in an oxygenated aqueous media and no attempt 
was made to eliminate oxygen from the samples. 
An example of the spectra obtained is shown in Figure 2.18, which shows 
the UV-Visible absorbance spectra for the phen2Ru(II) complexes. 
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-- l(pn. n)RuTpp)" 
....... l(ph. n)TRuTpQ'' 
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Wavelength (nm) 
Figure 2.18: - UV-Visible spectra of the (phen)2Ru extended terpyridine 
complexes recorded in acetonitrile solution 
The low energy bands (350-550nm) present in all of the ruthenium(II) 
complexes are characteristic of MLCT transitions from the ruthenium(II) 
centre to the various pyridyl components of the coordinated ligands. 
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These low energy transitions are similar in both energy and intensity 
(5,000 - 20,000 mol-l dm3 cm") to those observed in the numerous tris- 
phenanthroline and bis-terpyridine type complexes present in the 
literature, giving rise to their intense red through purple colours. The 
intense higher energy bands, typically <300nm can be assigned to ligand 
centered ir-> t and n-), transitions. 
The rhenium(I) complexes show much simpler UV-Visible spectra 
typically consisting of a sharp MLCT transition appearing around 300- 
320nm with a tail extending to around 450nm in the visible region. The 
ff 
ligand centered it-nn and n--+it transitions appeared as either two bands 
or one broad band in the 230 - 300nm region of the spectrum. Again 
these values are typical of other rhenium(l) polypyridyl complexes found 
in the literature. 
Table 2.3: - Spectroscopic data for the 4-extended terpyridine 
complexes recorded in acetonitrile solution 
Complex Absorption Emission 
Amax E Assignmen X0.7-sm 
(nm) (mol"1dm3 cm'') (nm) (nm) 
[TerpyRuTpymt][PF6]2 269 35,121 LC a-'n 296 20,531 LC t-* t 316 14,572 LC n-ýn 330 18,346 LC t-ºn 474 13,796 MLCT 
[TerpyRuTpt][PF6]2 (2.1) 
271 
280 
Sh 
37 183 LC n-ýn 
299 , 34,933 LC n--ýn * 326 sh LC n-+n 
479 14,350 LC n-*n 
MLCT 
[TerpyRuQtpy][PFB]2 (2.2) 2229 38 
Sh 
25 584 LC n-ýn -- 
273 , 36,438 LC n-+n 
309 35,498 LC n-+n 
324 sh LC n- +n 
485 15,204 MLCT 
[TerpyRuP-terpy][PF6]2 (2.3) 239 32,867 LC n->n 272 49,327 LC n-*n 279 48,267 
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307 61,000 LC t- n 
481 23,806 LC n- +n 
MLCT 
[TerpyRuTpp][PFe]2 (2.4) 194 10,800 LC 
224 13,300 LC 
274 10,000 LC n--* t 
283 sh LC n-+n* 310 10,600 MLCT 
[(phen)2RuTpt][PFg]2 264 62239 LC t. - 
n 450 725 
284 sh LC n-mn 
402 sh MLCT 
432 9912 MLCT 
470 7519 MLCT 
[(phen)2RuQtpy][PFe]2 244 31138 LC n-+n* * 
450 674 
287 45977 LC n-+n 
450 10428 MLCT 
[(phen)2RuP-terpy][PF6]2 220 60272 LC t-ýx 450 595 
264 72782 LC 7t-+n 
310 sh LC n-+n 
385 7134 MLCT 
450 9775 MLCT 
[(phen)2RuTpp][PF6]2 264 75751 LC n-7t 430 715 
344 21820 LC 7c-+n 
427 11308 MLCT 
488 7306 MLCT 
[(CO)3MeCNReTpt]` 251 26604 LC t-ýn 
295 27103 LC n-+n* 
302 25108 LC 7-ºn 
377 5171 MLCT 
[(CO)3MeCNReQtpy]; 253 28110 LC n-+n* 310 417 
279 sh LC n-+n 
330 12727 MLCT 
[(CO)3MeCNReP-terpy]` 251 26207 LC n-* n* 310 370 
277 26735 LC n-+n* 
328 17372 MLCT 
As expected, none of the terpy derivatives of the compounds show any 
room temperature luminescence, which is completely consistent with 
other published compounds. The lowest lying excited state which is the 
triplet metal-to-ligand-charge-transfer state 3[MLCT] normally centered on 
the ligand n LUMO, is very low lying in bis-terpyridine type complexes. 
This undergoes fast non-radiative deactivation <1 ns resulting in no room 
temperature emission101. The bis-phen ruthenium compounds show 
characteristic emission spectra. The complexes were excited at 450nm 
directly into the MLCT bands. The observed emissions occurred between 
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595 and 725nm. The more nitrogen atoms that are present in the 
extended terpyridine ligand, the lower the energy of the emission. This is 
because the LUMO, The ligand it is lowered in energy as the number of 
nitrogens increase (Figure 2.19). 
7t 
n 
Energy 
n 
n 
71 
71 
Increasing Nitrogens 
Figure 2.19: - Schematic of the relative energy of ligand ; rand ;c orbitals 
as the number of nitrogens in the aromatic system increase 
The two rhenium complexes [(CO)3MeCNReP-terpy]+ and 
[(CO)3MeCNReQtpy]+ showed very high energy (380-420nm) structured 
emissions (Figure 2.20). Both complexes were excited at 310nm and the 
resulting low energy emission is presumed to be ligand-centered, but at 
present the exact pathway is not known. Further studies are underway to 
try and quantify and hence find the origin of these interesting emissions. 
The Tpt complex showed no emission when excited at a range of 
different wavelengths. To our knowledge this is the first such rhenium(I) 
complex containing a triazine moiety and as such we can only postulate 
that the triazine serves to quench the excited state of the complex. 
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Figure 2.20: - Emission spectr recorded in acetonittile solution for 
((CO)3MeCNReQtpyf ` and ((CO)3MeCNReP-terpyr 
2.8 Conclusions 
A series of ruthenium(II) and rhenium(I) complexes containing 4'- 
extended terpyridine ligands has been prepared. 1H NMR, mass 
spectrum and in some cases X-ray crystal structures have shown the 
complexes to adopt the required geometry with the extended aromatic 
ligand projecting away from the metal centre. These complexes are 
ideally set up for interaction with double helical DNA. Moreover, they 
have been shown possess rich photophysical signatures that can be used 
to monitor their binding to DNA. Results from the DNA binding assays 
are discussed in Chapters 5 and 6. 
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Tris-pyrazolyl methane complexes 
of Ruthenium(II) 
3.1 Introduction 
Over the past decade or so, metal complexes incorporating the poly- 
aromatic ligand dppz have been extensively studied with respect to their 
interactions with DNA21'102'104. Particular interest has centred on the 
ability of ddpz complexes to report the nature of their surroundings24. In 
non-aqueous environments ruthenium dppz complexes show intense 
luminescence upon excitation with light of a suitable wavelength into the 
MLCT transition of the complex. In aqueous environments this 
luminescence is completely quenched through hydrogen bonding of water 
molecules to the phenazine nitrogens of dppz. When DNA is added to 
aqueous solutions the luminescence is switched back on21. It has been 
shown by a variety of techniques that the dppz ligand intercalates into the 
base stack of the DNA, thus protecting the phenazine nitrogens from 
water quenching, although the exact orientation of the complex with the 
DNA has been open to much debate 25,27, "05.1°6 Dppz complexes show 
good affinity for DNA, and coupled with their rich photochemistry and 
redox properties, they show great potential as DNA binding agents. 
There are, however, still many problems to be addressed before they 
possess the affinity and specificity of other DNA binding agents. 
Because of limitations in the synthetic procedures chelate complexes of 
ruthenium(II) have to be synthesised as a racemic mixture of A- and 0- 
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forms. As a consequence of the DNA binding properties differing 
between the two enantiomeric forms, they have to be resolved via long 
and tedious procedures, often resulting in a significant loss of 
compound27. Furthermore, as the ruthenium(II) centre is coordinately 
saturated any attempt to extend or modify the geometry of the system 
involves modification of the aromatic ancillary ligands themselves5960 
1o7 often resulting in wasteful statistical mixtures of compounds, 1os 
In this study we begin to address these two problems, firstly by 
developing an achiral ruthenium(II) system based around the well- 
characterised dppz moiety. Secondly, we have introduced a free 
coordination site, which is available to further extend the system or 
modulate the charge of the system. 
3.1.1 Tripodal facially coordinating ligands 
In order to achieve the required geometry for the proposed system we 
needed to cap one face of the octahedral ruthenium(II) complex. This will 
leave three more coordination sites available for further substitution. 
Reaction of the facially capped species with a bidentate ligand such as 
dppz would result'in the formation of a species with all the requirements 
for binding to DNA. The axial coordination site can then be used to tune 
the system further (Figure 3.1). 
ýI 
/--\ 
N 
"'. 
N 
N-M- ºN 
\I\ 
\ý 
NJ 
Figure 3.1: - Proposed route of synthesis 
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There were several candidates for use as the facially capping tripodal 
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ligand such as tris-(1-pyrazolyl)borate, tris-(1-pyridyl)methanol and tris-(1- 
pyrazolyl)methane (Tpm) (Figure 3.2). 
CtlD 
C(t'C 
N 
Figure 3.2: - Some tripodal ligands 
Cý N ýýý ýý . N 
Tris-(1-pyridyl)methanol109 requires a complicated synthesis and is 
difficult to obtain in large quantities. While the chemistry of tris-pyrazolyl 
borates is well developed, its use was not deemed suitable due to its 
tendency to hydrolyse in aqueous environments. 
Recent advances in synthetic procedures as reported by Reger et al. 
allows tris-(1-pyrazolyl)methane and derivatives to be easily prepared in 
high yields10, so this is used as the facially capping tripodal ligand in this 
study. 
In 1988 Mayer et-al. reported the synthesis of TpmRuCI3 . 3H20 and 
its 
reaction with bidentate ligands to produce [TpmCIRuL2]+ (where L2 = bipy, 
phen etc. ) (Scheme 3.1)111. 
94 
Chapter 3 Tris-pvrazolvl methane complexes of ruthenium(11) 
H 
C 
EtOH, reflux 3Hours 
\ 
ýN 
'f 
RuCl3.3H2O 
N 
/cw 
3: 1 EtOH/H20 
Et3N, reflux 10 min 
ýN 
NZ, 
.) 
N_ 
cl 
Scheme 3.1: - Mayers synthesis of Tpm ruthenium(Il) complexes 
The axial chloride can be substituted for practically any pyridine or nitrile 
ligand. First the chloride is removed with silver nitrate in ethanol/water. 
Addition of the nitrogen donor ligand and further refluxing affords the 
coordination of the ligand to the axial site. The reaction is almost 
quantitative and the substituted product requires little or no purification"'. 
3.2 Synthetic studies 
3.2.1 Ligand synthesis 
Tpm (3.3) was synthesised as reported by Reger et at from a CHCI3 - 
H20 phase transfer reaction10. A large excess of Na2CO3 base affords 
the deprotonation of pyrazole and initiates its subsequent reaction with 
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CHCI3 (Scheme 3.2) 
n/ 
Na2CO3, Bu4NBr(cat) N-N 
H2O / CHCI3 
reflux, 3days x 
H---< ...... 1,1" N-N 
N-N 
N- 
(3.3) 
Scheme 3.2: - Synthesis of Tpm (3.3) 
Dppz (3.2) was prepared by literature methods (Scheme 3.3) from the 
condensation of 1,10-phenanthroline-5,6-dione (dpq) (3.1) with o- 
phenyline-diamine in ethanol' 12. dpq (3.1) was prepared from the acidic 
oxidation of 1,10-phenanthroline with bromine27. 
N 
D-' 
I 
H2SO4, HNO3, NaBr 
Reflux 3 hours 
Ný\ý 
NN 
(3.2) 
(3.1) 
NH2 
NH2 
EtOH / Air, reflux 20 mins 
Scheme 3.3: - Synthesis of dppz (3.2) 
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3.2.2 Preparation of [TpmCIRudppz]+ (3.5) 
The starting material TpmRuCl3. xH2O (3.4) was prepared by the method 
reported by Mayer et al. by refluxing RuCI3.3H20 with a slight excess of 
Tpm in ethanol for three hours"'. 
Refluxing (3.4) with a slight excess of dppz in 3: 1 ethanol: water along 
with I ml of the reducing agent triethylamine for 10 minutes resulted in the 
formation of the mono cationic complex [TpmClRudppz]' (3.5) (Scheme 
3.4). The compound was isolated as a PF6 salt by reducing the solvent 
volume to 5ml and adding a molar excess of NH4PF6. The crude 
compound was purified by column chromatography on neutral alumina 
with 1: 1 acetonitrile: toluene as the eluent. The single dark red band 
contained the product (3.5), which was characterised by 1H NMR, FAB- 
MS and accurate mass. 
N 
NI 
RU-C 
G 
(3.4) 
f) dppz, UG, Et3N 
reflux 3: 1 EtOH/H20 
ii) NH4PFe 
H, 
Scheme 3.4: - Preparation of (TpmClRudppzf (3.5) 
3.2.3 Preparation of [TpmPyRudppz]2+ (3.6) 
(3.6) 
JPFJ2 
Conversion of (3.5) to its chloride salt by treatment with "Bu4NCI in 
acetone rendered it water soluble allowing it to be refluxed with two 
equivalents of AgNO3 in 1: 1 ethanol: water. This resulted in the 
abstraction of the axial chloride and its subsequent precipitation as 
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insoluble AgCI, which was removed from the reaction mixture by 
centrifugation. Addition of excess pyridine and further refluxing for 6 
hours leads to the formation of the pyridine substituted complex (3.6). 
Again the complex was isolated as its PF6 salt by reducing the volume of 
solvent and addition of a molar excess of NH4PF6. The product was 
shown to be pure upon isolation and no further purification was required. 
H CI, T' 
iN 
CI 
(3.5) 
q AQNO, 1: 1 EtOWH=O, mx 
A) Xs Pt ns, r, IYQ 6 haws 
YI) NH4PF, 
a 
r IRF. h 
9 
(3.6) 
Scheme 3.5: - Preparation of (TpmPyRudppzf + (3.6) 
3.2.4 Preparation of [TpmMeCNRudppz] 2+ (3.7) 
Refluxing (3.5) with AgCF3SO3 in freshly distilled acetonitrile leads to the 
abstraction of the axial chloride with precipitation of insoluble AgCI and 
subsequent substitution with acetonitrile (Scheme 3.6). The AgCI was 
removed by filtration through celite. To ensure complete metathesis to the 
PF6 salt the acetonitrile was removed and the residue was taken up in 1 
ml methanol. A molar excess of NH4PF6 was then added followed by 10 
ml water, which resulted in precipitation of (3.7) as its PF6 salt. No 
further purification was required and the compound was characterised by 
1H NMR, FAB-MS and accurate mass determination. 
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Scheme 3.6: - preparation of (TpmMeCNRudppzf + (3.7) 
3.3 lH NMR spectroscopic studies 
All three of the Tpm ruthenium(II) complexes showed well resolved 1H 
NMR spectra. 
Figure 3.3 shows the downfield region of the 1H NMR spectrum of 
[TpmCIRudppz]+ recorded at 250MHz in d6-acetone. A 2D COSY 
spectrum (not shown) recorded at 400MHz in d6-DMSO was used to aid 
the assignment of the protons although it was quite broad. 
The spectrum of complex is fairly simple due to the plane of symmetry 
running through the molecule. The sharp singlet at 9.63ppm is 
characteristic of the de-shielded proton on the Tpm methane (a)111. The 
doublet at 9.57ppm has a coupling constant of 9 Hz suggesting it is 
adjacent to a ring nitrogen. Cross-referencing of this proton on the COSY 
shows it is coupled to the double doublet at 8.06ppm, and the double 
doublet at 9.17ppm. All three of these protons integrate to two and can 
therefore be assigned to protons h, i and j on the phenanthroline section 
of dppz. The three proton signal at 8.57ppm can be assigned to protons 
pyrazole protons b and e and analysis of coupling patterns allows two of 
the protons of the three proton multiplet at 6.87ppm to be assigned to 
proton f on the two equatorial pyrazoles. The single proton triplet at 
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6.30ppm is coupled to both protons at 8.47ppm (b) and 6.87ppm and can 
be assigned to proton (c) with 6.87ppm being assigned to proton (d) of 
the axial pyrazole. The final two protons 8.52ppm and 8.17ppm each 
integrating to two protons coupled to each other and are the two 
phenazine proton k and I. 
ton is ss ss es 7i 1s of t 
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Figure 3.3: - Downfield region of 250MHz 1H NMR spectrum of 
(TpmClRudppzf* with proton labeling scheme 
The aromatic region of the 400MHz 1H NMR spectrum in d6-acetone of 
[TpmPyRudppz]2+ is shown in Figure 3.3 with the proton labelling 
scheme. The COSY spectrum of the complex is shown in Figure 3.5 with 
cross coupling between Tpm protons (blue), dppz protons (red) and 
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pyridine protons (green). Again the spectrum is fairly simple due to a 
plane of symmetry running through the molecule. With the help of the 2D 
COSY spectrum the complete assignment of the protons has been 
achieved. 
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Figure 3.4: - Downfield region of 400MHz 1H NMR (d6 acetone) of 
jTpmPyRudppif 4' with proton labelling scheme 
The sharp singlet at 9.93ppm can be assigned to the highly shielded 
methyl proton of Tpm. The six protons of the two equivalent pyrazoles 
occupying the equatorial positions are seen at 8.85ppm (b), 6.98ppm (c) 
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Figure 3.5: - 
1H COSY spectrum of [TpmPyRudppzf + showing protons 
from Tpm (blue), dppz (red) and pyridine ligands (green) 
and 5.52ppm (d), respectively, with all three integrating to two protons 
each. The three protons of the pyrazole occupying the axial coordination 
site integrate to one proton each and appear at 8.58ppm (e), 6.30ppm (f) 
and 6.93ppm (g), respectively. The characteristic signals of a 
coordinated pyridine appear at 7.8ppm (triplet) C4 proton, integrating to 
one proton, 7.15ppm (triplet) C3 proton, integrating to two protons and 
7.76ppm (doublet) C2 proton integrating to two protons. The proton at 
9.87ppm has a large coupling constant of 9Hz and can be assigned to 
proton b on the phenanthroline portion of the dppz ligand with cross 
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coupling allowing assignment of i 8.21 ppm and c 9.42ppm. The two 
phenyl protons appear at 8.56ppm (f) and 8.24ppm (h), respectively. All 
five of the dppz signals integrate to two protons each. 
The 250MHz 1H NMR spectrum (acetone) of [TpmMeCNRudppz]2+ and 
the proton-labelling scheme is shown in Figure 3.6. 
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Figure 3.6: - Downfield region of 250MHz 1H NMR spectrum of 
fTpmMeCNRudppzf " with proton labelling scheme 
The sharp singlet at 2.29ppm integrates to three protons and is in the 
expected position of a coordinated acetonitrile ligand (m). The singlet is 
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at 10.01 ppm, is characteristic of the methyl proton of Tpm (a). COSY 
cross coupling shows the three equatorial pyrazole protons each 
integrating to two protons each are the double doublet at 8.80ppm (b), the 
double doublet at 6.95ppm (c) and the double doublet at 8.86ppm (d). 
The three signals integrating to one proton each are the three axial 
pyrazole protons and are the double 7.07ppm (e), the double doublet at 
6.37ppm (f) and the double doublet at 8.62ppm (g). The characteristic 
9Hz doublet at 9.87ppm is the phenanthroline proton (h) of dppz with the 
other two being the double doublets at 8.27ppm (i) and 9.42ppm (j). 
Finally the two-phenazine protons appear at 8.22ppm and 8.56ppm 
respectively. 
3.4 Mass spectrometry data 
The FAB-MS data for the Tpm monomers is summarised in Table 3.1. 
The data back up the structural assignments made by 1H NMR, as the 
spectra of each of the three complexes show masses that can be 
assigned to the desired structures. Peaks corresponding to loss of one 
PF6 counter ion and then loss of the axial ligand are seen for each of the 
complexes. 
Table 3.1: - FAB-MS data for the Tpm monomers 
Compound M/z % Assignment 
[TpmClRudppz][PF6] 633 100 [TpmCIRudppzJ` 
597 30 [TpmRudppz]` 
[TpmPyRudppz][PF512 676 50 [TpmPyRudppzJ' 
752 100 [PyRudppz][PF6J2 
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598 30 [TpmRudppz]' 
[TpmMeCNRudppz][PFd]2 784 100 [TpmMeCNRudppz][PF6] 
638 70 [TpmMeCNRudppz]` 
597 80 [TpmRudppz]` 
3.5 Electrochemical studies 
Cyclic voltammetry (CV) was carried out on all three of the Tpm 
monomers. All measurements were carried out in nitrogen-saturated 
acetonitrile with OA M Bu4NPF6 as the support electrolyte and a saturated 
silver-silver chloride reference electrode. All the data were corrected for 
internal resistance using the AG&G electrochemistry power suite software 
package based upon normalization of the ferrocene oxidation couple. 
The CV's were recorded at 150mvs" and showed good reversibility with 
iEp< 100mV and I Epc / Epa I=1, unless otherwise stated. The data are 
summarised in Table 3.2. 
Table 3.2: - Electrochemistry data for the Tpm monomers 
Compound Oxidations Reductions 
E112 (V) AEp (mV) E12 (V)° 
[TpmClRudppz][PF, ] +0.89 97 -0.91 
[TpmPyRudppz][PF6]2 +1.30 60 -0.87 -1.24a 
[TpmMeCNRudppz][PF6]2 +1.36 90 -0.86 -1.29a -1.67a 
a reductions are not fully chemically reversible, only Ep values are quoted 
b ep <100 mV for all reduction processes 
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All three of the Tpm complexes display oxidations associated with the 
Rucouple. Figure 3.7 shows that all three of the complexes exhibits 
one reversible oxidation couple, however, the E% varies by nearly 400mV 
between the complexes. 
. 80 
[TpmClRudppz]+ - [TpmMeCNRudppz]2+ - [TpmPyRudppz]2+ 
Figure 3.7: - Electrochemical CV (current vs volts) for the Tpm 
monomers. 
The position of the Rucouple is dependent upon the nature of the 
axial ligand on the complex. When the ligand is chloride the Ru 
couple occurs at 0.89V, when it is pyridine the Ru("')/(") couple occurs at 
1.30V and when the ligand is acetonitrile the Ru("')/(") couple occurs at 
1.36V. This behaviour can be rationalised by the a- and 7t-donor and 
acceptor characteristics of the axial ligand. Chloride is a good ca-donor 
and a good n-donor so it effectively has an induction effect pushing 
electrons onto the metal centre and destabilising the Ru(II) oxidation 
state, and at the same time stabilising the Ru(lll) oxidation state, 
therefore the complex is relatively easy to oxidize. Pyridine is a good CT- 
donor ligand but also a good n-acceptor which means there is some 
delocalisation of the d-electrons off the metal onto the pyridine. This has 
the effect of stabilising the Ru(II) oxidation state and making the oxidation 
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more difficult. Nitriles are poorer a-donors and better it-acceptors than 
pyridines so the Ru(II) oxidation state is stabilised even more, resulting in 
the Ru("'Y(°) couple being slightly more anodic than for the pyridine. 
Moreover, the oxidation waves show the presence of only one oxidatively 
active domain, suggesting only one metal environment is present in each 
sample. This dismisses the possibility of any structural isomers or 
impurities being present in the samples. 
Characteristic ligand-centred reductions are also seen for each of the 
complexes. The first of these waves is reversible in each compound, 
however, subsequent waves are irreversible. Dppz is more easily 
reduced than other di-imine ligands such as phen and bipy. This is due to 
the lover lying n -orbital of the phenazine moiety. Thus the n-accepting 
site in dppz is localised on the phenazine portion of the ligand24. This 
makes any electrochemical and photochemical processes involving this 
orbital very sensitive to its surroundings. 
3.6 UV-Visible spectroscopic studies of the 
Tpm monomers 
The UV-visible spectra of the complexes were recorded in acetonitrile 
(Figure 3.8) and the data are summarised in Table 3.3. 
Table 3.3: - UV-Visible data for the Tpm monomers 
Compound 1. max c (mol'1 dm3 cm'1) Assignment 
(nm) 
[TpmCIRudppz]' 272 58403 n-*n 
351 14008 n-+n 
107 
Chapter 3 Tris-p vrazolvl methane complexes of ruthenium(II) 
367 12534 MLCT 
445 7853 MLCT 
519 sh MLCT 
[TpmPyRudppz]2) 277 62553 n-ºn* 
312 22315 non 
351 22718 n. +n 
398 9112 MLCT 
484 sh MLCT 
[TpmMeCNRudppz]2 277 55055 n- n 
356 13664 n-+n 
402 sh MLCT 
455 3804 MLCT 
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Figure 3.8: - UV-Visible absorption spectra in acetonitrile for the three 
Tpm monomers 
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All three spectra are dominated by the high-energy band at 270 - 290nm 
which correspond to the it-nn transitions of the aromatic nitrogen donor 
ligands. The absorption spectrum of the free dppz ligand in DMF shows a 
double absorption in the near UV region with maxima at X= 358 and 
376nm. These have been assigned to n--nn transitions of the phenazine 
ring in dppz24. Based on this, we can assign the moderately intense 
bands in the near UV regions of the complexes to this transition, which in 
the case of [TpmClRudppz]+ has two maxima at 351 nm and 367nm, 
[TpmPyRudppz]2+ one broad maxima at 351 nm and 
[TpmMeCNRudppz]2+ one broad maxima at 356nm. The MLCT bands all 
appear in the visible region of the spectrum which is characteristic of 
Ru(II) complexes with polyimine ligands coordinated. The bands for 
[TpmPyRudppz]2+ and [TpmMeCNRudppz]2', 398nm and 402nm, 
respectively, are both higher in energy than [TpmClRudppz]+, 455nm. 
This correlates with the electrochemistry data, in that the HOMO on the 
metal centre is stabilized with respect to the LUMO which is in turn 
destabilised resulting in a higher energy do (Ru)-->n MLCT transition in 
[TpmPyRudppz]2+ and [TpmMeCNRudppz]2+. The inductive effect of the 
chloride in [TpmClRudppz]+ destabilises the HOMO and stabilises the 
LUMO resulting in a lower energy do (Ru)-nn MLCT transition. 
3.7 Emission spectra of the Tpm monomers 
The emission spectra for the Tpm complexes [TpmClRudppz]', 
[TpmPyRudppz]2+ and [TpmMeCNRudppz]2` were recorded in 
acetonitrile solution and are shown in Figure 3.10. They have been 
scaled to the same height for clarity. 
The chloride complex [TpmClRudppz]+ shows a lower energy emission at 
Xmaxemm = 668nm as opposed to the pyridine complex [TpmPyRudppz]24' 
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Xmaxemm = 616nm and the acetonitrile complex [TpmMeCNRudppz]2+ 
XmaxeR m= 613nm. Excitation of each of the complexes was into the 
MLCT band at 446nm [TpmClRudppz]`, 432nm [TpmPyRudppz]2+ and 
448nm [TpmMeCNRudppz]2+, respectively. The lower energy emission of 
the chloride complex can again be attributed to the fact that chloride has 
an inductive effect. This de-stabilises the metal centred HOMO relative to 
the ligand centred LUMO 
LUMO 
AE 
HOMO 
LUMO 
AE 
HOMO 
L= Py, MeCN L=CI 
Figure 3.9: - Schematic showing the effect of the axial ligand L on the 
relative energy of the metal centred HOMO relative to the 
ligand centred LUMO. 
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Figure 3.10: - Luminescence emission spectra for the Tpm complexes 
recorded in acetonitrile solution 
3.8 Conclusions 
In this chapter the synthesis and characterisation of three novel achiral 
ruthenium(II) complexes based upon the dppz ligand have been 
discussed in detail. Tpm successfully facially coordinates to the 
ruthenium centre and the bidentate dppz ligand protrudes away from the 
metal centre in the axial plane. This results in a geometry, which is ideal 
for allowing these complexes to interact with DNA in an intercalation 
mode. With the axial chloride in place the overall charge on the complex 
is +1, but when the chloride is substituted with either pyridine or 
acetonitrile the overall charge is increased to +2. This substitution 
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process yields products that require no further purification. As there is no 
spectroscopic evidence of any major change of geometry after 
substitution, a system has been produced which should give a direct 
insight into the effects of charge on the DNA binding characteristics of 
these complexes. 
Furthermore, spectroscopic studies have revealed rich spectroscopic 
signatures in the form of characteristic UV-Visible and luminescence 
spectra, which can be used monitor DNA binding 
The DNA binding studies have been undertaken and will be discussed in 
Chapter 5. 
3.9 Further work 
Now that the methodology has been developed for quick and high yield 
substitution of the axial chloride in [TpmClRudppz]+ with pyridines and 
nitrites, further work could involve incorporation of bulkier ligands into this 
axial position. This would produce a new series of metallointercalators 
and would give an insight into the effect of steric bulk on the binding 
affinity and specificity of this new class of meta I lointerca lators. 
The intercalating ligand could also easily be changed allowing fine-tuning 
of the system to try and target specific DNA sequences. 
There is also scope for attaching peptide sequences to this axial position 
resulting in novel metal peptide conjugate systems. If, as assumed, the 
mode on interaction of these complexes with DNA is intercalation of the 
dppz ligand from the major groove, the axial position is ideally orientated 
for delivering any recognition element or functional domain straight into 
the major groove itself. Figure 3.11 shows an example of a bifunctional 
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agent comprising of a ruthenium dppz intercalating domain tethered to a 
cis-platin type moiety. Compounds of this type can easily be assembled 
using the "mix n match" methodology developed in this chapter. 
H 
N, 
% 
Ný I 
N k- 
\ 
N CI Pt 
N CI 
[PF6]2 
Ný 
\ 
Figure 3.11: - An example of a bifunctional DNA binding agent 
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Bimetallic complexes as DNA 
clips 
4.1 Introduction 
Recently a large amount of research has focused on developing 
bimetallic systems as DNA binding agents75. Kelly et al.. has taken the 
relatively weak binding system of tris phenanthroline ruthenium(II) and 
linked two of them together57. This has increased the binding affinity for 
DNA by over 100-fold58. As both of the ruthenium(II) centres are chiral 
joining two of them together only serves to increase the problems 
encountered when these chiral complexes are separated. 
In this chapter we report the synthesis and characterisation of a number 
of bimetallic complexes incorporating the well-characterised DNA 
intercalating ligand dppz21,25,113. Two such systems have been 
synthesised, one rhenium(I) system and one ruthenium(II) system. 
Moreover, each of these systems is achiral, alleviating the need for time 
consuming chromatographic separation of enantiomers. 
The mononuclear complex [(CO)3PyRedppz]+ has previously been shown 
to bind strongly to DNA42. The complex was synthesised with the 
method developed by Meyer et al. (Scheme 4.1)114. 
The starting material (CO)5ReCl is reacted with the dppz ligand in toluene 
to give the chloride complex (CO)3CIRedppz. This complex is reacted 
with silver in acetonitrile to give the acetonitrile substituted complex 
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[(CO)3MeCNRedppz]+ which can then be reacted with excess pyridine to 
give [(CO)3PyRedppz]+ in almost quantitative yield. 
OC AgCF3SO3. MeCN 
I 
II [CF3SOý] 
OC=Re-N reflux, Ehr CC.. 1 
NN 
OCRe` N 
CO 
NN 
Co 
AgCI 
Pyridine, THE 
reflux 3 hours 
[CF3SOýj 
C, `JJ N 
OC= ie-~ Y 
NN 
CO 
Scheme 4.1: - Synthesis of the mononuclear dppz complexes of 
rhenium(l) 
In this study we aim to replace the pyridine ligand with dipyridyl ligands 
and hence bridge two metal centres thus forming bimetallic rhenium 
complexes (Figure 4.1). The bridging ligands are 1,2-di(4-pyridyl)-ethane 
(dpe[2]), 1,3-di(4-pyridyl)-propane (dpp[3]) and 1,5-di(4-pyridyl)-pentane 
dpp[5]. These ligands have 2,3 and 5 carbon atoms, respectively, in the 
alkyl chain bridging the two metal centres. 
Furthermore, building on the synthetic methodology developed in Chapter 
3 for the synthesis of [TpmPyRudppz]2+, we aim to replace the pyridine 
ligand with the di-pyridyl ligands discussed above which can bridge two 
metal centres producing a ruthenium DNA clip (Figure 4.1). 
These bimetallic complexes should have increased binding affinity to 
DNA over their monometallic analogues and may bind cooperatively. 
They offer the possibility of producing synthetic complexes, which have a 
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binding affinity and specificity comparable to DNA binding protein. 
- ýj OCO 
_7 2+ ýL 
N\ 
OC`I 
0 
:c 
OC-Ru-LJ 
/_ý/ý 
-L% I 
u-CO /N 
\N 
N 
NI1 
NN 
NCI 
1 
4+ 
Figure 4.1: - Bimetallic rhenium and ruthenium complexes proposed in 
this study 
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4.2 Synthetic studies 
4.2.1 Ligand synthesis 
dppz12 and Tpm11° were synthesised as reported in previous chapters. 
dpe[2] and dpp[3] were obtained from commercial sources, however, 
dpp[5] was not commercially available. 
dpp[5] (4.1) was synthesised as described by Jampolsky et a!. 1f5 by de- 
protonation of 4-picoline with potassium amide in liquid ammonia and 
subsequent reaction with 1,5-dibromopentane (Scheme 4.2). 
N 
i) KNH2, NH3, stirr Ihr 
ii) Br Br 
N 
Q\/ 
\/N 
stirr 1h 
(4.1) 
Scheme 4.2: - Synthesis of 1,5-di(4-pyridyl)-pentane (dpp[5]) (4.1) 
4.2.2 Synthesis of the rhenium(I) clips 
Initial attempts at the synthesis of the bimetallic rhenium clips were 
attempted in one step, in an analogous way to the synthesis of 
[(CO)3PyRedppz]+ (4.4). The complex [(CO)3MeCNRedppz]+ (4.3) was 
synthesised as outlined previously42,114 and then refluxed with half an 
equivalent of the appropriate di-pyridyl linker in THE (Scheme 4.3). Even 
after 4 days refluxing no reaction had taken place. Separate studies with 
the monomer showed that at least a three-fold excess of pyridine was 
needed for the successful substitution of the acetonitrile ligand. 
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II 
OC. " 
N 
OC=ReýN 
cjl; 
N 
O 
ý-^ýýý THF, reflux oqj 
co 
OC-Ru-L-' ýL- ü-CO 
ý I\ 
NN 
\I 
I 
dve[2) 
Cpp(3) 
dvvls) 
Scheme 4.3: - Attempted one-step synthesis of rhenium(I) bimetallics 
Searching the literature we found a procedure adopted by Wolfgang et 
a/. "6 for bridging two mono-valent metal centres with di-pyridyl type 
ligands. This method relies on the fact that only mono-cationic species 
are soluble in dichloromethane solutions. As soon as the ligand bridges 
the two metal centres, resulting in a di-cationic species, the complex 
precipitates. This method affords tight control of the stoichiometry and 
also analytically pure products. 
When (CO)5ReCI is reacted with AgCF3SO3 in dichloromethane for 3 
hours the chloride is removed and precipitated as silver chloride. Upon 
addition of /2 equivalent of the required dipyridyl linker with stirring at 
room temperature in the dark for four days the bimetallic species 
[{(CO)5Re}2L-L]2+ (L= dpe[2] (4.5), dpp[3] (4.6) or dpp[5] (4.7)) is 
precipitated (Scheme 4.4). 
These clip precursors were reacted with an excess of dppz in 
nitromethane at 70°C for 4 days. This resulted in the coordination of a 
dppz ligand to each of the rhenium centres forming the bimetallic clips 
4.8-4.10) (Scheme 4.5). 
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! "L f(1i sthr 4 days 
(CF38O 
(CO), RS- 
(4.5) 
(CO), ReCl 
DCM, atlrt 3hr 
> atirr 4 days 
AGCl IM 
sort 4 days 
1 (CF)SO. 4 
(CO), Ro- 
\/\ -Re(CO). 
(4.6) 
- 
-1 ICF. $O 
1ýý1 
Scheme 4.4: - Synthesis of the bimetallic clip precursors (4.5-4.7) 
The crude products were collected by reducing the reaction mixture and 
flash precipitated by addition of diethylether. The clips (4.8) and (4.9) 
were purified by size exclusion chromatography on Sephadex LH-20 
resin. 3: 1 Toluene to acetonitrile was used as the eluent and the first 
band collected from the column contained the desired product. Clip 
(4.10) would not separate from impurities with size exclusion 
chromatography so purification was achieved with successive 
recrystalisations from acetone/water mixtures. All three of the clips were 
bright yellow solids and were characterised by 1H NMR and electrospray 
mass spectrometry. 
/ý/ý 
7+ 
(CO)5Re-L---/ý-L-Re(CO)y 
dpe121 
dpp[3j 
dvv[5] 
R 
Cý6 MONO2.70-C, 4 days 
Co 
7 
1 
dps(2J (4. e) 
dpP[3º (4. e) 
dPP[51 (41O) 
Scheme 4.5: - Synthesis of the bimetallic rhenium clips (4.8-4.10) 
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4.2.3 Synthesis of the ruthenium(II) clips 
Using methodology developed in Chapter 3 for the synthesis of 
[TpmPyRudppz]2+ we replaced pyridine with dpp[5] in order to attempt the 
synthesis of the bimetallic ruthenium complex [{TpmRedppz}2dpp[5]]4+ in 
one step. [TpmClRudppz]+ was reacted with silver nitrate in 1: 1 
EtOH/H20 for three hours to remove the axial chloride. Half an 
equivalent of dpp[5] was then added with continued refluxing. However, 
as in the rhenium case it was found that this reaction only works well 
when an excess of the pyridine is present and none of the bimetallic 
product was formed (Scheme 4.6). 
--lM 
Ný ýý 
N; 
N`ý 
N 
ý'Ru-N 
Nyyýý CI``ýý 
Jy 
i) AgNO3, Hp/EtOH, reflux 
fi) wem, , reflux 
Scheme 4.6: - The attempted synthesis of ruthenium(II) bimetallics in one 
step. 
It was clear that as in the case of the rhenium bimetallics the synthesis 
had to be carried out in two steps. 
[TpmClRudppz]+ (3.5) was reacted with AgNO3 for three hours in 
refluxing ethanol/water, resulting in removal of the axial chloride 
precipitation as AgCI. A 10-fold excess of dpp[5] (4.1) was added with 
further refluxing for 10 hours which lead to the mono-coordination of 
dpp[5] to the axial position (Scheme 4.7) (4.11). 
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Ncl% 
N 
Ný 
N 
Ný 
12+ 
(3.5) 
Q AgNO EtOH/H2O, reflux ihr 
0) app(s), renux 101w 
A9CI 
(4,1 1) 
Scheme 4.7: - Synthesis of (Tpmdpp[5]Rudppzr (4.11) 
The red orange solution was then concentrated and 
[Tpmdpp[5]Rudppz]2+(4.11) was isolated as a PF6 salt by addition of 
NH4PF6. Bu4NCI was added to a solution of (4.11) in acetone, which 
leads to its precipitation as a chloride salt, allowing the excess ligand to 
be washed away with acetone. Conversion of (4.11) back to the PF6 salt 
and subsequent drying affects a 95% yield of (4.11), which is analytically 
pure by 1H NMR, FAB-MS and accurate mass determination. 
The final bimetallic was assembled as follows. [TpmClRudppz]+ (3.5) was 
reacted with AgNO3 for three hours in refluxing ethanol/water as before, 
thus abstracting the axial chloride. The AgCl precipitate was remove by 
centrifugation and the solution was added dropwise to a two-fold excess 
of [Tpmdpp[5]Rudppz]2+ (4.11) which was refluxing in ethanol/water. The 
dropwise addition coupled with the two-fold excess of 
[Tpmdpp[5]Rudppz]2+ ensured that the pendant pyridine was always in a 
large excess relative to the other half of the clip allowing the reaction to 
take place (Scheme 4.8). 
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Scheme 4.8: - Synthesis of the bimetallic ruthenium(II) clip (4.12) 
The burgundy red solution was concentrated and the crude products were 
isolated as PF6 by addition of NH4PF6. The products were purified by ion 
exchange column chromatography on Sephadex CM-C25 ion exchange 
resin. Several monometallic complexes were eluted off the column with 
low salt eluents but were not characterised. The product (4.12) was 
eluted off the column with OA M NaCl in 5: 3 H20/acetone and was 
recovered as a PF6 salt in an overall yield of 14%. The reaction was not 
optimised for yield. 
The low yield is probably due to the excessive length of the reaction time. 
The reaction proved difficult to monitor by TLC as all of the products and 
reactants ran with very similar Rf values. Reducing the reaction time to a 
few hours could dramatically improve the yield, as the redox active dppz 
ligand is prone to decomposition upon prolonged reaction. 
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4.3 1H NMR spectroscopic studies 
The 250MHz 1H NMR spectra of the di-rhenium clip precursors were 
recorded in d6 acetone and the data is shown in Table 4.1. The spectra 
were well-resolved showing peaks only associated with the complex. The 
two protons on the pyridine ring were both doublets and the one with the 
greatest downfield shift and large coupling constant (9Hz) was assigned 
to proton a adjacent to the ring nitrogen. The first alkyl proton C was in 
each case a triplet integrating to four protons. The other alkyl protons d 
and e, where present were multiplets integrating to four and two protons 
respectively. 
Table 4.1: - 
1H NMR data for the dirhenium clip precursors 
2+ 
d ?? co --?? co 
OC -Re-N /ce\ IN-Re-CO 
OC CO ab 
OC CO 
Complex Chemical shift (ppm) 
a bcde 
[{(CO)6Re}2dpe[2]]2+ 9.21 7.74 3.25 -- 
[{(CO)5Re}2dpp[3]]2+ 9.17 7.67 2.93 2.07 - 
[{(CO)5Re}2dpp[5]]2 9.16 7.62 2.84 1.74 1.49 
The rhenium clips themselves were equally well resolved and their 
spectra recorded again in d6-acetone essentially showed the 
characteristic dppz signals as well as the pyridyl signals seen above for 
the linkers. The full assignment of the signals were made with the help of 
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a COSY spectrum (not shown), the data are summarised in Table 4.2. 
Table 4.2: - 
1H NMR data for the rhenium(l) clips recorded in ds 
acetone 
0 
Complex Chemical shift (ppm) 
a b c d e f g hIj 
[{(CO)3Redppz}dpe[2]]2+' 9.85 8.17 9.76 8.50 8.38 8.41 7.17 2.63 -- 
[{(CO)3Redppz}dpp[3]]2 9.71 8.10 9.88 8.39 8.23 8.46 7.13 2.39 1.55 - 
[{(CO)3Redppz}dpp[5]]2+ 9.91 8.16 9.97 8.45 8.40 8.47 7.16 2.37 1.31 1.10 
a spectrum recorded in d6-DMSO 
The 400MHz 1H NMR spectrum of [Tpmdpp[5]Rudppz]2+ is shown in 
Figure 4.2. The spectrum is well resolved and is fairly simple due to the 
symmetry of the molecule. The 2D COSY spectrum (Figure 4.3) shows 
the cross coupling between the different ligand sets, Tpm (blue), dppz 
(red) and dpp[5] (green). 
The characteristic deshielded methane proton of the Tpm moiety is found 
as a singlet at 9.91 ppm. Cross coupling analysis shows the pyrazole 
protons appearing at 8.53ppm (p), 6.30ppm (o) and 6.92ppm, all one 
hydrogen for the axial pyrazole and 9.89ppm (d), 6.99ppm (m) and 
8.46ppm (f), all two hydrogens for the two equatorial protons. The 
phenanthroline protons of dppz appear at 9.89ppm (b), 8.23ppm (i) and 
9.42ppm (c) all three integrating to two protons each. The two phenazine 
protons appear at 8.55ppm and 8.25ppm. Due to coordination of one of 
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Figure 4.2: - 
IH NMR spectrum (d6-acetone) of fTpmdpp[5]Rudppzf 
with proton labelling scheme 
the pyridine moieties of the dpp[5] ligand to the ruthenium centre, all 7 
sets of the protons are rendered inequivalent. The four aromatic sets 
appear at 8.44ppm (g) and 7.61 ppm (j). The large coupling constant 
indicating these protons reside adjacent to ring nitrogens, and the one 
with the furthest downfield shift was assumed to be coordinated to the 
ruthenium. The other aromatic protons appear at 7.23ppm (k) and 
7.02ppm (I). The two closely positioned triplets at 2.55ppm and 2.60ppm 
are protons p and q on the alkyl linker. Protons r and s appear as 
multiplets at 1.59ppm and I. 52ppm. The central alkyl proton t appears as 
a multiplet at I. 26ppm. 
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Figure 4.3: - 
'H COSY spectrum of [Tpmdpp[5]Rudppzf + recorded in 
d6-acetone 
The 'H NMR spectrum recorded in d6-acetone of the bimetallic 
ruthenium(II) clip [{TpmRudppz}2dpp[5]]4+ is shown in Figure 5.5. The 
spectrum was fully assigned with the help of a 2D COSY spectrum shown 
in Figure 5.6. The protons from the Tpm (blue), dppz (red) and dpp[5] 
(green) ligand sets can easily be seen. 
Again the methyl proton of Tpm can be found as a sharp singlet at 
10.10ppm. The axial pyrazole protons can be found at 8.60ppm (e), 
6.28ppm (n) and 6.89ppm (m) all integrating to two protons each. The 
equatorial pyrazole protons can be found at 8.86ppm (d), 6.93ppm (I) and 
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a 
Figure 4.4: - 400MHz 
1H NMR spectrum recorded in d6-acetone of 
[{TpmRudppz)2dpp[5]r+and proton labelling scheme 
8.42ppm (g) integrating to four protons each. Analysis of cross coupling 
shows the phenanthroline dppz protons appear at 9.85ppm (b j=9Hz), 
8.17ppm (i) and 9.37ppm (c). The phenazine type protons appear at 
8.55ppm (f), which is coupled, to the proton at 8.24ppm (h). The 
formation of the bimetallic species means that this time the dpp[5] linker 
ligand is symmetrical with the aromatic protons appearing at 7.55ppm (j, 
j=9Hz) and 6.93ppm (k). The splitting of the alkyl protons has also 
disappeared and the three protons appear at 2.44ppm (o, triplet), 
1.41 ppm (p, multiplet) and 1.18ppm (q, multiplet) with integrals of four, 
four and two respectively. 
As well as complete assignment of all protons and simplification of the 
spectrum upon formation of the bimetallic complex, further evidence can 
be drawn from the ratios of integrals. 
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Figure 4.5: - 'H COSY spectrum of [(TpmRudppz)2dpp[5]r recorded in 
d6-acetone 
In the monometallic complex [Tpmdpp[5]Rudppz]2+ the integral ratio of 
the methyl proton of Tpm (a) to the central methyl proton (q) of the linker 
ligand is 1: 2. Whereas in the bimetallic complex the ratio is 2: 2, 
indicating two Tpm ligands and thus two ruthenium centres are present 
for each linker. 
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4.4 Mass spectrametric data 
All of the complexes showed fragments in their mass spectrum 
corresponding to their proposed structures. No obvious impurities were 
detected in the mass spectra of the complexes discussed in this chapter. 
Generally peaks were found that corresponded to sequential loss of 
counter ions for most of the complexes. The data are summarised in 
Table 4.3. 
Table 4.3: - Mass spectrametric data for the clips and precursors 
Complex M/z % Assignment 
(CO)3CIRedppz 552 30 [(CO)3Redppz]* 
60 5 40 [(CO)2CIRedppz]+ 
524 10 [(CO)2Redppz]+ 
[(CO)3MeCNRedppz][CF3SO3] 593 80 CNRedppz]+ 
5 52 25 [(CO)3Re 
[(CO)3PyRedppz][CF3SO3] 631 30 
52 5 45 [(CO)3Redppzl+ 
903 15 [(CO)2PyRedppz]+ 
[{(CO)5Re)2dpe[2]][CF3SO3]2 986 40 ]]4CF3SO3]+ [ 2 {( 
8 37 90 dpe 2 [ CO)5Re} 
[{(CO)5Re}2dpp[3]][CF3SO3]2 999 50 [{(CO)5Re}2dpp[3]]ýCF3SO3]+ 
850 70 [{(CO)5Re}2dpp[3]] 
[{(CO)5Re}2dpp[5]][CF3SO3]2 1028 20 ] [+CF3SO3J+ [{( pp[ ) } 
8 0 5 CO 5Re 2d 
[{(CO)3Redppz}2dpe[2][CF3SO3]2 1438 20 [{(CO)3Redppz}2dpe[2][CF3SO3]+ 
1289 25 [{(CO)3Redppz}2dpe[2]]+ 
[{(CO)3Redppz}2dpp[3][CF3SO3]2 1452 40 [{(CO)3Redppz}2dpp[3][CF3SO3]+ 
1303 50 [{(CO)3Redppz}2dpp[3]]+ 
[{(CO)3Redppz}2dpp[5][CF3SO3]2 1480 15 [{(CO)3Redppz}2dpp[5][CF3SO3]+ 
1331 20 [{(CO)3Redppz}2dpp[5]]+ 
[Tpmdpp[5]Rudppz][PF6]z 1113 5 [Tpmdpp[5]Rudppz][PF6]Z+ 
968 40 [Tpmdpp[5]Rudppz] PF6]+ 
823 50 [Tpmdpp[5]Rudppz] 
[{TpmRudppz}2dpp[5]][PF614 1858 10 [{TpmRudppz}2dpp[5]][PF6]3+ 
857 70 [{TpmRudppz}2dpp[5]][PFS]2 
4.5 Spectroscopic studies 
The UV-Visible and luminescence studies were recorded in acetonitrile 
solution for all the complexes except [Tpmdpp[5]Rudppz][PF6]2 and 
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[{TpmRudppz}2dpp[5]][PF6]4 which were recorded in methanol. The data 
are summarised in Table 4.4. 
Table 4.4: - Spectroscopic data of the mono and bimetallic complexes 
Complex Absorption Emission 
Xmax c Asslgnmen %, ex ! bm 
(nm) (mof1dm3 cm'') (nm) (nm) 
[(CO)3MeCNRedppz]+ 
277 4 , 343 364 0 10,343 
282 10,649 MLCT 
' [(CO)aPYRedPPz] 
278 41,187 360 560 
364 9,626 
384 9,608 MLCT 
Re}2dpe[2]]2+ [{(CO) 
236 
277 
Sh 
h 
-- 
5 s 
316 3699 MLCT 
Re}2dpp[3]]2+ [{(CO) 
233 
276 
sh 
h 
- 7C-+7T* - 
5 s 71. +n 
316 3,717 MLCT 
Re}2dpp[5]]2+ [{(CO) 
233 
276 
sh 
h 
n-+n 
* 5 s n-*7[ 
317 3,710 MLCT 
RedPPz}2dPe[2]]2' I{(CO) 
281 57,584 
_ 
IC-+n 
- 3 363 12,556 MLCT 
383 11,866 MLCT 
Redppz}2dpp[3]]2+ [{(CO) 
280 56,159 71-C7ý 
3 363 12,622 MLCT 
383 11,779 MLCT 
Redppz}2dpp[5]]2+ [{(CO) 
281 56,879 
3 362 12,234 MLCT 
384 11,992 MLCT 
[Tpmdpp[5]Rudppz]2+ 
279 44,039 7T-->7C. 450 624 317 16,202 71-+7C 348 17,559 MLCT 
397 6,883 MLCT 
470 2,363 MLCT 
[{TpmRudppz}2dpp[5]]4+ 
279 163,997 t-*n 450 672 
317 50,718 
351 53,251 MLCT 
399 20,192 MLCT 
470 6,982 MLCT 
All of the complexes show characteristic absorption spectra for rhenium(l) 
or ruthenium(II) di-imine complexes'". The bisrhenium clip precursors 
show extremely simple absorption spectra with the only feature being a 
weak band at around 316nm, which can be assigned to a MLCT transition 
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to the pyridine linker. The rhenium(l) clips show absorption spectra very 
similar to their previously reported monometallic analogues42. The broad 
transition at ca. 280nm is characteristic of ligand centered n-*n 
transitions24, with the twin transition of moderate intensity being 
characteristic of MLCT transitions. 
The absorption spectra of [Tpmdpp[5]Rudppz][PF6]2 and 
[{TpmRudppz}2dpp[5]][PF6]4 are very similar except that the higher energy 
7r->7i transitions are much more intense in the bimetallic species than in 
the monometallic species (c (279) = 163,997 and 44,039 moE1 dm3 cm'1, 
respectively). 
The monometallic rhenium(l) complexes show a strong emission in 
acetonitrile solution at 550-570nm, however, the bimetallic clips show no 
emissions at all. The excited state is presumably being quenched by the 
close proximity of the second metal centre. Kelly and others have 
observed similar phenomena in other bimetallic systems58. 
Both [Tpmdpp[5]Rudppz][PF6]2 and [{TpmRudppz}2dpp[5]][PF6]4 show 
characteristic emissions in methanol solution, however, the emission from 
the bimetallic is noticeably weaker than the emission from the 
monometallic species. Again there could be a certain amount of self 
quenching from the second ruthenium centre taking place resulting in the 
weaker emission. 
4.5 Conclusions 
A synthetic strategy has been developed for the assembly of bimetallic 
systems of both rhenium(I) and ruthenium(II). The methodology 
demonstrates a "pick n mix " approach to the synthesis. The intercalating 
domain, linker and even the metal centre can easily be varied at each end 
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of the clips, by adding the appropriate ligands at different stages of the 
synthesis. In the future, synthesis of novel hetero-bimetallic clips could 
result in multifunctional DNA binding agents. For example one metal 
centre could act as a stable anchor to the helix and the second centre 
acting as a cleaving agent. 
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DNA binding studies 
5.1 Introduction 
Once a suitable library of potential metal DNA binding agents had been 
assembled they were assayed with DNA and determine how well they 
interact with DNA and what structural or electronic characteristic of the 
compounds affects the nature of this interaction. 
In order to quantify the DNA binding properties of the complexes two 
different assays were employed. 
The first of these was a broad spectroscopic assay, in which the entire 
library was screened against generic calf thymus DNA, with the 
interaction being observed indirectly through spectral shifts in either the 
UV-Visible spectra or for those that luminesce, the emission spectrum. 
Once this broad assay was complete a selection of the "better" binding 
agents were subjected to calorimetry studies where they were assayed 
against more specific sequences of natural DNA such as 
poly(dG). poly(dC) and poly(dA). Poly(dT) homo-polymers. 
5.2 Spectroscopic binding studies 
All of the metal complexes in this study exhibit a well-defined UV-Visible 
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spectrum in both lipophilic and aqueous environments. When a complex 
binds to DNA it is subjected to a change of local microenvironment from 
being completely solvated in aqueous solution to being in the hydrophobic 
environment of the DNA grooves and base stack. This change in local 
microenvironment can be monitored by perturbations that occur in the 
UV-Visible spectrum of the complex when the binding event takes 
place' 7. Binding brings the positive metal centre and the aromatic 
ligands into close proximity to the poly-anionic backbone of the DNA and 
the hydrophobic interior of the DNA grooves. This causes perturbations in 
the metal centred MLCT band and the ligand centred n-*n bands of the 
UV-Visible spectrum of the complexes23,24, "'. These hypochromic shifts 
in the spectrum are often accompanied by either hypsochromic or 
bathochromic shifts indicating that the energy of the transition has been 
altered by stabilisation or destabilisation of the HOMO/LUMO orbitals 
involved in the transitions upon binding to DNA' 7. 
As well as perturbations in the UV-Visible spectra of the complexes, the 
excited state luminescence emission spectra are also sensitive to the 
microenvironment of the complexes. Polar water molecules can be 
efficient quenchers of excited states, particularly where they can 
hydrogen bond to nitrogen donor sites on the complexes. When the 
complexes bind to DNA they are protected from the aqueous solvent by 
the hydrophobic interior of the grooves and the base stack. This results 
in an increased emission upon binding to DNA21, which can also be used 
to quantify the interaction with DNA. 
5.2.1 Formulating a binding curve"' 
If DNA is titrated into a solution of drug of known concentration the 
degree of shift in any given band in the UV Visible spectrum or the 
luminescence spectrum is proportional to the fraction of drug bound to the 
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DNA. 
For hypochromic shifts in the UV-Visible spectrum the binding curve is 
constructed as follows. If the absorbance of the free unbound drug is 
given as Au, the absorbance of the fully bound drug at saturation is given 
by Ab and Aabs is the observed absorbance of the drug at any given 
titration point then the fraction of drug bound (x) to the DNA is given by; 
(Au - Aobs ) X (Au -Ab) 
(5.1) 
Similarly for luminescence titration where the emission intensity of the 
drugs increase upon binding to DNA the fraction bound is given by; 
(lobs 
-I0) 
(lb -/U 
(s. 2) 
where lobs, I and lb are the emission intensities of the observed, free and 
fully bound drug respectively. 
If x is plotted against the ratio DNA concentration to drug concentration, 
also called the mixing ratio (R) then a saturation binding curve can be 
constructed (Figure 5.1). 
I 
0 
PNAibp +g1 
Figure 5.1: - Schematic of a binding curve showing saturation binding 
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5.2.2 Determination of bound and free drug 
concentrations18 
If the initial concentration of drug is denoted as Ci it is easy to calculate, 
from knowing the fraction of drug bound, the concentrations of free (Cf) 
and bound drug (Cb) at any given titration point. 
Cb =x Ci (5.3) 
From this as Ci = Cb + Cf 
Cf = Cl - Cb (5.4) 
5.2.3 Scatchard plots18 
A Scatchard plot (Figure 5.2) was developed as a way of the transforming 
the hyperbola binding data into a linear binding isotherm, which can be 
fitted with a least square linear regression analysis to the Scatchard 
equation (5.5). 
r Bmax r (5.5) 
Cf KK 
Where r= specific binding 
K= equilibrium binding constant 
Bm, ax = binding density 
Scatchard plots are constructed from a plot of specific binding (r) against 
the ratio of specific binding to free ligand (r/Cf). 
_ 
Cb 
r [DNA] 
(5.6) 
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From this the intrinsic equilibrium binding constant (K) can be determined 
from the reciprocal of the slope, and the binding site size (S) can be 
determined from the reciprocal of the binding density (Bmax), which is the 
X-axis intercept. 
r/Ci 
Figure 5.2: - Schematic of a Scatchard plot 
5.2.4 Development of more accurate models 
The Scatchard model was developed for the binding of small ligands to 
non-interacting isolated binding sites on proteins18. Although this simple 
linear transformation of the binding data works well for 1: 1 binding 
situations, it quickly begins to show weaknesses in more complex 
systems, as the data are no longer linear. This is the case when calf 
thymus DNA (CT DNA) is used. CT-DNA is assumed to be an isotropic 
uniform lattice, with one binding site defined as one base pair. So on any 
given CT DNA strand there are hundreds if not thousands of potential 
overlapping binding sites for a drug molecule, hence in our assays the 
binding isotherm deviated from linearity and a more suitable model was 
needed to determine the binding parameters K and S. 
Since the early 1960's, when this problem first came to ligh, t several 
papers were published which attempted to solve the inaccuracies caused 
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by the overlapping of binding sites and co-cooperativity. Latt and Sober 
(1967) were the first to take into account these problems and developed a 
highly simplified model for ligand binding to a homogeneous lattice119. In 
1964 Lifson developed a combinatorial method (which in practice proved 
to be insoluble) and a method of sequence generating functions120. The 
latter gave rather good estimates for binding constants but was unable to 
determine site sizes. Crothers (1968) attempted to solve the non-linearity 
for more complex heterogeneous binding lattices by using a Monte-Carlo 
method as a limiting case 12'. Zasedatelev et aL. (1971) used a 
combinatorial method accounting both for ligand size and ligand-ligand 
cooperatively122. Shellman (1974) used sequence-generating functions 
on the heterogeneous lattice problem accounting for both potential 
binding site overlap and nearest neighbour cooperativity123. In addition to 
these general treatments there have been a number of other solutions to 
more specific binding problems. Although some of these solutions are 
very elaborate, none of them are particularly practical allowing them to be 
easily and universally applied to any general binding problem. 
5.2.5 The Mcghee-von Hippel model124 
It was not until 1974, when the statistical treatment of ligand-lattice 
interactions was published by Mcghee and von Hippel that a practical 
model was available for analysing non-linear Scatchard plots and 
accurately determining binding constants and site sizes. 
The aim of Mcghee and von Hippel was to analyse the simplest possible 
model of ligand-lattice interactions, which allows for the treatment of 
potential overlap of ligand binding sites. 
However, the model does make some large assumptions. First it 
assumes all of the binding sites on the lattice are isotropic with an equal 
probability of the drug molecule choosing any given site. There is 
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assumed to be no cooperativity between the lattice and the drug and in 
the simple non-cooperative form that we have used there is assumed to 
be no drug-drug cooperativity. This implies that a drug molecule has no 
preference for choosing a free binding site over a site adjacent to a bound 
drug. The non-cooperative form of the model is shown below. 
Cf 
K(1- Sr) "1 
1(SS 
1)r 
S-1 
(5.7) 
Where K= Intrinsic binding constant 
S= Binding site size in base pairs 
Non-linear Scatchard plots are fitted to the Mcghee-von Hippel model 
using a non-linear least squares approach. As the lattice reaches 
saturation, the number of free binding sites less than S residues in length 
increase significantly. An effective concentration of drug up to two orders 
of magnitude can be needed to increase the occupancy from 90-100%. 
This has a significant effect on the data and artificially increases the 
observed binding constant. To minimise these artificial effects the model 
is fit to experimental data between 30% and 90% bound drug. 
5.3 Isothermal titration calorimetry125'126 
Isothermal titration calorimetry (ITC) is a titration technique used to 
quantify the thermodynamic binding parameters of a given bimolecular 
equilibrium. ITC is the only technique available to directly measure the 
heat of interaction of two or more components, and hence binding 
constants and other thermodynamic parameters can be obtained without 
the partitioning of the components and subsequent spectroscopic 
determination of bound and free drug concentrations. 
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5.3.1 The ITC experiment 
A schematic of a modern micro-calorimeter is shown in Figure 5.3. 
containing ligand 
Reference c 
containing k 
nechanism 
Sample cell containing 
macromolecule 
Jacket cell 
Sample cell-reference 
cell power feedback 
Figure 5.3: - Schematic of a modern micro-calorimeter 
The instrument consists of two identical cells housed in an isothermal 
jacket. The jacket is constantly cooled so energy is constantly required to 
keep the two cells in thermal equilibrium (AT=O) at the chosen 
experimental temperature throughout the duration of the experiment. 
One cell, the reference cell is filled with buffer solution. The other cell is 
filled with a solution of the fixed component of the titration in the buffer. A 
known volume of a solution of the variable component in identical buffer 
is then titrated at regular intervals into the sample cell. The interaction of 
the ligand and the drug causes heat to be released or absorbed in the 
sample cell and the output of the experiment is the heat energy per unit 
time required to keep the cells in thermal equilibrium. If the interaction is 
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exothermic, less heat per unit time will be required by the sample cell to 
keep the two cells in thermal equilibrium. If the interaction in endothermic 
more heat per unit time will be needed to keep the cells in thermal 
equilibrium. 
The raw data output is plotted as the power input/output required to keep 
the sample cell at the experimental temperature versus time. The heat 
output is determined by integrating the peaks with respect to time. This 
data is then plotted against the molar ratio of the interacting compounds. 
The experimental data contain sufficient information to determine the 
OBH, KB and stoichiometry (n) of the interaction. 
Consider the following equilibrium 
A+B =AB 
Where A is in the calorimeter cell (of Volume V) and B is added in equal 
aquilots. 
The fractional saturation, F, of species A at any point in the titrationcan be 
determined from the total heat input/output, Q, using the following 
equation: 
Q= nFATABHV (5.8) 
Where AT is the total concentration of A (free and complexed). Since KB 
= F/(1-F)[B] and [B] = BT - nFAT, the following quadratic relationship is 
obtained: 
F2 - F{1+(BT/nAT)+(1/nKBAT)}+(BT/nAT) =0 (5.9) 
Where Br is the total concentration of B. Solving equation 5.9 for F and 
substituting this value into equation 5.8 gives: 
Q= nATOBH (V/2) {X-[X2-(4BT/nAT)'2r1 (5.10) 
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Where X= {1+(BT/nAT) + (1/nKBAT)}. Thus, Q gives a value for the heat 
content of the interaction after a given injection, which is dependent on 
the values of the independent variables OBH, KB, and n. 
These data are reported as a least-squares fit with inherent statistical 
error. There are other algorithms available to fit binding data for more 
complex interactions involving several independent or interactive binding 
events. 
5.4 Materials and methods 
5.4.1 Preparation of calf thymus DNA12' 
Calf thymus DNA (CT-DNA) was purchased from Sigma chemical 
company as the lyophilised solid sodium salt. A concentrated stock 
solution of about 5mM was extracted with phenol-chloroform to remove 
any residual protein. The purity of the sample was determined by UV- 
visible spectroscopy with A260/A280 >1.9 indicating a protein free sample. 
The DNA pellets obtained from the purification were dissolved in doubly 
distilled water, with the concentration being determined by 0260 = 6600 
mol 1 dm3 cm 1. The concentration of the DNA used in the titrations was 3 
- 20 mmol in base pairs. 
5.4.2 UV-Visible titration protocol 
All of the UV-Visible titrations were performed to the following protocol. 
The buffer used for the titrations was 25mM NaCl, 5mmol Tris, pH 7.0 
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made with doubly distilled water from a Millipore water purification 
system. The drug complex was converted to its chloride salt by treating 
the PF6 salt with n-Bu4CI in acetone, with the chloride salt being collected 
by centrifugation and copiously washed with acetone. Approximately 
10mg of vacuum dried complex was dissolved into 20ml of spectroscopic 
grade methanol (or buffer if the complex was soluble in buffer alone), and 
the concentration was determined. This stock solution was then diluted 
into 5ml of buffer containing 5% methanol (250µI) in total, to give a final 
drug complex concentration of 15µM. 3000µI of the sample solution was 
then loaded into a1 cm path length optical glass cuvette and loaded into 
the spectrometer sample block, which was maintained at 25°C. 3000µI of 
5% methanolic buffer was loaded into another identical cuvette and 
placed in the reference cell of the spectrometer. Both the sample and the 
reference cells were mixed 30 times with a Gilson P1000 pipette, after 
which the cells were checked for bubbles. After 30 minutes, to allow the 
cells to equilibrate, first spectrum was recorded between 650 and 200 nm. 
2- 5µI of DNA solution was then added to both the sample and reference 
cell, followed by a further 30 times mixing. After checking for bubbles, the 
spectrum was taken again, this time showing the hypochromic shift 
indicating the formation of a drug - DNA complex. The titration process 
was repeated until there was no change in the spectrum for at least four 
titrations indicating binding saturation had been achieved. 
5.4.4 Luminescence titration protocol 
All of the luminescence titrations were performed to the following protocol. 
The buffer used for the titrations was 25mM NaCl, 5mmol Tris, pH 7.0 
made with doubly distilled water from a Millipore water purification 
system. The drug complex was converted to its chloride salt by treating 
the PF6 salt with n-Bu4CI in acetone, with the chloride salt being collected 
by centrifugation and copiously washed with acetone. Approximately 
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10mg of vacuum dried complex was dissolved into 20ml of spectroscopic 
grade methanol (or buffer if the complex was soluble in buffer alone) and 
the concentration was determined. This stock solution was then diluted 
into 5ml of buffer containing 5% methanol (250µI) in total to give a final 
drug complex concentration of 30-60µM. 3000µI of the sample solution 
was then loaded into a 1cm path length optical glass cuvette and loaded 
into the fluorimeter sample block, which was maintained at 25°C. The 
sample was mixed 30 times with a Gilson P1000 pipette, after which the 
cell was checked for bubbles. After 30 minutes to allow the cells to 
equilibrate first spectrum was recorded. 2- 5µI of DNA solution was then 
added the sample cell, followed by a further 30 times mixing. After 
checking for bubbles, the spectrum was taken again, this time showing 
the increase in emission indicating the formation of a drug - DNA 
complex. The titration process was repeated until there was no change in 
the spectrum for at least four titrations indicating binding saturation had 
been achieved. 
5.4.5 Dialysis of the DNA samples for ITC126 
poly(dA). poly(dT) and poly(dG). poly(dC) homo-polymers were purchased 
from Pharmacia Botech Ltd and were used as received. Each sample 
was dissolved in two ml of the buffer (25mmol NaCl, 5mmol Tris. HCI, pH 
7.0) and then placed in dialysis tubing. The samples were dialysed for at 
least 24 hours. The concentration of the DNA was determined by UV 
spectroscopy using the following molar absorption coefficients (mol" 
'dm3cm") poly(dA). poly(dT), 6000 at 260nm; and poly(dG). poly(dC), 
7400 at 253nm. 
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5.5 Results and discussion 
5.3.1 DNA binding studies on the Tpm monometallic and 
bimetallic complexes 
Both UV-Visible and luminescence binding studies were carried out of all 
of the Tpm ruthenium(II) mono and bimetallic complexes. The raw 
titration data for the UV-Visible titration of [TpmPyRudppz]2+ with CT-DNA 
is shown in Figure 5.4. 
Both the bands at 278nm and 350nm which have be shown to be arising 
from t->7c* transitions centred on dppz show a high degree of 
hypochromicity. There is also a significant bathochromic shift as the 
278nm band approaches saturation. Both of these phenomena are 
characteristic of an interaction between the metal complex and the DNA 
helix' 17 . 
The high percentage hypochromicity also indicates that the 
interaction is probably intercalative in nature. All of the Tpm ruthenium(II) 
complexes produced binding data similar to those shown above and the 
raw data are available on the supplementary data CD. 
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Figure 5.4: - Raw titration data for [TpmPyRudppzf + interacting with 
CT-DNA as moniterd by UV-Visible spectroscopy 
The binding curves for the Tpm ruthenium(II) complexes are shown in 
Figure 5.5. They all show that saturation binding is taking place. 
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Figure 5.5: - Binding curves obtained by UV-Visible titrations for the 
Tpm ruthenium complexes binding to CT DNA, 25mmol 
Na Cl, 5mmol Tris-HCI, pH 7.0,25 C. 
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The intrinsic binding constants for the ruthenium(II) complexes were 
determined from fits of the McGhee-von Hippel binding model to non- 
linear Scatchard plots of the titration data. The Scatchard plots showing 
the Mcghee-von Hippel best fits is shown in Figure 5.6 and the binding 
data is summarised in Table 5.1. 
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Figure 5.6: - Scatchard plots with Mcghee-von Hippel best fits obtained 
by UV-Visible titrations for the Tpm ruthenium complexes 
binding to CT DNA, 25mmol NaCI, 5mmol Ths-HCI, pH 7.0, 
25 `C. 
The Scatchard plots were constructed from the binding data of each 
complex between 30 and 95% fraction bound. The model fits the data 
reasonably well and in all cases the R2 value for the non-linear least 
squares fit was >0.9. 
For the three monometallic complexes [TpmCIRudppz]+, 
[TpmPyRudppz]2+ and [TpmMeCNRudppz]2`, the intrinsic binding 
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constants were determined as 3.75x105,5.16x106 and 4.89x106 mol-'dm3, 
respectively. The ratios of binding constants [TpmClRudppz]+: 
[TpmPyRudppz]2+ and TpmClRudppz]+: [TpmMeCNRudppz]2+ are 13.76 
and 13.04, respectively. This shows that there is over an order of 
magnitude increase in binding affinity for the di-cations over the mono- 
cation. Since the shape and size of all three of the monometallic 
complexes are almost identical, this increased binding affinity for DNA 
must be due to enhanced electrostatic interactions between the di-cations 
and the poly anionic DNA. The site sizes for all three of the complexes 
are around three base pairs per drug. This is consistent with values 
reported for many other intercalators75. 
The complexes [TpmPyRudppz]2+, [TpmMeCNRudppz]2+ and 
[{TpmRudppz}2dpp[5]]4+ all showed the phenomenon known as the 
molecular light switch effect21. 
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Figure 5.7: - Raw titration data for the interaction of [TpmPyRudppzf' 
with CT-DNA 
Analogous to [(phen)2Rudppz]2+, these complexes do not show any 
luminescence emission when they are in aqueous environments due to 
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deactivation of the excited state due to water hydrogen bonding to the 
phenazine nitrogens of dppz. 
However, when bound to DNA the phenazine nitrogens are protected 
from water by the hydrophobic interior of the DNA grooves and the 
emission is switched on. Figure 5.7 shows the raw emission data for the 
titration of [TpmPyRudppz]2+ with CT-DNA. 
This raw data are typical of that obtained for all of the Tpm complexes. 
The rest of the plots can be found on the supplementary data CD. 
When the data from the titrations are processed, saturation binding 
curves are produced and they are shown in Figure 5.8. 
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Figure 5.8: - Binding curves obtained by luminescence titrations for the 
Tpm ruthenium complexes binding to CT DNA, 25mmol 
Na Cl, 5mmol Tris-HCI, pH 7.0,25 `C. 
Intrinsic binding constants and binding site sizes were obtained from the 
Mcghee-von Hippel best fits of non-linear Scatchard plots (Figure 5.9). 
Again the model fits the data well and the values obtained are in 
agreement with the values obtained from UV-Visible titrations. The 
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intrinsic binding constants for [TpmPyRudppz]2+ and 
[TpmMeCNRudppz]2+ were 4.73x106 and 2.87x106 mol''dm3 with site 
sizes around 4 base pairs. 
Unfortunately, the mono-cationic complex [TpmClRudppz]+ did not show 
any emission when titrated with DNA so binding data could not be 
obtained from this method. 
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Figure 5.9: - Scatchard plots with Mcghee-von Hippel best fits obtained 
by luminescence titrations for the Tpm ruthenium 
complexes binding to CT DNA, 25mmol Na Cl, 5mmol Tris- 
HCI, pH 7.0,25 t. 
In summary, the spectroscopic binding studies on the Tpm monometallic 
complexes reveal a good affinity for DNA with the dicationic complexes 
showing a 10-fold enhanced affinity over the monocationic complexes. 
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Figure 5.10: - Scatchard plot with Mcghee-von Hippel best fit obtained by 
luminescence titration for the Tpm ruthenium clip binding to 
CT DNA, 25mmol Na Cl, 5mmol Tris-HCI, pH 7.0,25IC. 
These binding affinities are comparable to those obtained for 
[(phen)2Rudppz]2+ (3.2x106 and 1.7x106 mol-1dm3 for the 0- and A- 
enantiomers, respectively) 128. As our complexes are completely achiral 
this suggests that chirality and shape selection has little effect on the 
ability of the complexes to interact with DNA. The difference in binding 
affinity between the mono and di-cationic species seems to indicate a 
significant electrostatic component is present in the overall binding affinity 
of these complexes with DNA. Salt dependence experiments are 
underway to try and quantify this further. 
Although the monometallic complexes showed good affinity for DNA, the 
relatively small increase in affinity of the bimetallic [{TpmRudppz}2dpp[5]]; 
ruthenium clip was disappointing. Analysis of the binding data obtained 
from the spectroscopic titrations (Table 5.1) and visual analysis of the 
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binding curves and Scatchard plots revealed that the binding parameters 
for the mono and bimetallic complexes were almost identical. Although 
this is possible it was thought extremely unlikely that this was the case, so 
the two systems were further investigated with ITC. 
Table 5.1: - Spectroscopic binding data for the Tpm complexes binding 
to CT-DNA, 25mmol NaCI, 5mmol Tris, pH 7.0 
Complex UV-Visible Luminescence 
KS %hyp KS I/lo 
(mol-1 dm3) (bp) (mol" dm3) (bp) 
[TpmCIRudppz]+' 3.75x105 2.51 33.38 --- 
[TpmPyRudppz] 2+ 5.17x106 3.39 50.76 4.73x106 3.87 13.54 
[[TpmMeCNRudppz]2 4.89x106 2.94 52.40 2.87x106 3.57 14.10 
[(TpmRudppz)2dpp[5]]2+ 1.17x106 2.95 60.59 2.11x106 3.27 9.04 
a titration performed in 5% methanolic buffer 
ITC was performed on both [TpmPyRudppz]2` and 
[{TpmRudppz}2dpp[5]]2+ with poly(dA). poly(dT) and poly(dG). poly(dC) 
natural homo-polymers. All the titration were performed at 25°C and the 
data are summarised in Table 5.2. 
The raw ITC binding data and the binding isotherm for the interaction of 
[TpmPyRudppz]2+ with poly(dA). poly(dT) is shown in Figure 5.11. The 
interaction shows a small positive enthalpy of 10.2 Kcal mol-1 indicating 
the interaction of [TpmPyRudppz]2+ and poly(dA). poly(dT) is endothermic 
12s in nature 
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Figure 5.11: - Raw ITC binding data (top) and binding isotherm (bottom) 
for the interaction of 0.823mmol (TpmPyRudppzf * with 
0.295 mmol(bp) poly(dA). poly(dT) at 25 °C 
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Figure 5.12: - Raw ITC data (top) and Binding isotherm (bottom) for the 
interaction of 0.772 mmol [TpmPyRudppzf + with 0.223 
mmol(bp) poly(dG). poly(dC) at 25 °C 
The raw ITC data and the binding isotherm for the interaction of 
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[TpmPyRudppz]2+ with poly(dG). poly(dC) is shown in Figure 5.12. The 
interaction produces a small negative binding enthalpy of -1.03 Kcal mol 
1 
indicating the interaction is exothermic126. 
The binding constants determined from the ITC experiments for 
[TpmPyRudppz]2+ binding to poly(dA). poly(dT) and poly(dG). poly(dC) are 
1.45x105 and 1.12x106 mol"'dm3, respectively. This means 
[TpmPyRudppz]2+ has a near 8-fold preference for GC rich sequences of 
DNA over AT rich sequences. Moreover, the sign of the binding 
enthalpies indicates that binding of [TpmPyRudppz]2+ to GC rich 
sequences is enthalpically driven and binding to AT sequences is driven 
by entropic contributions. The binding site size for binding to both 
poly(dA). poly(dT) and poly(dG). poly(dC) is around three base pairs which 
is typical of intercalators. The ITC data obtained for [TpmPyRudppz]2+ 
binding to the homo-polymers is in good agreement with that obtained by 
the spectroscopic methods for binding to CT-DNA. 
Table 5.2: - ITC binding data for the Tpm -ruthenium(II) 
complexes 
Complex (DNA) Al-lb 
(kcal mol'1) 
K 
(mol'1dm3) 
N 
(bp) 
[TpmPyRudppz]2+ (poly(dA). poly(dT)) +10.2 1.45x105 0.364 
(2.7) 
[TpmPyRudppz]2+ (poly(dG). poly(dC)) -1.03 1.12x106 0.357 
(2.8) 
[{TpmRudppz}2dpp[5]]2+ (poly(dA). poly(dT)) +2.38x104 4.23X105 0.158 
(6.38) 
[(TpmRudppz)2dpp[5]]2` (poly(dG). poly(dC)) +7260 4.40x105 0.132 
(7.59) 
The raw ITC data for both poly(dA). poly(dT) and poly(dG). poly(dC) show 
evidence of a second interaction before the main intercalation event. The 
first few injections in the poly(dG). poly(dC) titration can be used to 
estimate the binding parameters for this interaction. The binding constant 
is estimated at 3x107 mol''dm3 with a site size estimated at 100 base 
pairs. This indicates the homo-polymers contain a small number of highly 
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specific tight binding sites, which get saturated quickly, with the first few 
injections of the titration. The normal intercalation interaction then takes 
over. This phenomenon has bee observed before by Loontiens et al. in 
the interaction of Hoechst 33258 with poly(dA). poly(dT) and 
poly(dG). poly(dC)129. 
Figures 5.13 and 5.14 show the raw ITC data and binding isotherms for 
[{TpmRudppz}2dpp[5]]2+ binding to poly(dA). poly(dT) and 
poly(dG). poly(dC), respectively. 
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Figure 5.13: - Raw ITC data (top) and binding isotherm (bottom) for the 
interaction of 0.80mmol ((TpmRudppz)2dpp[5]f + with 
0.182mmol(bp) poly(dA). poly(dT) at 25 9C 
Binding to both polymers results in a positive binding enthalpy, which 
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indicates the binding, is entropically driven. The binding constants for 
[{TpmRudppz}2dpp[5]]4+ binding to poly(dA). poly(dT) and 
poly(dG). poly(dC) are 4.23x105 and 4.40x105 mol"'dm3, respectively. This 
immediately shows that the sequence specificity shown in the 
monometallic complex is lost in the bimetallic complex. The magnitudes 
of the binding constants are again in good agreement with the 
spectroscopic data. Both ITC and spectroscopic studies show no 
significant increase in binding affinity for DNA between the monometallic 
and bimetallic complexes. 
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Figure 5.14: - Raw ITC data (top) and binding isotherm (bottom) for the 
interaction of 0.80mmol [(TpmRudppz)2dpp[5] with 
0.224mmo1(bp) poly(dG). poly(dC) at 25 `C 
ITC does, however, show a larger site size (6.4 and 7.5 for 
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poly(dA). poly(dT) and poly(dG). poly(dC), respectively) which shows that 
both of the metal centres are interacting with the DNA. The values of the 
binding constants and site sizes are comparable to those obtained by 
Kelly et al. 58 for the interaction of the bimetallic ruthenium(II) complex 
[(phen)2Ru(Mebipy)-(CH2)5-(bipyMe)Ru(phen)2]4+ (K = 2.4x105 mol-'dm3, 
S=6.4). This bimetallic complex has been shown to bind to DNA 
through electrostatic and groove binding interactions. It is probable, 
therefore, that [{TpmRudppz}2dpp[5]]4+ is binding in a similar manner 
within the grooves of the DNA. Instead of the increased binding affinity 
expected through cooperativity when two intercalators were joined 
together, we seem to be observing anti-cooperativity as neither of the 
metal centres are intercalating into DNA. Further synthetic studies are 
under way to lengthen the linker between the ruthenium centres to 
determine the optimum length to allow both centres to intercalate. 
5.5.2 DNA binding studies on the rhenium mono- and 
bimetallic complexes 
The interaction [(CO)3PyRedppz]+ with CT-DNA, poly(dA). poly(dT) and 
poly(dG). poly(dC) has been reported elsewhere42. Luminescence 
titrations reveal binding parameters of 4.2x104 mol'1dm3 and a site size of 
2 base pairs with CT-DNA after analysis of binding data with the Mcghee- 
von Hippel Model. Unfortunately the rhenium(l) bimetallic clip 
[{(CO)3Redppz}2dpp[3]]2+ does not show any luminescence upon binding 
to DNA, so UV-Visible titrations are the only way to characterise the 
binding of these complexes spectroscopic ally. In order to carry out a 
comparative study, it was decided to synthesise the monometallic 
complexes [(CO)3MeCNRedppz]+ and [(CO)3PyRedppz]+ and re- 
investigate their DNA binding properties, along with the bimetallic clip by 
performing UV-Visible titrations under identical conditions. 
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As expected, all three of the complexes show saturation binding 
characteristics portrayed through hypochromic shifts in their dppz n->n* 
transitions upon titration with CT-DNA. The raw binding data for 
[(CO)3MeCNRedppz]+ is shown in Figure 5.15. 
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Figure 5.15: - Raw binding data for the titration of [(CO)3MeCNRedppzj+ 
with CT-DNA 
The data for [(CO)3PyRedppz]+ are very similar and can be found on the 
supplementary data CD. 
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Figure 5.16: - Raw binding data for the titration of 
({(CO)3Redppz)2dpp[3]f with-CT DNA 
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Figure 5.17: - Binding curves obtained by luminescence titrations for the 
Re dppz monometallic complexes binding to CT DNA, 
25mmol Na Cl, 5mmol Tris-HCI, pH 7.0,25 `C. 
The data obtained from the titration of [{(CO)3Redppz}2dpp[3]]2+ with CT- 
DNA were not, however, quite as simple. The raw titration data are 
162 
Chapter 5 DNA binding studies 
shown in Figure 5.16. 
The data obtained from the titrations of [(CO)3PyRedppz]+ and 
[(CO)3MeCNdppz]+ with CT-DNA produce classical saturation binding 
curves as shown in Figure 5.17. 
The binding curve from the data obtained from the titration of 
[{(CO)3Redppz}2dpp[3]]2+ with CT-DNA shows two distinct events taking 
place. Figure 5.18 shows the binding curve obtained when the initial 
event is treated as the classical intercalation interaction seen for 
[(CO)3PyRedppz]+ and [(CO)3MeCNdppz]+. If a sigmoidal curve is fitted 
to the initial binding event, which saturates at a fraction bound of 1, the 
second event can clearly be seen. 
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Figure 5.18: - Binding curve obtained by UV-Visible titration for the Re [3] 
clip binding to CT DNA, 25mmol NaCl, 5mmol Tris-HCI, pH 
7.0,25 `C. 
Table 5.3 summarises the binding parameters obtained from Mcghee-von 
Hippel best fits of non-linear Scatchard plots of the binding data (Figure 
5.19). The % hypochromicity observed in the high-energy bands at ca. 
278nm is approximately half (40%) in the bimetallic 
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[{(CO)3Redppz}2dpp[3]]2+ than in the two monometallic complexes 
(86.36% and 88.88%, respectively, for [(CO)3PyRedppz]+ and 
[(CO)3MeCNdppz]+). As [{(CO)3Redppz}2dpp[3]]2+ contains two identical 
intercalating domains, one would expect the % hypochromicity to be 
similar to the monometallic complexes if both rhenium centres are 
interacting with the CT-DNA. As [{(CO)3Redppz}2dpp[3]]2+ only displays 
half the hypochromicity in the initial binding event, it suggests that only 
one rhenium binding domain is interacting with the DNA. We believe this 
is due to the steric constraints of the three carbon linker which does not 
allow sufficient freedom for both rhenium centres to intercalate into the 
DNA. It would, however, leave the second rhenium centre free to interact 
with a second DNA duplex 
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Figure 5.19: - Scatchard plots with Mcghee-von Nippel best fits obtained 
by UV-Visible titrations for the Rhenium dppz complexes 
binding to CT DNA, 25mmol NaCI, 5mmol Tiffs-HCI, pH 7.0, 
25 cC. 
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We believe the second binding event seen at higher concentrations of 
DNA is interstrand cross-linking of the second rhenium centre to a second 
DNA duplex. 
Table 5.3: - Spectroscopic binding data for the rhenium dppz mono- 
and bimetallic complexes binding to CT-DNA, 25mmol 
NaCl, 5mmol Tris, pH 7.0 
Complex UV-Visible Luminescence 
KS %hyp KS I/lo 
(mol"1 dm3) (bp) (mol"1 dm3) (bp) 
[(CO)3MeCNRedppz]+a 2.20x105 3.11 88.9 --- 
[(C0)3PyRedppz]+8 1.66x105 3.96 86.4 4.20x104,0 2c 13c 
[{(CO)3Redppz}2dpp[5]]", b 7.17x105 4.49 40.1 --- 
a Titration performed in 5% methanolic buffer 
b Binding data is obtained from the initial binding event with DNA 
c Data obtained from Yam et aL42. 
The binding parameters obtained from the titrations are consistent with 
the mono-intercalative nature of the initial binding event. The ratio of 
binding constants [(CO)3PyRedppz]+ : [{(CO)3Redppz}2dpp[3]]2+ is 4.3. If 
the both of the rhenium domains were intercalated to the DNA helix and 
the drug was acting as a bis-intercalator then an increase in binding 
affinity of at least 1000- fold would be expected as seen in other 
systems57,5813o This 5 or so fold increase in binding affinity can again be 
attributed to an increased electrostatic interaction of di-cationic bimetallic 
over its mono-cationic monometallic analogue. The site size is only 
slightly bigger for the bimetallic (4.49bp compared to 3.96bp), which is 
again consistent with mono-intercalation. 
Although [{(CO)3Redppz}2dpp[5]]2+ has been synthesised, there has been 
insufficient time in this study to fully quantify its interaction with CT-DNA, 
and the work is still in progress. 
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5.5.3 DNA binding studies on the rhenium 4'-extended 
terpyridine complexes 
The 4'-extended terpyridine complexes of rhenium(l) all showed 
hypochromic shifts in their UV-Visible spectra upon titration with CT-DNA. 
The raw titration data for [(CO)3MeCNReQtpy]+ is shown in Figure 5.20. 
0.8 
0.7 
0.6 
w 
v 0.5 C 
0.4 16. 
0 
N 0.3 
0.2 
0.1 
0.0 
200 250 300 350 400 450 
Wavelength (nm) 
500 550 600 650 
Figure 5.20: - Raw binding data for the titration of [(CO)3MeCNReQtpyt 
with CT-DNA 
The UV-Visible spectrum shows hypochromicity in all of the transitions 
upon titration of CT-DNA. The raw data for the other two rhenium(l) 
complexes can be found on the supplementary data CD. 
Manipulation of the spectral shifts produces saturation binding curves for 
all three of the rhenium(I) extended terpyridine complexes (Figure 5.21). 
[(CO)3MeCNReQtpy]+ and [(CO)3MeCNReP-terpy]+ show well defined 
curves reaching saturation between 5-10 base pairs per drug. The 
binding of [(CO)3MeCNReTpt]+ to CT-DNA produces a significantly 
different binding curve, which is more linear in nature. Saturation is not 
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achieved until a ratio of about 20-25 base pairs per drug is reached. 
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Figure 5.21: - Binding curves obtained by UV-Visible titrations for the 
rhenium(l) extended terpyridine complexes binding to CT 
DNA, 25mmol Na CI, 5mmol Tris-HCI, pH 7.0,25 cC. 
The binding parameters were again determined from non-linear least- 
squares fits of the Mcghee-von Hippel model to the non-linear binding 
isotherms obtained from Scatchard plots (Figure 5.22). The data are 
summarised in Table 5.4. 
Table 5.4: - Spectroscopic binding data for the rhenium 4'-extended 
terpyridine complexes binding to CT-DNA, 25mmol Na Cl, 
5mmol Tris, pH 7.0 
Complex UV-Visible 
KS %hyp 
(mol-1 dm') (bp) 
[(CO)3MeCNReTpt]''a 1.34x1 OS 12.19 17.8 
[(CO)3MeCNReQtpy]+'° 2.97x105 2.04 64.8 
[(CO)3MeCNReP-terpy]+4' 4.32x105 2.24 79.2 
a titration performed in 5% methanolic buffer 
167 
Chapter 5 DNA binding studies 
50+5 
46+5 
3e"5 
Y 
2s. 5 
10.5 
0 
" [(CO)3MeCNReTpt)' 
- ((CO)3MeCNReTpQ' 15000 
" [(CO)3MeCNReQtpyr 
- [(CO)3MaCNReOtpy)' 
f [(CO)3MeCNReP4*rpyt 
CNR ' CO M P t 10000 erpy) .... (( )3 e e - 
5000 
\ 0 
0 
0 
0.04 005 005 0.07 
r 
00 0.1 0.2 03 0.4 06 06 
f 
Figure 5.22: - Scatchard plots with Mcghee-von Hippel best fits obtained 
by UV-Visible titrations for the Tpm ruthenium complexes 
binding to CT DNA, 25mmol NaCl, 5mmol Tris-HCI, pH 7.0, 
25 cC. 
The Mcghee-von Hippel best fits show immediately that 
[(CO)3MeCNReTpt]+ is interacting with the DNA in a different manner to 
[(CO)3MeCNReQtpy]+ and [(CO)3MeCNReP-terpy]+, which show all the 
hallmarks of a classical intercalative interaction with DNA. The 
magnitude of the intrinsic binding constants (2.97x105 and 4.32x105 mol' 
'dm3, respectively for [(CO)3MeCNReQtpy]+ and [(CO)3MeCNReP- 
terpy]+) are typical of those expected for intercalation as are the site sizes 
(2.04 and 2.24 for [(CO)3MeCNReQtpy]` and [(CO)3MeCNReP-terpy]+ 
respectively)9. In contrast, the site size determined for 
[(CO)3MeCNReTpt]+ is 12.19 base pairs which is extremely large for a 
small molecule binding to DNA, especially is intercalation is the 
suspected mode of interaction. The binding constant is 1.34x105, which is 
comparable to the other two complexes. The percentage hypochromicity 
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when fully bound is also small (17.75%) compared to 64.8 % for 
[(CO)3MeCNReQtpy]+ and 79.2% for [(CO)3MeCNReP-terpy]+. All the 
evidence points to a non-intercalative mode of interaction for 
[(CO)3MeCNReTpt]+ with CT DNA, except for the high binding constant. 
The preference of [(CO)3MeCNReTpt]+ for a small number of very specific 
tight binding sites could explain the abnormal binding parameters 
associated with complex. Further studies need to be undertaken before 
this hypothesis can be confirmed. 
5.5.4 DNA binding studies on the TerpyRu2+ extended 
terpyridine complexes 
All five of the achiral terpyRu2+ extended terpyridine complexes showed 
hypochromic shifts in their UV-Visible spectrum upon titration with CT- 
DNA. 
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Figure 5.23: - Raw binding data from the titration of [TerpyRuQtpyf with 
CT-DNA 
Figure 5.23 shows the raw data from the titration of [TerpyRuQtpy]2+ with 
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CT-DNA. Hypochromicity is seen in both the high energy ligand centred 
bands (<320nm) and the MLCT band. This is not the case for all of the 
extended terpyridine complexes as [TerpyRuTpymt]2+ and [TerpyRuTpt]2+ 
show no hypochromic shifts in the MLCT band, with only the higher 
energy ligand centred band showing any significant hypochromicity. 
Figure 5.24 shows the raw binding data for [TerpyRuTpymt]2+ interacting 
with CT-DNA. 
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Figure 5.24: - Raw binding data for the titration of [TerpyRuTpymt]2+ with 
CT-DNA 
The saturation binding curves obtained from the titrations are shown in 
Figure 5.25. The curves obtained for [TerpyRuTpymt]2+, [TerpyRuTpt]2+, 
[TerpyRuQtpy]2+ and [TerpyRuP-terpy]2+ are all quite similar. The binding 
curve obtained for [TerpyRuTpp]2+ is notably different to the others, which 
can be expected due to the different geometry of the Tpp ligand. 
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Figure 5.25: - Binding curves obtained by UV-Visible titrations for the 
Terpy Ru extended terpy complexes binding to CT DNA, 
25mmol Na CI, 5mmol Tris-HCI, pH 7.0,25 c. 
The binding parameters were determined by non-linear least-squares fits 
of the Mcghee-von Hippel model to non-linear Scatchard plots of the 
binding data (Figure 5.26 and Figure 5.27). The binding data are 
summarised in Table 5.5. 
Table 5.5: - Spectroscopic binding data for the TerpyRu2+ extended 
terpyridine complexes binding to CT-DNA, 25mmol Na CI, 
5mmol Tris, pH 7.0 
Complex UV-Visible 
K 
(mol" M)- 
S 
( 
%hyp 
[TerpyRuTpymt]2+'' 8.14x10° 8.43 19.8 
[TerpyRuTpt]Z+ 8.28x104 9.79 15.9 
[TerpyRuQtpy]2+ 7.63x10° 12.67 48.4 
[TerpyRuP-terpy]2+ 6.38x104 10.96 49.4 
[TerpyRuTpp]2+' a 1.28x105 20.71 31.5 
a titration performed in 5% methanolic buffer 
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Figure 5.26: - Scatchard plots with Mcghee-von Hippel best fits obtained 
by UV-Visible titrations for the Terpy ruthenium tetrazine 
complexes binding to CT DNA, 25mmol Na CI, 5mmol Tris- 
HCI, pH 7.0,25 cC. 
Analysis of the binding parameters and the Scatchard plots reveals three 
distinct types of interaction with the CT-DNA. The % hypochromicity seen 
in the UV-Visible spectrum of [TerpyRuTpymt]2+ and [TerpyRuTpt]2 is 
less than half of that seen for [TerpyRuQtpy]2+ and [TerpyRuP-terpy]+ 
(19.77% and 15.93% compared to 48.36% and 49.37%, respectively). 
The binding site size is also slightly smaller for [TerpyRuTpymt]2+ and 
[TerpyRuTpt]2+ than it is for [TerpyRuQtpy]2+ and [TerpyRuP-terpy]+. This 
suggests that the triazines interact in a slightly different mode to the 
terpyridines. The binding constants for all four of the extended terpyridine 
type complexes are similar but there is a definite trend to a higher binding 
affinity with increased nitrogens. 
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Figure 5.27: - Scatchard plots with Mcghee-von Hippel best fits obtained 
by UV-Visible titrations for the Terpy ruthenium terpyridine 
complexes binding to CT DNA, 25mmol Na CI, 5mmol Tris- 
HCI, pH 7.0,25 CC. 
From Figure 5.26 it is clear that [TerpyRuTpp]2+ interacts with CT-DNA in 
a very different mode than the other complexes. The binding site size is 
over twice as big as for the other complexes and it also has the greatest 
binding affinity (1.28x105 mof'dm3). Again this is probably due to the 
extra aromatic ring present in Tpp and not the other ligands. 
5.5.5 DNA binding studies on the (phen)2Ru2+ extended 
terpyridine complexes 
All four of the (phen)2Ru2+ extended terpyridine complexes showed both 
hypochromic shifts in their UV-Spectra and increased emission in their 
luminescence spectra upon binding to CT-DNA. The raw binding data 
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from the titration of [(phen)2RuP-terpy]2+ with CT-DNA is shown in Figure 
5.28. 
1 
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Figure 5.28: - Raw data from the titration of [(phen)2RuP-terpyf with CT- 
DNA 
Again all of the (phen)2Ru2+ complexes show little or no hypochromicity in 
the low energy MLCT bands. They do however show pronounced 
hypochromicity in the higher energy ligand centred transitions. The % 
hypochromicity observed in [(phen)2RuTpt]2+ is about half of that shown in 
the other complexes. This again is an indication of a different interaction 
of the triazine and terpyridine complexes with CT-DNA. 
The emission titration raw data for the titration of [(phen)2RuP-terpy]2+ 
with CT-DNA is shown in Figure 5.29. 
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Figure 5.29: - Raw binding data from the luminescence titration of 
[[(phen)2RuP-terpyf with CT-DNA 
The (phen)2Ru2+ complexes with the extended terpyridine ligands cannot 
be described as molecular light switches for DNA, as they show 
considerable luminescence without any DNA present. They do, however, 
show an increased emission when bound to CT-DNA. 
The binding data for both the UV-Visible and luminescence titrations are 
summarised in Table 5.6. The data were once again obtained from non- 
linear least-squares fits of the Mcghee-von Hippel model to non-linear 
Scatchard plots of the binding data. Figure 5.30 shows the Scatchard 
plots for the UV-Visible binding data and Figure 5.31 shows the 
Scatchard plots for the luminescence binding data. 
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Figure 5.30: - Scatchard plots with Mcghee-von Hippel best fits obtained 
by UV-Visible titrations for the (phen)2Ru2+ extended 
terpyridine complexes binding to CT DNA, 25mmol Na CI, 
5mmol Tris-HCI, pH 7.0,25 C. 
Table 5.6: - Spectroscopic binding data for the (phen)2Ru2+ extended 
terpyridine complexes binding to CT-DNA, 25mmol NaCl, 
5mmol Tris, pH 7.0 
Complex UV-Visible Luminescence 
KS %hyp K S 1/l0 
--- - 
(mol'' dT)_ (bp) 
-Jmof' 
dm) (bp) 
[(phen)2RuTpt]2+' ° 5.24x104 11.8 31.9 1.30x105 7.77 6.4 
[(phen)2RuQtpy]2f 9.94x104 10.63 57.7 1.97x105 7.24 17.9 
[(phen)2RuP-terpy]2+ 1.25x105 11.38 57.7 2.17x105 6.99 18.2 
[(phen)2RuTpp]2+'a 7.54x105 11.19 28.2 8.73x104 3.83 16.5 
a titration performed in 5% methanolic buffer 
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Figure 5.31: - Scatchard plots with Mcghee-von Hippel best fits obtained 
by luminescence titrations for the (phen)2Ru2+ extended 
terpyridine complexes binding to CT DNA, 25mmol NaCl, 
5mmol Tris-HCI, pH 7.0,25 CC. 
Analysis of the binding parameters for the (phen)2Ru2+ extended 
terpyridine complexes with CT-DNA shows that they all bind moderately 
well to CT-DNA. The association constants for the complexes increase 
as the number of nitrogens in the extended terpyridine ligand decreases. 
[(phen)2RuTpt]2+ has an intrinsic binding constant of 5.24x104 mol-' dm3, 
whilst [(phen)2RuP-terpy]2+ has an intrinsic binding constant of 1.25x105 
mol-' dm3. This shows a 2.3x increase in affinity. [(phen)2RuTpp]2+ has 
an intrinsic binding constant of 7.54x104 mol-' dm3 which is between 
[(phen)2RuTpt]2+ and [(phen)2RuQtpy]2+. The binding site size is between 
9 and 11 for all four of the complexes. This value is quite high for the 
classical intercalation of relatively small monometallic complexes to CT- 
DNA. This suggests that the mode of interaction is not classical 
intercalation but more likely some kind of groove binding association, or 
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possible a combination of the two. 
The luminescence data, however, paint a slightly different picture. The 
values of the binding constants for all three complexes [(phen)2RuTpt]2+, 
[(phen)2RuQtpy]2+ and [(phen)2RuP-terpy]2+ are larger that determined 
from UV-Visible studies but the same trend is observed, P-terpy > Qtpy > 
Tpt. There is a 1.7x increase in binding affinity of [(phen)2RuP-terpy]2+ 
over [(phen)2RuTpt]2+. The binding site sizes are around 7 base pairs for 
all three complexes, which is slightly smaller than observed in the UV- 
Visible titrations. 
The intrinsic binding constants obtained for [(phen)2RuTpp] 2+ when 
titrated with CT-DNA are similar for both the UV-Visible and luminescence 
titrations (7.54x104 and 8.73x104 mol-' dm3, respectively). The site size 
however, is much smaller 3.83 base pairs compared to 11.19 base pairs 
obtained from UV-Visible titrations. The nature of the Scatchard plot for 
[(phen)2RuTpp]2+ compared to the other (phen)2Ru2+ also shows that a 
very different mode of interaction with [(phen)2RuTpp]2+ and CT-DNA. 
The site size and magnitude of the binding constant are consistent with 
those observed in this study and others for classical intercalation. It is, 
however, impossible to determine the exact nature of the interactions 
from these simple spectroscopic assays alone. 
5.6 Conclusions and future work 
In this study a number of novel metallo DNA binding agents have been 
synthesised and their DNA binding studies reported. This study is one of 
the few examples where achiral metal complexes have been assayed 
alongside chiral complexes. It is clear from this study that chirality forms 
a minor role in determining how well these complexes bind to DNA. 
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Other factors such steric bulk, charge and the nature of the intercalating 
domain dominate the ability of these complexes to bind to the DNA helix. 
In particular the mono- and bimetallic ruthenium and rhenium complexes 
of dppz show great potential for further development as DNA binding 
agents. The complex [TpmPyRudppz]2+ has been shown to have a 
strong preference for GC rich sequences of DNA over AT rich sequences. 
This is in contrast to the related complex [(phen)2Rudppz]2+ which shows 
a preference for AT rich sequences. Along with the contrast in binding 
affinity, trends of the terpyRu extended terpy and (phen)2Ru extended 
terpy this show that very minor changes in structure of the complex can 
have a profound effect on its DNA binding characteristics. 
There is no better example of this than the two sets of bimetallic systems. 
Previous studies show that joining two binding agents together increases 
their affinity for DNA, due to cooperativity by several orders of 
magnitude5961. In this case the length of the linkers were not optimised to 
afford bis-intercalation so no significant cooperative effects were 
observed. In the future molecular modelling studies would serve to 
determine the optimum linker length. 
The difference in binding affinity between [TpmClRudppz]2' and 
[TpmPyRudppz]2+ has highlighted how important electrostatic 
contributions are to the overall affinity of the complexes for DNA. Further 
tuning of the charge by incorporating rhodium(Ill) or iridium(Ill) could 
enable the binding properties to be modulated even further. 
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Experimental techniques and 
synthetic procedures 
6.1 Chemicals 
All chemicals were purchased from commercial sources and were used 
as supplied unless otherwise stated. 
6.2 Solvents 
Solvents were obtained from commercial sources and were dried and 
purified using standard literature methods131. 
6.3 Reaction conditions 
Unless otherwise stated all reactions were carried out under an oxygen 
free nitrogen atmosphere. 
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6.4 Chromatography 
Alumina column chromatography was carried out on either grade I or 
grade 11 with acetonitrile / toluene solvent systems. 
Silica chromatography was carried out with acetonitrile / water / KN03 
solvent systems. 
Size exclusion chromatography was carried out on Sephadex LH-20 resin 
with acetonitrile / toluene solvent systems. 
Ion exchange chromatography was carried out on Sephadex CM-C25 
cation exchange resin with a 5: 3 water / acetone solvent system 
containing varying amounts of NaCl. 
All column sizes were approx. 15cm x 3cm unless otherwise stated 
except the LH-20 column which was 1mx1 cm. 
6.5 Nuclear magnetic resonance spectra 
Standard 'H NMR spectra were recorded on a Brucker AM250 machine, 
working in Fourier transform mode. 
More complex 1H NMR experiments including COSY experiments were 
perfomed by Sue Bradshaw in the NMR service within the department. 
The spectra were recorded on a Brucker AMX2400 machine. 
The following abbreviations are used in the annotation of 11-1 spectra. 
br- broad, s- singlet, d- doublet, dd- double doublet, dt- double triplet, t- 
triplet, q- quartet and m- multiplet. 
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6.6 Mass spectra 
FAB mass spectra were obtained on a Kratos MS80 machine working in 
positive ion mode, with a m-nitrobenzyl alcohol matrix 
6.7 Electrochemistry studies 
Cyclic voltammograms were recorded using an EG&G model 362 
potentiostat and either the condecon 310 hardware/software package or 
the EG&G electrochemistry power suite software package. 
Measurements were made using approx. 2mmol solutions of material 
made up in freshly distilled acetonitrile that contained O. 1 M Bu4NPF6 as 
the support electrolyte. 
Potentials were measured against a Ag/AgCI reference electrode and 
ferrocene was used as an internal reference. 
All CV's were software corrected for internal resistance 
6.8 UV-Visible absorption spectra 
General UV-Visible spectra were recorded on a Unicam UV2 
spectrometer in twin beam mode. Spectra were recorded in matched 
quartz cells (Helmer) and were baseline corrected. 
UV-Titrations were performed on a Varian-Carey bio-3 UV-Visible 
spectrometer connected to a Viglen PC running Carey Win UV software. 
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The spectrometer was operating in twin beam mode and the spectra were 
baseline corrected. 
6.9 Emission spectra 
Emission spectra were recorded on a Hitachi F4500 spectrophotometer 
operating in luminescence wavelength scan mode. The photomultipler 
tube was set to a potential of 700V, the excitation and emission slit widths 
were both 10nm, the scan speed was 240nms"1 and the response time 
was set to 0.05s. 
6.10 Isothermal Titration Calorimetry 
ITC was performed using a Microcal VP-ITC micro-calorimater connected 
to a Gateway 200 PC. Microcal Origin was used to analyse the data. 
6.11 Synthetic procedures 
6.11.1 Preparation of 2-cyanopyrimidine (2.1)94 
N 
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DABCO (1.9g, 17mmol) and NaCN (11.07g, 0.178mol) were added to 
freshly distilled DMSO at 35°C and allowed to stir for 1 hour. To the 
resulting suspension 2-chloropyrimidine (20g, 0.175mol) was added in 
three portions at 15 minute intervals. The mixture was allowed to stir at 
40°C for 4h after which it was treated with water (150ml) and allowed to 
cool to room temperature. The resulting dark red solution was then 
extracted with diethylether (6x100ml), with the combined organics being 
further washed with water (50ml). The solution dried (MgSO4) and the 
ether was removed under vacuum to give 17.5g (96.38%) of a waxy white 
solid. 1H NMR (CDCI3): SH = 7.62 (t, J= 5.6Hz, 1H), 8.89 (d, J= 9Hz, 2H). 
-MS; m/z (%): 105 (75) [M+]. 
6.11.2 Preparation of tris(2'-pyrimidine)-2,4,6-triazine 
(2.2)93 
2-Cyanopyrimidine (10g, 98.01 mmol) was heated under a N2 atmosphere 
to 1500C for 3 days in a dry round-bottomed flask. After cooling, the 
black solid was crushed and treated with diethylether (50ml) to remove 
any starting material. The solid was dissolved in 6M HCI and filtered to 
remove a fine black solid. The hydrochloride salt was precipitated by 
addition of acetone (1I) and collected on a sinter. The salt was taken up 
into water (10ml) and deprotonated by addition of concentrated ammonia 
solution, upon which the free base precipitated and was collected and 
dried giving 4.45g (43.24%) of 2.2. Fine cream solid. 1H NMR (DCI/D20): 
8H = 6.48 (t, J= 5 Hz, 3H), 7.57 (d, J= 9Hz, 6H). -MS; m/z (%): 316 (70) 
[M+]. 
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6.11.3 Preparation of 0-(dimethylamino)-2-pyridyl-ketone 
(2.3)132 
I 
We 
N 
O 
A solution of 2-acetylpyridine (20g, 0.165mol) and N-N-di- 
methylformamide-di-methylacetal (24g, 0.201 mol) were heated to reflux 
with stirring in toluene (100mi). Methanol was gradually distilled off over 
24 hours using a Dean Stark trap. The yellow solution was then cooled 
and toluene was removed under vacuum leaving a yellow oil, which 
crystallised upon addition of cyclohexane (50 ml) and overnight cooling. 
The pale yellow crystals were collected by filtration and air-dried, 16.5g 
(56.82%). Mp 125-127°C (lit mp 125-127°C). -1H NMR (CDCI3): 8H = 3.06 
(br d, 6H), 6.45 (d, 1 H), 7.24-7.44 (m, 1 H), 7.78 (dt, 1 H), 7.90 (d, 1 H), 
8.15 (d, 1 H), 8.59 (dd, 1 H). 
6.11.4 Preparation of 2,2': 6', 2" terpyridine (2.4)132 
N Nzý 
CN 
N 
Potassium tertiary butoxide (3.25g, 28.7mmol) was added to a stirred 
solution of 2-acetylpyridine (1.73g, 14.3mmol) in THE (80ml). After two 
hours ß-(dimethylamino)-2-pyridyl-ketone (2.53g, 14.4mmol) was added 
to the lilac solution and stirred for 18 hours. The deep red solution was 
then treated with ammonium acetate (10.8g, 140mmol) in acetic acid 
(200ml) and the mixture was refluxed for 2.5 hours. The solution was 
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coiled and the solvent removed under vacuum leaving a thick black oil 
which was taken up into water (80ml) and made alkaline by the addition 
of sodium carbonate. The aqueous solution was extracted with 
dichloromethane (3x50ml) with the combined organic extracts being dried 
over MgSO4 and evaporated to dryness. The resulting black tar was 
taken up in toluene and filtered through celite to remove a fine black solid. 
The mother liquor was concentrated and passed through a short grade II 
alumina chromatography column (3x3cm) with 1: 1 hexane DCM as the 
elluent. The solvent was removed under vacuum and the tan oil was 
recrystallised from ethanol giving tan crystals, 1.75g (52.5%), which were 
collected, and air-dried. Mp 84-86°C (lit mp 84-86°C). -1H NMR (CDCI3): 
SH = 7.29 (dd, 2H), 7.81 (td, 2H), 7.91 (t, 1H), 8.45 (d, 2H), 8.62 (d, 2H), 
8.69 (dm, 2H). 
6.11.5 Preparation of 4'-phenyl-2,2': 6,2"-terpyridine (2.5)95 
2-Acetylpyridine (25cm3,0.33mol) was added dropwise to a stirred 
solution emulsion of benzaldehyde (11.5cm3,0.11 mol) in EtOH (100cm3) 
and NaOH(aq) (150cm3,1.5M). The mixture was stirred for 24hr at room 
temperature, after which the white precipitate was collected by filtration, 
and washed with EtOH. The white solid was refluxed in EtOH with 
ammonium acetate (40g) for a further three hours then cooled to 0°C. 
The resulting precipitate was collected and washed with boiling water 
(100ml) and EtOH (100ml) then recrystalised from 10% DMF in EtOH. 
The white crystals were dried in vacuo to give 25.4g (74%) of 2.5.1H 
NMR (CDCI3): SH = 7.34 (tm, 2H), 7.43-7.55 (m, 3H), 7.83-7.74 (m, 4H), 
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8.66 (dd, 2H), 7.7-7.77 (m, 4H). 
6.11.6 Preparation of 2,2': 4,4": 6,2"-quaterpyridine (2.6)96 
To a stirring solution of 2-pyridinecarboxaldehyde (0.1047mmol) in MeOH 
(40cm) cooled to -15°C, 2-acetylpyridine in 20cm3 MeOH and 20% 
NaOH(aq) (40cm) were added simultaneously dropwise over 20 mins. 
The mixture was stirred for 3hr at -15°C, then slowly warmed to room 
temperature and filtered. The filtrate solution was refluxed with 
ammonium acetate (40g) for 4 hr. The resulting precipitate was collected 
and washed with boiling water (100cm3) and hot EtOH (100cm3). The 
crude product was recrystalised from 15%DMF in EtOH and dried in 
vacuo. Mass = 9.46g (69%) white solid. Mp 214-215°C (lit mp 216- 
218°C). -1H NMR (CDCI3): SH = 7.36 (td, 2H), 7.77 (dd, 2H), 7.86 (td, 2H), 
8.64 (dd, 2H), 8.73 (m, 4H). 
6.11.7 Preparation of 2,3,5,6-tetrakis-(2-pyridyl)pyrazine 
(2.7)97 
\I pj I\ 
/N N/ 
Pyridoin (20g) and ammonium acetate (90g) were heated 180°C for 2 
hours with stirring. The green melt containing yellow crystals was allowed 
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to cool to room temperature and the solid was filtered off. The pale 
yellow product was washed with ETOH (100cm3) and dried in vacuo. 
Mass = 5.68g (27.5%). Mp 280-283°C (lit mp 284C). -1H NMR (CDC13): 8H 
= 7.24 (dd, 4H), 7.77 (td, 4H), 8.04 (d, 4H), 8.37 (dd, 4H). 
6.11.8 Preparation of TerpyRuCI3.3 H2O (2.8) 
Ruthenium(III) trichloride tri-hydrate (522mg, 2.52mmol) and terpyridine 
(466mg, 2mmol) were refluxed for 3 hours in ethanol (250cm3). The 
solution was cooled to 4°C for 18 hours then filtered leaving a dark green 
solid which was washed with ice-cold ethanol (2x25cm3) and diethylether 
(2x25 cm3) and air-dried, 685mg (78%). MS; m/z (%): 406 (90) [M+- Cl] 
6.11.9 Preparation of [TerpyRuTpt][PF6]2 (2.9)98 
[PFek 
TerpyRyC13.3H20 (110mg, 0.25mmol) and Tpt (2eq, 160mg, 0.50mmol) 
were refluxed for 24 hours in 1: 1 EtOH/H20 (25cm) . After cooling to 0°C 
the purple solution was filtered, concentrated and the crude product was 
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precipitated by adding NH4PF6. The crude product was collected and 
chromatographed on grade II alumina using 1: 1 toluene/MeCN as the 
eluent. The fractions containing the product were concentrated and Et2O 
was added to precipitate the product which was collected by filtration and 
dried in vacuo. Mass = 134mg (57%) purple solid. 1H NMR (d3- MeCN): 
8H = 7.13 (dd, 2H), 7.45 (m, 4H), 7.61 (dd, 2H), 7.77 (dd, 1 H), 7.94 (td, 
2H), 8.13 (td, 2H), 8.24 (td, 1H), 8.49-8.54 (m 4H), 8.8 (d, 2H), 9.04-9.16 
(m, 4H) -MS; m/z (%): 791 (35) [M+-[PF6]], 646 (80) [M+-2[PF6]]. 
6.11.10 Preparation of [TerpyRuP-terpy][PF6]2 (2.10)85 
-] 
[PFb 
TerpyRuC13.3H20 (100mg, 0.23mmol) and P-terpy (71 mg, 0.23mmol) 
were added to methanol (30cm3) with stirring and brought to reflux. After 
10 minutes 5 drops on N-methylmorpholine was added and the solution 
was refluxed for a further hour. The purple solution was then cooled and 
filtered, and reduced to 5cm3. Aqueous NH4PF6 was added to induce 
precipitation of a purple solid which was chromatographed on silica eluted 
with 7: 1: 1, acetonitrile: water: KNO3(sat). The fractions containing the 
product were combined and reduced in volume to 5ml, and treated with 
NH4PF6 to precipitate the product. The precipitate was collected by 
filtration, washed with water (2x 20cm3), diethylether (2x 20cm3) and then 
dried in vacuo. Mass = 108mg (50%) purple solid. 1H NMR (d3- MeCN): 
8H = 7.16 (m, 4H), 7.34 (dd, 2H), 7.43 (dd, 2H), 7.64-7.73 (m, 3H), 7.92 
(m, 4H), 8.18 (dd, 2H), 8.39 (t, IH), 8.48 (dd 2H), 8.63 (dd, 2H), 8.74 (d, 
2H), 9.01 (s, 2H). -MS; m/z (%): 789 (53) [M+-[PF6]], 644 (100) [M+- 
2[PFg]]. 
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6.11.11 Preparation of [TerpyRuTpp][PF6]2 (2.11)99 
-7 
JPFs 2 
TerpyRuCI3.3H20 (152mg, 0.345mmol) and Tpp (3eq, 413mg, 1.06mmol) 
were refluxed in 2: 1 EtOH/H20 (30cm3) with triethylamine (1.5cm3) with 
stirring for 5 hrs. The purple solution was cooled and filtered, and 
reduced to 5 ml. Aqueous NH4PF6 was added resulting in the 
precipitation of the crude product as a purple solid. The crude product 
was chromatographed on grade II alumina using 1: 1 MeCN/toluene as 
the eluent. The main purple fraction was reduced in volume and adding 
Et2O precipitated the product. The product was collected by filtration, 
washed with water (2x 20cm) , 
diethylether (2x 20cm3) and dried in 
vacuo. Mass = 143mg (61.4%) purple solid. 1H NMR (d3- MeCN): SH = 
7.29 (m, 2H), 7.37 (m, 2H), 7.63-7.88 (m, 8H), 7.98 (dd, 11-1), 8.11 (dd, 
2H), 8.80 (td, 2H), 8.48 (dd, 2H), 8.66 (t 2H), 8.76 (m, 2H), 8.87 (d, 2H), 
9.16 (d, 2H). -MS; m/z (%): 869 (80) [M+-[PF6]], 723 (100) [M+-2[PF6]]. 
6.11.12 Preparation of [TerpyRuQtpy][PF6]2 (2.12) 
[PF b 
TerpyRuCI3.3H20 (220mg, 0.50mmol) and Qtpy (2eq, 310mg, 1.0mmol) 
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were heated to 180°C with stirring in freshly distilled ethylene glycol 
(15cm) for 2 hours. The cooled purple solution was diluted with water 
(20ml) and filtered to remove a fine black precipitate. The solution was 
the treated with NH4PF6 (3eq), which resulted in the precipitation of a 
purple solid, which was collected on a sinter, washed with water (2 x 
20cm) and diethylether (2 x 20cm3) and air dried. The crude product 
was dissolved in acetonitrile (2cm3) and chromatographed on silica eluted 
with 7: 1: 1, acetonitrile: water: KNO3(sat). The main purple band containing 
the product was reduced in volume to 5cm3, and treated with NH4PF6 to 
precipitate the product. The precipitate filtered, washed with water (2x 
20cm3), diethylether (2x 20cm3) and dried in vacuo. Mass = 240mg 
(51.3%) purple solid. 1H NMR (d3- MeCN): SH = 7.10-7.25 (m, 4H), 7.38 
(dd, 2H), 7.43 (dd, 2H), 7.88-8.03 (m, 4H), 8.41 (dd, 2H), 8.51 (dm, 2H), 
8.67 (m, 2H), 8.75 (dd 2H), 9.02 (m, 3H), 9.08 (d, 2H). -MS; m/z (%): 791 
(80) [M+-[PF6]], 646 (100) [M+-2[PF6]]. Anal. Calcd. for C35H25N7RuPFe 
(M+ -[PF6]): 790.0858. Found: 790.0792. 
6.11.13 Preparation of [TerpyRuTpymt][PF6]2 (2.13) 
(PFJ2 
NJ 
ýfN 
TerpyRuC13.3H20 (200mg, 0.45mmol) and Tpymt (3eq, 429mg, 
1.362mmol) were heated to 180°C in freshly distilled ethylene glycol 
(20cm) for 1 hour. The purple solution was diluted with water (20cm) 
and filtered to remove unreacted ligand. NH4PF6 was added in excess 
until precipitation of a purple solid was complete, which was collected by 
filtration and washed with ice-cold water (2x20cm3) and air-dried. The 
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crude product was taken up in the minimum amount of 5: 3 water: acetone 
and loaded onto a Sephadex CM-C25 ion exchange chromatography 
column and eluted with 0.05M NaCl in 5: 3 water: acetone to remove a 
brown impurity which was discarded. The desired product was eluted as 
a purple band with O. 1 M NaCl in the solvent, and was recovered by 
reducing the volume of eluent and precipitation with NH4PF6 and filtration. 
The product was washed with ice-cold water (2x2Ocm3) and dried in 
vacuo. Mass = 209mg (49.46%) purple solid. X-Ray quality crystals were 
grown from nitromethane / diethylether solvent diffusion. 'H NMR (d3- 
McNO2): SH = 7.15 (td, 2H), 7.42 (dd, 2H), 7.54 (dd, 2H), 7.88 (t, 1H), 8.00 
(td, 2H), 8.17 (dd, 2H), 8.60 (d, 2H), 8.64 (t, 1H), 8.91 (d, 2H), 9.14 (dd, 
2H), 9.31 (d, 2H). -MS; m/z (%): 795 (30) [M+-[PF6]], 325 (100) [M2+- 
2[PF6]]. Anal. Calcd. for C30H2ON12RuPF6 (M+ -[PF6]): 795.0619. Found: 
795.0590. 
6.11.14 Preparation of (phen)2RuCI2.2H20 (2.14) 
Ruthenium(Ill) chloride trihydrate (10g, 38.2mmol), 1,10 phenanthroline 
(13.84g, 76.9mmol) and LiCI (11g) were dissolved in anhydrous sure seal 
DMF (60cm3) and refluxed for 8 hours. The purple solution was then 
cooled and poured into stirred acetone (200cm3) and cooled to 4°C for 18 
hours. The dark solid was collected by filtration and washed with water 
(3x25cm3) and diethylether (3x25cm3) then dried in vacuo. Mass= 14.5g, 
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(66.8%) brown-green solid. MS; m/z (%): 532 (45) [M+], 497 (80) [M+ - 
Cl]. 
6.11.15 Preparation of [(phen)2RuTpt][PF6]2 (2.15) 
7 (PFS 
(phen)2RuCI2.2H20 (300mg, 0.53mmol) and Tpt (2eq, 1.06mmol, 329mg) 
were suspended McOH (40cm3) and purged with nitrogen for 10 minutes. 
The suspension was then brought to reflux for 10 hours after which the 
cooled solution was concentrated and loaded onto a silica 
chromatography column. The product was eluted with 7: 1: 0.5 
acetonitrile/ water/ KNO3(sat), with the desired product being collected as 
the first main red band. The fractions containing the product were 
concentrated and addition of NH4PF6 afforded precipitation of the product 
as its hexafluorophosphate salt, which was collected, washed with iced 
water (2.25 ml) and dried in vacuo. Mass=109mg (19.35%) red solid. 
1H 
NMR (d6- acetone): 8H = 6.94 (dd, 1H), 7.18 (m, 2H), 7.37 (td, 1H), 7.50 
(dd, 1 H), 7.59 (dd, 1 H), 7.66 (td, 1 H), 7.73 (td, 1 H), 7.85 (dd, 1 H), 7.96 
(m, 2H), 8.06-8.25(m, 4H), 8.33-8.51 (m, 6H), 8.69 (dd, 1 H), 8.77 (dd, 1H), 
8.84 (dd, 1 H), 8.91 (dd, 1 H), 8.96 (dd, 1 H), 9.42 (dd, 1 H), 9.94 (dd, 1 H) - 
MS; m/z (%): 919 (40) [M+-[PF6]], 774 (40) [M2+-2[PF6]]. Anal. Calcd. for 
C42H28N1ORuPF6 (M+ -[PF6]): 919.1184. Found: 915.1129 
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6.11.16 Preparation of [(phen)2RuQtpy][PF6]2 (2.16) 
1IPFJ2 
(2.16) was prepared in an analogous way to (2.15) with 
(phen)2RuCI2.2H20 (150mg, 0.264mmol) and Qtpy (2eq, 166mg, 
0.528mmol). Mass = 88mg (31.4%) red solid. 1H NMR (d6- acetone): 8H 
= 7.27 (td, 1 H), 7.44 (dd, 1 H), 7.74 (dd, 1 H), 7.81 (dd, 1 H), 7.92-8.06 (m, 
4H), 8.23 (m, 4H), 7.36-8.55 (m, 7H), 8.22 (dd, 1H), 8.29 (dd, 1H), 
8.32(dd, 2H), 8.36 (m, 4H), 9.02 (dd, 1 H), 9.23 (s, 2H), 9.39 (dd, 11-1). - 
MS; m/z (%): 916 (25) [M+-[PF6]], 772 (40) [M2+-2[PF6]]. Anal. Calcd. for 
C44H32N8RuPF6 (M+ -[PF6]): 919.1435. Found: 915.1478. 
6.11.17 Preparation of [(phen)2RuP-terpy][PF6]2 (2.17) 
[PF4 
(2.17) was prepared in an analogous way to (2.15) with (phen)2RuCI2 . 
2H20 (300mg, 0.53mmol) and P-terpy (163mg, 0.53mmol. Mass= 
210mg (37.4%) orange solid. X-ray quality crystals were grown from 
Et2O/acetone vapour diffusion. 1H NMR (d3- MeCN): 8H = 6.79 (td, 1H), 
6.80 (m, 2H), 6.99 (dd, 1H), 7.21 (td, 1H), 7.32 (m, 2H), 7.46 (dd, 1H), 
7.57 (m, 2H), 7.76 (dd, 1H), 7.80 (dd, 1H), 7.94 (m, 3H), 8.01-8.34 (m, 
8H), 8.41 (dd, 1 H), 8.58 (dd, 1H), 8.71 (dd, 1H), 8.74 (dd, 1H), 8.79 (d, 
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1 H), 8.87 (d, 2H). -MS; m/z (%): 771 (15) [M2 -2[PF6]], 591 (30) (M+- 
phen-2[PF6]). Anal. Calcd. for C45H31N7RuPF6 (M+ -[PF6]): 916.1326. 
Found: 916.1348. 
6.11.18 Preparation of [(phen)2RuTpp][PF6]2 (2.18) 
-7 
LPFai 
(2.18) was prepared in an analogous way to (2.15) with 
(phen)2RuCI2.2H20 (300mg, 0.53mmol) and P-terpy (2eq, 403mg, 
1.04mmol). Mass= 110mg (18.3%) orange solid. X-ray quality crystals 
were grown from Et20/acetone vapour diffusion. 1H NMR (d6- acetone): 
8H = 6.73 (br, 1 H), 6.92 (br, 1 H), 7.17 (m, 1 H), 7.22 (td, 1 H), 7.51 (dd, 
1H), 7.57-7.91 (m, 9H), 8.04 (dd, 1H), 8.12 (m, 2H), 8.18-8.48 (m, 10H), 
8.64 (dd, 1H), 8.75-8.84 (m, 2H), 8.98 (dd, 1H), 9.16 (br, 11-1). -MS; m/z 
(%): 850 (60) [M2+-2[PF6]], 670 (80) (M+-phen-2[PF6]). Anal. Calcd. for 
C48H32N1oRuPF6 (M+ -[PF6]): 995.1497. Found: 995.1511. 
6.11.19 Preparation of (CO)3CIReTpt (2.19) 
OC,. I 
N 
-N. ý OC-Re N, 
Nýý`Ný 
0 ý0ý 
Tpt (3eq, 646mg, 2.08mmol) was added to a refluxing solution of 
(CO)5ReCI (250mg, 0.69mmol) in toluene ( 100cm3). The mixture was 
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refluxed under N2 for 4 hours and then cooled. The resulting precipitate 
was collected by filtration and was stirred in DCM (50cm3) for 10 min to 
remove any unreacted ligand. The orange solid was filters and washed 
with DCM (2x20cm3) and Et2O (2x20cm3) and dried in vacuo. Mass = 
225mg (92%) orange solid. -MS; m/z (%): 618 (35) [M+]], 590 (75) (M+- 
CO), 582 (75) (M+-CI), 562 (30) (M+-2CO), 555 (80) (M+-CO-CI). Anal. 
Calcd. for C21H13CIN6O3Re (MH+): 619.0295. Found: 619.0295. 
6.11.20 Preparation of (CO)3CIReQtpy (2.20) 
OC". 
-? OC=Re N, N 
N 
Co 
(2.20) was prepared in an analogous way to (2.19) using Qtpy (3eq, 
646mg, 2.08mmol) and (CO)5ReCl (250mg, 0.69mmol). Mass = 230mg 
(92%) yellow solid. 1H NMR (d6- DMSO): 5H = 7.63 (td, 1H), 7.79 (t, 1H), 
7.90 (dd, 1 H), 8.07 (t, 1 H), 8.28-8.52 (m, 4H), 8.79 (d, 1 H), 8.96 (m, 2H), 
9.11 (m, 2H), 9.27 (s, 1H). -MS; m/z (%): 617 (100) [M+], 589 (15) (M+- 
CO). Anal. Calcd. for C23H15CIN4O3Re (MH+): 617.0390. Found: 
617.0382. 
6.11.21 Preparation of (CO)3CIReP-terpy (2.21) 
t 
OC ". 
N 
OC=Re N 
I "- CO 
(2.21) was prepared in an analogous way to (2.19) using P-terpy (256mg, 
0.83mmol) and (CO)5ReCI (300mg, 0.83mmol). Mass= 480mg (94.1%) 
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yellow solid. 1H NMR (d8- DMSO): 8H = 7.63 (m, 3H), 7.78 (t, 1H), 7.92 
(dd, 1 H), 8.06 (t, 1 H), 8.21 (m, 3H), 8.49 (td, 1 H), 8.81 (dd, 1 H), 9.12 (m, 
3H). -MS; m/z (%): 615 (30) [M+], 587 (80) (M+-CO) 879 (100) [M+-CI], 
552 (30) [M+ -CO-CI]. Anal. Calcd. for C24H16CIN3O3Re (MH+): 616.0438. 
Found: 616.0441. 
6.11.22 Preparation of (CO)3CIReTpp (2.22) 
050 xN% 
OC, NN 
OC Ru N\ N 
lo 
_N 
(2.22) was prepared in an analogous way to (2.19) using P-terpy (3rq, 
960mg, 2.49mmol) and (CO)5ReCI (300mg, 0.83mmol). Mass= 345mg 
(59.9%) yellow solid. -MS; m/z (%): 694 (5) [M+], 666 (10) (M+-CO) 638 
(10) [M+-2CO], 610 (15) [M+ -3CO]. Anal. Calcd. for C27H17CIN6O3Re 
(MH+): 695.0608. Found: 695.0601. 
6.11.23 Preparation of [(CO)3MeCNReTpt][CF3SO3] (2.23) 
ý(CF3SOJ 
(CO)3CIReTpt (230mg, 0.37mmol) and AgCF3S 03 (96mg, 0.37mmol) 
were refluxed for 10 hours in freshly distilled acetonitrile. After cooling the 
green solution, the solvent was removed. The green solid was taken up 
into DCM (10cm3) and filtered through Celite to remove the insoluble 
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AgCl. The mother liquor was reduced to 1 cm3 then added to cold 
pentane (100cm3), which resulted in precipitation of the product, which 
was filtered and dried in vacuo. Mass = 193mg (67%) green solid. 1H 
NMR (d3- McNO2): 6H = 2.14 (s, 3H), 7.8 (m, 2H), 8.06 (td, 1 H), 8.19 (m, 
1H), 8.30 (d, 1H), 8.98 (m, 4H), 9.25 (m, 2H). -MS; m/z (%): 624 (10) 
[M+-CF3SO3], 583 (60) [M+-CF3SO3-MeCN] 555 (30) [M+-CF3SO3-MeCN- 
CO], 532 (10) [M+-CF3SO3-MeCN-2CO]. Anal. Calcd. for C23H15N7O3Re 
(M+-CF3SO3): 624.0794. Found: 624.0810. 
6.11.24 Preparation of [(CO)3MeCNReQtpy][CF3SO3] (2.24) 
111 
7 ICF3SO3I 
OC N 
N 
N OC iu 
`N N. 
CO 
(2.24) was prepared in an analogous way to (2.23) using (CO)3CIReQtpy 
(150mg, 0.242mmol) and AgCF3SO3 (63mg, 0.242mmol) Mass = 135mg 
(72%) pale yellow solid. 1H NMR (d6- acetone): 8H = 2.09 (s, 3H), 7.64 (m, 
3H), 7.78 (td, 1H), 7.89 (td, 1H), 8.05-8.28 (m, 3H), 8.41 (t, 1H), 8.52 (td, 
11-1), 8.90 (d, 1H), 9.11-9.34 (m, 3H). -MS; m/z (%): 582 (40) [M+- 
CF3SO3-MeCN] 554 (50) [M+-CF3SO3-MeCN-CO], 525 (30) [M+-CF3SO3- 
MeCN-2CO]. Anal. Calcd. for C25H19N5O3Re (M+-CF3SO3): 624.1046. 
Found: 624.1051. 
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6.11.25 Preparation of [(CO)3MeCNReP-terpy][CF3SO3] 
(2.25) 
III ICF3SO3] 
oC N 
N 
OC RuN 
`N= 
CO 
(2.25) was prepared in an analogous way to (2.23) using (CO)3CIReP- 
terpy (150mg, 0.242mmol) and AgCF3S 03 (63mg, 0.242mmol) Mass = 
135mg (72%) pale yellow solid. 1H NMR (d6- acetone): 8H = 2.09 (s, 3H), 
7.32 (dd, 1H), 7.63 (m, 3H), 7.76 (td, 1H), 7.96 (t, 1H), 8.11-8.24 (m, 3H), 
8.42 (dd, 1H), 8.51 (td, 1H), 8.91 (dd, 1H), 9.1-9.35 (m, 3H). -MS; m/z 
(%): 702 (30) [M+-MeCN-CO], 674 (100) [M+-MeCN-CO], 552 (80) [M+- 
CF3SO3-MeCN-2CO]. Anal. Calcd. for C26H18N4O3Re (M+-CF3SO3): 
621.0937. Found: 621.0947. 
6.11.26 Preparation of 1,10 phenanthroline-5,6-dione 
(3.1)27 
0 
ý1ýý. 
1,10-phenanthroline (5g, 27.8mmol) was dissolved in small portions into 
concentrated sulfuric acid (30cm3). Sodium bromide (2.5g) and nitric acid 
(15cm3) were then carefully added and the mixture was refluxed for 40 
minutes. The condenser was then removed and the mixture was allowed 
to simmer until all of the bromine had vented off. The golden solution 
was cooled and poured over ice (400g) and neutralised to pH 7.0 by 
addition of 10M NaOH. The mixture was filtered and the solid was 
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extracted into boiling water. when cool all the aqueous layers were 
combined and extracted with DCM (5 x 100cm3). The combined organic 
layers were washed with water (50cm3) and dried with MgSO4. The 
solvent was removed and the yellow product was recrystalised from 
water/methanol. Mass = 2.4g (41.1%) yellow solid. 1H NMR (CDCI3): SH = 
7.56 (dd, 2H), 8.47 (dd, 2H), 9.07 (dd, 2H). -MS; m/z (%): 211 (100) 
[MH+]" 
6.11.27 Preparation of dipyrido[3,2-a: 2', 3'-c]phenazine 
(3.2) 
i\ NNI\\\ 
Ný 
Ný \% 
1,10 phenanthroline-5,6-dione (500mg, 2.38mmol) and o-phenylene- 
diamine (257mg, 2.38mg) were refluxed in EtOH (150cm3) for 20 minutes. 
Upon cooling at 4°C for 18 hours a yellow solid formed in the dark 
solution, which was collected by filtration. The solid was recrystalised 
from 1: 1 water/EtOH. Mass = 640mg (95.1%) yellow fluffy solid. 1H NMR 
(d6-DMSO): 6H = 7.93 (dd, 2H), 8.06 (dd, 2H), 8.37 (dd, 2H), 9.21 (dd, 
2H), 9.49 (dd, 2H). -MS; m/z (%): 282 (100) [M+]. 
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6.11.28 Preparation of TpmRuCI3 (3.4)hh' 
H 
Ný 
N 
Ný 
N\ ". 
N R; CI 
I 
CI - 
Cl 
Tris(1-pyrazoyl)methane (1g, 4.67mmol) and RuCI3.3H20 (1.22g, 
4.67mmol) were refluxed in ethanol (500cm3) for 3 hours. After cooling 
the dark precipitate was filtered and washed with cold ethanol (2x20cm3) 
and Et20 (2x20cm3) and dried in vacuo. Mass = 1.45g (73.8%) brown 
solid. -MS; m/z (%): 386 (20) [M+-CI]. 
6.11.29 Preparation of [TpmRuCidppz][PF6] (3.5) 
H7 [PFa 
- 
I 
1 
NRu; 
CI -N 
TpmRuC13 (500mg, 1.19mmol), dppz (1.1 eq, 371 mg , 1.31 mmol) and LiCI 
(400mg) were heated to reflux in 3: 1 ethanol: H20 (100cm3) for 10mins. 
12 drops of triethylamine were added and refluxing continued for 3 hours. 
After cooling, the solvent was removed and the black residue was 
dissolved in methanol (20ml) and a fine black solid was filtered out. The 
product was precipitated by addition of aqueous NH4PF6 and collected by 
filtration. The crude product was chromatographed on grade I alumina 
with 1: 1 acetonitrile. The deep purple band was collected and 
concentrated. Addition of Et20 precipitated the product as a purple solid. 
Mass = 440mg (48.8%) purple solid. 
1H NMR (d6- acetone): 8H = 6.30 (td, 
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1H), 6.87 (m, 3H), 8.06 (dd, 2H), 8.17 (dd, 2H), 8.42 (dd, 2H), 8.52 (dd, 
2H), 8.57 (m, 3H), 9.17 (dd, 2H), 9.57 (dd, 2H), 9.63 (s, 11-1). -MS; m/z 
(%): 633 (100) [M+-PF6], 597 (30) [M+-PF6-CI]. Anal. Calcd. for 
C28H2OCIN10Ru (M+-PF6): 633.0604. Found: 633.0612. 
6.11.30 Preparation of [TpmpyRudppz][PF6]2 (3.6) 
, PFJ2 
[TpmClRudppz][CI] (70mg, 0.90mmol) and AgNO3 (2.1eq, 1.89mmol, 
32mg) were refluxed in 1: 1 water/EtOH for 4 hours. Excess pyridine 
(1cm3) was added and the refluxing was continued for a further 4 hours. 
The cooled solution was then filtered through celite to remove AgCl. 
NH4PF6 was added to precipitate the product, which was collected by 
filtration and washed with water (2x20cm3) and Et20 (2x20cm3) then dried 
in vacuo. Mass = 68mg (78.1%) orange solid. 
1H NMR (d6- acetone): 5H = 
6.30 (dd, 1H), 6.93 (dd, 1H), 6.98 (m, 2H), 7.15 (dd, 2H), 7.76 (dd, 2H), 
7.80 (t, 1H), 8.21 (dd, 2H), 8.24 (dd, 2H), 8.52 (dd, 2H), 8.56 (m, 2H), 
8.58 (dd, 1H), 8.85 (dd, 2H), 9.42 (dd, 2H), 9.87 (dd, 2H), 9.93 (s, 11-1). - 
MS; m/z (%): 676 (50) [M+-2PF6], 752 (100) [M± Tpm], 598 (30) [M+-2PF6- 
Py]. Anal. Calcd. for C33H25N11RuPF6 (M+-PF6): 822.0910. Found: 
822.0902. 
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6.11.31 Preparation of [TpmMeCNRudppz][PF6]2 (3.7) 
[PFat 
[TpmClRudppz][PF6] (100mg, 0.128mmol) and AgCF3SO3 (1.1eq, 
0.141 mmol, 36mg) were refluxed in freshly distilled acetonitrile (50cm3) 
for 10 hours. After cooling the solvent was removed and the residue was 
taken up into methanol (20 ml) and filtered through celite to remove AgCI. 
The mother liquor was treated with aqueous NH4PF6 to induce the 
precipitation of the product, which was collected by filtration and dried in 
vacuo. Mass = 119mg (98%) red solid. 1H NMR (d6- acetone): SH = 2.29 
(s, 3H), 6.37 (dd, 1H), 6.95 (dd, 2H), 7.07 (dd, 1H), 8.22 (dd, 2H), 8.27 
(dd, 2H), 8.56 (t, 2H), 8.62 (dd, 1H), 8.80 (dd, 2H), 9.42 (dd, 2H), 9.86 
(dd, 2H), 9.87 (dd, 2H), 10.01 (s, 1H). -MS; m/z (%): 784 (100) [M'-PF6], 
638 (70) [M+-PF6], 597 (80) [M+-PF6-MeCN]. Anal. Calcd. for 
C33H25N,, RuPF6 (M+-PF6): 784.0823. Found: 784.0836. 
6.11.32 Preparation of 1,5-di(4-pyridyl)pentane (4.1)15 
N 
Q rJ 
N 
To 250cm3 of liquid ammonia cooled by a C02/acetone bath was added 
portion wise over a period of 30 mins 7g of potassium metal, followed by 
200mg Fe(N02)3.9H20. After 30 minutes stirring, the intense blue colour 
had been replaced by a grey suspension indicating the formation of 
potassium amide. 4-picoline (11.75g, 0.126mol) was added dropwise 
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over 30 minutes. After a further 30 minutes stirring 1,5-dibromopentane 
(12.75g, 0.063mol) in Et20 was added drop wise over 30 minutes. 
Stirring was continued for 3 hours at -78°C, then ammonium chloride 
(10g) was added and the cooling bath removed. After all the ammonia 
had evaporated, the residue was taken up in water (100cm3) and 
extracted with Et20. After drying with Na2CO3, the solvent was removed 
yielding a tan solid. Mass = 10.07g (70.7%) tan solid. 1H NMR (CDCI3): 
SH = 1.35 (t, 2H), 1.61 (m, 4H), 2.59 (t, 4H), 7.05 (d, 4H), 8.44 (d, 4H). 
6.11.33 Preparation of (CO)3CIRedppz (4.2)42 
CI 
OC 
OC Re N 
N N 
CO 
(CO)5ReCI (120mg, 0.425mmol) and dppz (0.425mmol, 154mg) were 
refluxed in toluene (50cm) for 6 hours. After cooling to room 
temperature, a yellow precipitate formed which was collected by filtration, 
washed with toluene (2x25cm3) and Et20 (2x25cm3) and dried in vacuo. 
Mass = 235mg (94%). -MS; m/z (%): 588 (15) [M+], 560 (90) [M`-CO], 
524 (100) [M+-CO-CI]. 
6.11.34 Preparation of [(CO)3MeCNRedppz][CF3SO3] (4.3)42 
(CF, SO, j 
OC,. 
N 
OC- i e- N 
NN 
CO 
(CO)3CIRedppz (360mg, 0.613mmol) and AgCF3SO3 (158mg, 
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0.613mmol) were suspended in freshly distilled MeCN (50cm3) which had 
been purged with N2 for 10 mins. The mixture was brought to reflux for 
10 hours and cooled. The solvent was removed and the residue was 
taken up in DCM, and filtered through celite to remove AgCl. The filtrate 
was added to 100 cm3 of cold pentane and the resulting precipitate was 
collected, washed with Et20 and dried in vacuo. Mass = 430mg (94.5%) 
yellow-green solid. 1H NMR (d3-McNO2): 8H = 2.16 (s, 3H), 8.14(dd, 2H), 
8.26 (dd, 2H), 8.45 (dd, 2H), 9.94 (dd, 2H). 
6.11.36 Preparation of [(CO)3PyRedppz][CF3SO3] (4.4)42 
7 [CFrSOJ 
(`ýJl 
ý e OC= i 
N 
CO 
[(CO)3MeCNRedppz][CF3SO3] (150mg, 0.202mmol) and an excess of 
pyridine (1cm) were refluxed in THE (50cm) for 4 hours. Upon cooling 
the solution was filtered, then added to cold pentane (200cm) . The 
resulting precipitate was collected and washed with Et20 (2x25cm3) and 
dried in vacuo. Mass = 125mg (79.3%) green solid. 1H NMR (d6- 
acetone): 8H = 7.42 (t, 2H), 7.92 (t, 1 H), 8.16 (dd, 2H), 8.37-8.56 (m, 4H), 
8.71 (dd, 2H), 9.98 (m, 4H). 
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6.11.37 Preparation of [{(CO)5Re}2dpe[2]][CF3SO3]2 (4.5) 
COCO [CF3SOJ2 
OC ýRe-N 
OC Cl 
N-i; CO 
Coco 
(CO)5ReCI (0.5g, 1.38mmol) and AgCF3SO3 (355mg, 1.38mmol) were 
dissolved in DCM (50cm3) and stirred at room temperature under N2 for 
18 hours. The solution was filtered through celite to remove AgCI, with 
the mother liquor being returned to the flask. 1,2-Di(4-pyridyl)ethane (1/2 
eq, 119mg, 0.65mmol) was added and the mixture was stirred in the dark 
under N2 for 4 days after which a white precipitate was removed by 
filtration, washed with DCM (2x20cm3) and dried in vacuo. Mass = 
390mg (71.7%) white solid. 1H NMR (d6-acetone): 8H = 3.25 (s, 4H), 7.74 
(d, 4H), 9.21 (d, 4H). -MS; m/z (%): 986 (40) [M+-CF3SO3], 837 (90) [M; - 
CF3SO3]. Anal. Calcd. for C23H12N2O13SF3Re2 (M+-CF3SO3): 986.9128. 
Found: 986.8452. 
6.11.38 Preparation of [{(CO)5Re}2dpp[3]][CF3SO312 (4.6) 
(CF3SO3J= 
OCO OC O 
OC 
i e-N -Re 
CO 
OC CO COCO 
(4.6) was prepared in an analogous way to (4.5) using (CO)SReCI (0.1g, 
2.76mmol) and AgCF3SO3 (709mg, 2.76mmol) and 1,3-di(4- 
pyridyl)propane (1/2 eq, 274mg, 1.38mmol). Mass = 1200mg (75.7%) 
white solid. 1H NMR (d6-acetone): 8H = 2.07 (m, 2H), 2.93 (t, 4H), 7.64 (d, 
4H), 9.17 (d 4H). -MS; m/z (%): 999 (50) [M+-CF3SO3], 850 (70) [M`- 
CF3SO3]. Anal. Calcd. for C24H14N2O13SF3Re2 (M+-CF3SO3): 1000.9284. 
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Found: 1000.9281. 
6.11.39 Preparation of [{(CO)5Re}2dpp[5]][CF3SO312 (4.7) 
-1 [CF3SW2 
oco oC o 
OC-ie-ND / 
OC Co COCO 
(4.7) was prepared in an analogous way to (4.5) using (CO)5ReCl (0.5g, 
1.38mmol) and AgCF3SO3 (355mg, 1.38mmol) and 1,5-di(4- 
pyridyl)pentane (1/2 eq, 156mg, 0.69mmol). Mass = 639mg (78.7%) 
white solid. 1H NMR (d6-acetone): 5H = 1.49 (m, 2H), 1.74 (m, 4H), 2.84 (t, 
4H), 7.62 (d 4H), 9.16 (d, 4H). -MS; m/z (%): 1028 (20) [M`-CF3SO3], 879 
(80) [M+-CF3SO3]. Anal. Calcd. for C26H18N2O13SF3Re2 (M''-CF3SO3): 
1028.9597. Found: 1028.9639. 
6.11.40 Preparation of [{(CO)3Redppz}2dpe[2]][CF3SO3]2 
(4.8) 
oc co 
[CF3S03]2 
`; - OC-Re-N OC CO 
N-W-CO 
N 
/\ /\ 
NN 
[{(CO)3Redppz}2dpe[2]][CF3SO3]2 (100mg, 0.120mmol) and dppz (2 eq, 
69mg, 0.240mmol) were dissolved in nitromethane (30cm3) and heated at 
70°C for 2 days with stirring. After cooling to solution was concentrated to 
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5ml and the product was precipitated by the addition of diethylether 
(100ml). The pale yellow solid was collected by filtration and was purified 
by column chromatography on Sephadex LH2O size exclusion resin (1 mx 
1 cm) with 2.5: 1 toluene/acetonitrile as the eluent. The fractions 
containing the product were combined and the solvent concentrated to 5 
ml, with addition of Et20 (100cm3) to precipitate the product, which was 
collected by filtration and dried in vacuo. 95mg (49.9%) yellow solid. 1H 
NMR (d6-DMSO): 6H = 2.63 (m, 4H), 7.17 (d, 4H), 8.17 (dd, 4H), 8.38 (m, 
4H), 8.41 (d, 4H), 8.50 (dd, 4H), 9.76 (dd 4H), 9.85 (dd, 4H). -MS; m/z 
(%): 1438 (20) [M+-CF3SO3], 1289 (25) [M+-2CF3SO31. Anal. Calcd. for 
C55H32N10O9SF3Re2 (M+-CF3SO3): 1439.1142. Found: 1439.1089. 
6.11.41 Preparation of [{(CO)3Redppz}2dpp[3]][CF3SO3]2 
(4.9) 
[CF3SO3I2 
oc - OC% co 
N -Pa-CO 
\N /\ 
(4.9) was prepared in an analogous way to (4.8) using 
[{(CO)3Redppz}2dpp[3]][CF3SO3]2 (600mg, 0.523mmol) and dppz (2.1 eq, 
295mg, 1.0450mmol). Mass = 240mg (49.9%) yellow solid. 1H NMR (de- 
acetone): SH = 1.55 (m, 2H), 2.39 (m, 4H), 7.13 (d, 4H), 8.10 (dd 4H), 8.23 
(m, 4H), 8.39 (dd, 4H), 8.46 (d, 4H), 9.71 (dd 4H), 9.88 (dd, 4H). -MS; 
m/z (%): 1452 (40) [M+-CF3SO3], 1303 (50) [M+-2CF3SO3]. Anal. Calcd. 
for C55H34N10O6PF6Re2 (as PF6 salt) (M+-PF6): 1449.1420. Found: 
1449.1403. 
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6.11.41 Preparation of [{(CO)3Redppz}2dpp[5]][CF3SO3]2 
(4.10) 
71 
ICF3S0312 
00 OC CO 
R Co 
/ 
IFF\JII 
/\/\'/\ 
(4.10) was prepared in an analogous way to (4.8) using 
[{(CO)3Redppz}2dpp[5]][CF3SO312 (500mg, 0.43mmol) and dppz (3 eq, 
360mg, 1.29mmol). Further purification was achieved by recrystalisations 
from 1: 1 H20/acetone. Mass = 40mg (49.9%) yellow solid. 1H NMR (d6- 
acetone): SH = 1.10 (m, 2H), 1.31 (m, 4H), 2.37 (m, 4H), 7.16 (d, 4H), 8.16 
(dd 4H), 8.40 (dd, 4H), 8.45 (dd, 4H), 8.47 (d, 4H), 9.91 (dd 4H), 9.97 (dd, 
4H). -MS; m/z (%): 1480 (15) [M+-CF3SO3], 1331 (20) [M+-2CF3SO3]. 
Anal. Calcd. for C58H38N10O9F3SRe2 (M+-CF3SO3): 1481.1611. Found: 
1481.1647. 
6.11.42 Preparation of [Tpmdpp[5]Rudppz]C12 (4.11) 
1CPFJ2 
[TpmCIRudppz]CI (450mg, 0.59mmol) and AgNO3 (2.1eq, 1.22mmol, 
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191 mg) were refluxed in 1: 1 EtOH/water (100cm3) for 3 hours. The 
solution was cooled and filtered through celite to remove AgCI. The 
filtrate was returned to the flask along with dpp[5] (10eq, 5.792mmol, 
1.31g) and the mixture was refluxed for 10 hours. After cooling, the 
solution was concentrated and NH4PF6 was added until the complex 
precipitated. After collection by filtration the crude product was dissolved 
in acetone (5cm) . Bu4NCl was added to precipitate the product as a 
dichloride salt which was collected by filtration and copiously washed with 
acetone to remove excess dpp[5]. The red solid was dried in vacuo. 
Mass = 454mg (66.6%). A small amount of the product was converted to 
its PF6 for analysis. 'H NMR (d6-acetone): 8H = 1.25 (m, 2H), 1.51 (m, 
2H), 1.59 (m, 2H), 2.54 (m, 2H), 2.59 (m, 2H), 6.30 (t, 1H), 6.92 (dd, 1H), 
6.98 (m, 4H), 7.23 (dd 2H), 7.61 (dd, 2H), 8.23 (m, 4H), 8.44 (dd, 2H), 
8.46 (dd, 2H), 8.58 (m, 4H), 8.85 (dd, 2H), 9.42 (dd, 2H), 9.89 (dd, 2H), 
9.91 (s, IH). -MS; m/z (%): 1114 (5) [M+], 969 (40) [M+-PF6], 824 (50) 
[M+-2PF6]. Anal. Calcd. for C43H38Nt2PF6Ru (M+-PF6): 1114.1670. Found: 
1114.1677. 
6.11.43 Preparation of [{TpmRudppz}2dpp[5]][PF6]4 (4.12) 
I 
(PF6J4 
Ný 
I 
Nm 
N 
N- CIN- 
Ru Ný /N 
N 
NI 
N 
N 
ýI 
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[TpmClRudppz]CI (100mg, 0.13mmol) and AgNO3 (2.05eq, 42mg, 
0.264mmol) were refluxed in 1: 1 EtOH/water (30cm3) for 3 hours. The 
cooled solution was filtered through celite to remove AgCI. The filtrate 
was added dropwise to a refluxing solution of [Tpmdpp[5]Rudppz]C12 
(0.257mmol, 230mg) in 1: 1 EtOH/water (30cm) . 
The solution was left to 
reflux for 3 days. The cooled solution was concentrated and 
chromatographed on Sephadex CM-C25 ion exchange resin. The 
product was the first band eluted from the column with 0.1 M NaCI in 5: 3 
water: acetone. The fractions containing the product were concentrated 
and the product was precipitated by addition of NH4PF6. The product was 
collected by centrifugation, washed with water, Et20 and dried in vacuo. 
Mass = 43mg (16.5%) red powder. 1H NMR (d6-acetone): SH = 1.19 (m, 
2H), 1.40 (m, 4H), 2.44 (t, 4H), 6.28 (t, 2H), 6.89 (dd, 2H), 6.93 (m, 8H), 
7.55 (dd 4H), 8.18 (dd, 4H), 8.24 (dd, 4H), 8.42 (dd, 4H), 8.57 (m, 6H), 
8.86 (dd, 4H), 9.37 (dd, 4H), 9.86 (dd, 4H), 10.10 (s, 2H). ). -MS; m/z 
(%): 1858 (10) [M+-PF6], 857 (50) [M2+-2PF6). Anal. Calcd. for 
C71 H58N22P3F18Ru2 (M+-PF6):. 1857.2227. Found: 1857.2277. 
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